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Abstract 
R. Joseph. Synthesis of Unusual Sterols from Marine Sources, 388 pages, 12 tables, 38 figures, 2017. 
The syntheses of some unusual marine sterols are reported. 24-Epiconicasterol, an epimer of the 
bioactive marine sponge sterol conicasterol, an epimer of the bioactive marine sponge sterol conicasterol 
was synthesized in 10 steps and a 13% overall yield from ergosterol. Similarly, the 24-epimer of the 
bioactive sponge sterol theonellasterol, 24-epitheonellasterol, was synthesized from stigmasterol. 
Pfiesterol, an unusual sterol isolated from the toxic dinoflagellate Pfiesteria piscicida and potential 
biomarker for the species, was synthesized from 16-dehydropregnolone acetate. 4-Methylcholestane-
3β,4β-diol, a synthetic pavlovol, was synthesized from cholestenone in a seven-step sequence and a 38% 
overall yield. The simple analogs of petrosterol, a bioactive sponge sterol and potential inhibitor of 
invertebrate sterol metabolism, were synthesized as a mixture from the i-methyl 22-iodide in a six-step 
sequence and a 43% overall yield. The structures of two novel highly alkylated cyclopropyl sterols from a 
tropical jewel orchid were elucidated by synthesis.  
Methods for sterol synthesis were developed. The use of a sealed reaction vessel shortened the 
reaction time for the Kirk-Petrow reaction by at least a day. 1-Dodecanethiol was successfully used 
instead of thiophenol to obtain an odorless product in good yield and with equivalent reactivity. A new 
method for the oxidation of allylic alcohols via thiyl radicals was developed. Phenyl disulfide and visible 
light were used to generate the thiyl radicals. This is the first account of the direct involvement of thiyl 
radicals in the oxidation of allylic alcohols. 
 This work provided synthetic methods for the aforementioned unusual marine sterols and 
analogs, which can be used as reference compounds and samples for biological studies. The consumption 
of unusual marine sterols may affect the growth and development ecologically important marine grazers 
like copepods. 
Keywords: Sterols, marine sterols, biomarkers, unusual sterols, marine sponges, harmful algae, 
dinoflagellates, phytosterols, pavlovols, conicasterol, organic, synthesis, bioactive sterols, sterol 
metabolism, thiyl radicals, allylic alcohols, selective oxidation. 
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Introduction 
 
Sterols are essential lipids present in all eukaryotic cells predominantly as membrane 
components. Their biosynthesis and function have been extensively studied.1 Outside of their role in 
regulating membrane fluidity and permeability, sterols are involved in interactions with other lipid and 
protein membranes and are precursors to bioactive compounds vital to cellular and developmental 
processes.2 However, the production of sterols is not restricted to eukaryotes. A few species of bacteria 
are known to synthesize their own sterols.1 Cholesterol (1), the major sterol of vertebrates, is structurally 
simple compared to sterols from plants, fungi, algae and bacteria.3 Because of their unique and unusual 
structures, many sterols have been used as biomarkers for marine and terrestrial organisms.4-6 Marine 
organisms are a major source of structurally diverse sterols and other bioactive compounds. Unusual 
marine sterols like 24-propylidenecholesterols (2) and brevesterol (3) have been proposed as biomarkers 
for algae and dinoflagellate species responsible for harmful algal blooms, respectively (Figure 1.1).7-10 
Other unusual marine sterols like petrosterol (4) and its natural oxygenated analogs were found to exhibit 
biological activities that include anticancer and antifouling.11-16 Other marine sterols were also found to 
exhibit antibacterial, antioxidant, anticancer, antidiabetic and anti-hypercholesterolemia properties.16  
 
HO
4
HO
1
HO HO
2 3   
Figure 1.1.  Cholesterol and some unusual marine sterols. 
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Marine sterols with unusual side chains are hypothesized to present in many species as chemical 
defense against predators.17 These sterols are thought to interfere with the invertebrate metabolism of 
phytosterols to cholesterol. Invertebrates are unable to biosynthesize cholesterol, which is a precursor to 
steroid hormones and is necessary for growth and reproduction.18 In this work, some unusual marine 
sterols and analogs were synthesized as part of an investigation to determine their effects on phytosterol 
metabolism, growth and reproduction in invertebrates. The biological studies, not this described this 
work, were performed with calanoid copepods (Acartia hudsonica, Eurytemora affinis, and Calanus 
finmarchicus), a model crustacean, Artemia salina by R. Patrick Hassett at Ohio University. Copepods are 
ecologically important; they are primary consumers of phytoplankton and play a key role in the cycling of 
elements in the oceans.19 The 24-epimers of two bioactive sponge sterols were also generated to confirm 
the stereochemical assignments of the natural products and also provide sample for biological studies. 
Two unusual highly substituted cyclopropane sterols from a tropical orchid were identified and 
characterized by synthesis. Methods for sterols synthesis were also developed.  
 
Conicasterol (5) and theonellasterol (6) are two unusual unsaturated marine sterols isolated as the 
primary components of the Red Sea sponges Theonella conica and Thenonella swinhoei, respectively 
(Figure 1.2).20 Both sterols and their natural analogs were found to be potent and highly selective agonists 
and antagonists of the orphan nuclear receptors Pregnane X receptor (PXR) and Farnesoid X Receptor 
(FXR).21 FXR, a bile acid nuclear receptor, has been considered a bile acid sensor that has evolved to 
maintain systemic bile acid homeostasis and protect liver and cells from potentially harmful cellular bile 
acid overload.22 PXR, a xenobiotic nuclear receptor, plays a vital role in the protection of gastrointestinal 
tract and liver tissues from xenobiotics and toxic bile acids.23  The 24-epimer of conicasterol, 24-
epiconicasterol (7),  was synthesized from ergosterol and characterized by NMR. This synthesis would 
allow the verification of the reported stereochemistry of the 24-methyl of conicasterol and provide 
samples for biological studies of the synthetic analogue. The C-24 epimer of theonellasterol, 24-
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epitheonellasterol (8), synthesized from stigmasterol, was also characterized by NMR and compared with 
the natural product. (Chapter 2). 
HO HO
HO
5
6
7 8
Conicasterol Theonellasterol
24-Epiconicasterol 24-Epitheonellasterol
22
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Figure 1.2. Conicasterol, theonellasterol and their C-24 epimers. 
 
 
Pfiesterol (9), a new sterol isolated from two strains of the toxic dinoflagellate Pfiesteria 
piscicida, was identified as a potential biomarker for that species.7c Pfiesteria has been linked to massive 
fish kills and human health isssues.24 A published analysis of the sterols in Pfiesteria piscicida did not 
report that compound.25 Pfiesterol was successfully synthesized from 16-dehydropregnenolone acetate 
(Figure 1.3). Pfiesterol was also synthesized with a 4-13C-methyl for metabolic studies in copepods 
(Chapter 3).  
HO
9  
Figure 1.3. Pfiesterol (9). 
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Pavlovols, 3β,4β-dihydroxy-4-methylsterols, are natural sterols that have been exclusively 
isolated in microalgae belonging to the genera Pavlova and Diacronema.26-29 Pavlovols in cultured 
Pavlova spp. behave as analogs of the natural hormone ecdysone in northern bay scallop (Argopecten 
irradians irradians) larvae.30 4-Methylcholestane-3β,4β-diol (10) was synthesized from cholestenone in a 
seven-step sequence with a 38% overall yield. Another method to 4-methylcholestane-3β,4β-diol from 4-
methylenecholestanol is also described. The synthetic pavlovol (10) was characterized by NMR and 
compared with natural pavlovols (Figure 1.4).26 The synthesis those pavlovols also provided a new 
substrate for biological studies on bay scallops (Chapter 4). 
 
HO
HHO
10RR R
R
A B
 
Figure 1.4. Natural pavlovols (A) and (B) and synthetic pavlovol (10). 
 
 
Many marine invertebrates like crustaceans are unable to biosynthesize sterols and depend on 
their diet as a source of exogeneous sterols like cholesterol.31,32 Like in insects, 24-alkyl phytosterols are 
converted to cholesterol in invertebrates via a well-known dealkylation process (Scheme 1.1).31,33 Like 
gorgosterol, petrosterol (4) is a potential inhibitor of invertebrate sterol metabolism. The 24-dealkylation 
process in both sterols would lead to a highly reactive cyclopropylcarbinyl cation capable of disabling the 
dealkylating enzyme (Scheme 1.2).34 Two simple analogs of petrosterol (4) were synthesized as a mixture 
for samples to study their potential use as inhibitors of invertebrate sterol metabolism. Some potential 
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metabolic products of the analogs 11, 24-cyclopropyl-24-methylenechol-5-en-3β-ol (12) and 24,25-
epoxy-24-cyclopropyl-24-homochol-5-en-3β-ol (13) were also synthesized (Chapter 5). 
 
O
OH
R R R
R
-2H Ox
OHR
H H
H-Shift +2H
 
 
Scheme 1.1. Phytosterol dealkylation mechanism in insects. 
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Scheme 1.2. Carbocation intermediates from the dealkylation of gorgosterol and petrosterol. 
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Figure 1.5. Petrosterol 4 and its analogs 11 and potential metabolic products 12 and 13. 
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Sterols with side chain cyclopropanes like petrosterol and gorgosterol (Figure 1.5) are unusual in 
plants. Sterols with cyclopropane-containing side chains have been predominantly observed in marine 
organisms like dinoflagellates and sea sponges33. Two novel cyclopropyl sterols (14 and 15), isolated in 
microgram quantities from a tropical jewel orchid, were synthesized and characterized by synthesis 
(Figure 1.6). To elucidate their stereochemical configurations, all stereoisomers of the candidate 
structures were synthesized and characterized by 800 MHz NMR. The determination of the 
stereochemistry of the side chain cyclopropanes was achieved through a series of correlations ultimately 
resting on (24R)-24-ethyl-24-methylcholestan-3β-ol, the structure of which ultimately rests on 
crystallography.35 These correlations included ones with isotopic labeling of prochiral groups (Chapter 6). 
 
HO HO14 15  
 
Figure 1.6. Unusual tropical jewel orchid sterols 14 and 15. 
 
 
In addition to synthesizing several unusual sterols, two methods for sterol synthesis were 
developed. The Kirk-Petrow reaction offers a facile and selective method to 4-methyl steroids from 3-
oxo-∆4-steroids via a 2-step method (Scheme 1.3).36-37Other reported methods to monomethylate 3-oxo-
∆4-steroids at C4 are described as awkward in practice and unselective.36,38 A few modifications of the 
Kirk-Petrow reaction are reported. The use of a sealed reaction vessel reduced the reaction time by at least 
a day with methanol as the solvent. The use of 1-dodecanethiol instead of thiophenol gave an odorless 
alkylthiomethylated product in good yield and with comparable reactivity to the typical Kirk-Petrow 
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reaction product. Cholest-1-en-3-one was used as a substrate for the Kirk-Petrow reaction to probe its 
mechanism (Chapter 7). 
O
Kirk-Petrow
O
SPh
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R
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Scheme 1.3. Possible 4-methyl sterols from the Kirk-Petrow reaction. 
 
 
A new method for the oxidation of allylic alcohols is also reported. A solution of phenyl disulfide 
in hexanes/EtOAc was found to oxidize allylic alcohols to their corresponding ketones and aldehydes 
under visible light. This new oxidation method is selective and works very well for 3-hydroxy-∆4-sterols 
(Scheme 1.4). This is the first account of the involvement of thiyl radicals in the oxidation of allylic 
alcohols. A few non-steroidal, low molecular-weight allylic and benzylic alcohols were also oxidized 
with the reaction in CDCl3 as a solvent (Chapter 8). 
 
1) Li/NH3
OHO
SPh
2) light16 17
 
Scheme 1.4. Desulfurization and oxidation of compound 16 to 17. 
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CHAPTER 2 
 
Synthesis and Characterization of 24-Epiconicasterol 
 
Abstract 
 
The synthesis and characterization of the 24-epimer of conicasterol from ergosterol is reported. 
The key step in this synthetic sequence involves the PtO2 catalyzed hydrogenation of (3β,5α,8α,22E)-
epidioxyergosta-6,22-dien-3-ol to (3β,5α)-ergost-8(14)-en-3,5-diol. In one step, this reaction reduces the 
side chain and ∆6 double bonds and sets the nuclear ∆8(14) through the reduction of endo-peroxide and 
subsequent elimination of the intermediate C8 hydroxyl. The synthesis was achieved in a 10-step 
sequence and a 13% overall yield. The spectral data for the 24-epimer of theonellasterol and 24-
desmethylconicasterol are also reported. This synthesis allowed the verification of the stereochemical 
assignments of the natural products and provided samples for the biological studies of the synthetic 24-
epimers as potential ligands of the nuclear receptors PXR and FXR.  
 
2.1 Introduction 
 
Conicasterol (1) and theonellasterol (2) are two unusual unsaturated marine sterols isolated as the 
primary components of the Red Sea sponges Theonella conica and Thenonella swinhoei, respectively. 
They were the first reported sterols to simultaneously contain the 4-methylene and ∆8(14) functionalities 
(Figure 2.1).1 The side chain stereochemistry for conicasterol and theonellasterol were elucidated via 1H 
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NMR  comparison with two known sterols with similar side chains.1 Several sterols derived from the 
oxidation of these sterols have been isolated.2 Conicasterol, theonellasterol and their natural analogs are 
potent and highly selective agonists and antagonists of the orphan nuclear receptors Pregnane X receptor 
(PXR) and Farnesoid X Receptor (FXR).3 FXR, a bile acid nuclear receptor, has been considered a bile 
acid sensor that has evolved to maintain systemic bile acid homeostasis and protect liver and cells from 
potentially harmful cellular bile acid overload.4 PXR, a xenobiotic nuclear receptor, plays a vital role in 
the protection of gastrointestinal tract and liver tissues from xenobiotics and toxic bile acids.5  It is also 
expressed at a lower level in the kidney and ovary tissues and its dysfunction is associated with immune 
disorders including primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and 
inflammatory bowel diseases (IBDs), ulcerative colitis and Crohn’s disease.6 The observed biological 
activities of these limited and not so readily accessible natural products make it important to synthesize 
analogs that may share their biological properties  and potential pharmacological interests.  
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Figure 2.1. Conicasterol, theonellasterol and their C-24 epimers. 
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Herein, the synthesis of the 24-epimer of conicasterol and its NMR spectral data are reported. 
This synthesis is important as it allows the verification of the reported stereo chemistry of the 24-methyl 
of conicasterol and provides samples for biological studies of the synthetic analogue. Spectral data for the 
C24 epimer of theonellasterol, 24R-theonellasterol (4), synthesized from stigmasterol (6) are also 
described. The 1H NMR spectrum of 24-desmethylconicasterol is also reported. 
 
2.2 Results and Discussion 
 
An original approach to the synthesis of 24-epiconicasterol from ergosterol is described in 
Scheme 2.1. The ∆7 was carried through the first of two steps the sequence before converting it into the 
desired ∆8(14) by catalytic hydrogenation.7 The desired product, 24-epiconicasterol (3), was obtained at the 
end of the sequence; however, this approach was considered ineffective because of the poor yield and 
many unidentified side products obtained from the hydrogenation/∆7isomerization step.   
Toluene
MIPK, Al(iPrO)3
OHO
1) NaOOH
HO
H2, PtO2
2) LAH
OH
HO
OH
1) PCC
2)
 
MsCl/TEA O
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BnBr BnO
1)BMS
2)NaOOH
3)PCC
BnO
O H
Ph3P=CH22)
1) NaOH/MeOH
BnO
H (Major)
Li/NH3, -78
 oC
HO
H
3
5 7 8
9 11 13
15 16c
(14)
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Scheme 2.1. Synthesis of 24-epiconicasterol from ergosterol. 
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A more efficient method was developed to synthesize 24-epiconicasterol (3) from ergosterol (5).   
The first four steps in Scheme 2.1 were replaced just with two steps to achieve the ∆8(14)-diol intermediate 
(8). A retrosynthetic analysis is displayed in Scheme 2.2. 
 
HO
H 3
BnO
O
H 16b
BnO 13b
O 11 HO OH 9c HO 5  
Scheme 2.2. Retrosynthetic analysis of 24-epiconicasterol (3). 
 
The synthesis of 24-epiconicasterol began with the dye-activated photooxygenation of ergosterol 
(5) to afford the endoperoxide 18 as the major product (Scheme 2.3).8 The PtO2/AcOH catalyzed 
hydrogenation of compound 18 gave the unsaturated diol 9c.9 The 3-OAc of compound 9c and (3β,5α)-
ergost-8(14)-en-3-ol (not displayed in the schemes) were also isolated as side products. (3β,5α)-Ergost-
8(14)-en-3-ol was likely obtained by the elimination of the 5α-OH in compound 9c followed by 
subsequent hydrogenation of the resulting double bond. The 3-OAc was easily converted to compound 9c 
via transesterification with methanolic NaOH. Compound 9c was then oxidized with PCC to the 
unsaturated keto-alcohol 10.10 The dienone 11 was generated in good yield upon treatment of intermediate 
10 with MsCl and Et3N.11 The treatment of compound 11 with LAH gave a hard to separate mixture of 
the dienol 12 with a 2.6 to 1 ratio favoring the desired isomer 12b. The dienol 12b was considered the 
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desired diastereomer as a hydroboration test with a similar benzylated substrate 3β-benzyloxy-cholest-4-
ene (21b) gave only one product (3β,4α,5α)-3-benzyloxy-cholesta-3,4-diol (22b) with the desired 
stereochemistry at positions 3 and 5 (Scheme 2.5). The dienol mixture was benzylated with benzyl 
bromide and the product 13 was converted to 14 via a hydroboration-oxidation reaction (Scheme 2.4). A 
modest 48% yield was observed for the hydroboration reaction as some more polar undesired side 
products were generated during the oxidation step of the reaction. Gentle heating during the oxidation 
step was found to help improve the reaction yield.  
 
HO
Methylene blue, hu           
DCM
69%
HO
         
H2, PtO2
EtOAc, AcOH, DCM
72%O
O
HO
PCC, DCM
92%
OH O
MsCl, Et3N      
DCM
83%
OH
O
LAH , Et2O
97%
HO
99%
BnCl, NaH     
THF
BnO
5 18
9c 10
11 12
13
2.6:1 b/a
a: 3a
b: 3b
a: 3a
b: 3b  
Scheme 2.3. Synthesis of intermediate 13 from ergosterol. 
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Since a separation via flash chromatography was still difficult on a large scale at that stage the 
mixture of 14 was oxidized with PCC in a high yield (95%) to afford 15 as a mixture with a 2.6 to 1 ratio 
that favored the desired diastereomer 14b. That product mixture was consistent with the ratio obtained 
from LAH reduction of the enone 11 and the isolated hydroboration products. The ketone mixture was 
then methylenated via a Wittig reaction to get a mixture of 4 products (16); compound 16c was the major  
and desired product. The different components of the mixture were identified by deprotecting a sample of 
the crude product mixture and matching each product with previously identified sterols in our lab. The 
yield and 1H NMR data of the products are listed in Table 2.1. The product ratio of the Wittig reaction 
suggests that an epimerization of the starting ketones occurred before methylenation took place. This was 
verified by treating the intermediates 15a and 15b individually with 5% methanolic NaOH and refluxing 
the mixture for 1 h. Ketone 15b appeared to be stable to those conditions or thermodynamically favored 
as no other products were recovered. However, ketone 15a gave a mixture of products that included 
intermediate 15b. Energy minimization calculations (MM2) with Chem3D12 of the ketones 15a and 15b 
revealed that the major product of the methylenation (16c) (79%) was generated from the higher-energy 
intermediate (15b), 56.2 kcal/mol, (Table 2.1). The lower-energy ketone 15a, 52.4 kcal/mol, was 
responsible for only 7% of methylenation products, compound 16b. The final ratio of the methylenation 
products was likely more dependent on the energy of their transition states rather than that of their 
corresponding starting ketones based on MM2 calculation data. 
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 Scheme 2.4. Synthesis of 24-epiconicasterol from intermediate 13. 
 
Table 2.1. Ergost-8(14)-en-3-benzyloxy-4-methylene products. 
Product % yield 4-Methylene 1H (ppm) Benzyl   1H (ppm) 
3α5α (16a) 6 4.934, 4.737 4.481 (d, J = 12.1 Hz), 4.281 (d, J= 12.1 Hz) 
3α5β (16b) 7 5.439, 5.002 4.657 (d, J = 12.2 Hz), 4.606 (d, J= 12.2 Hz) 
3β5α (16c) 79 5.217, 4.650 4.701 (d, J = 12.1 Hz), 4.569 (d, J= 12.1 Hz) 
3β5β (16d) 8 5.084 (2H) 4.487 (d, J = 12.2 Hz), 4.273 (d, J= 12.2 Hz) 
 
The Wittig reaction was also attempted with the ketones 15a and 15b with an ethoxymethyl 
protecting group instead of the benzyl group. No improvement in yield was observed and the stability of 
each starting ketone was relatively the same. A 7:1 (3α5β/3β5α) mixture of the ∆0-cholesterol analogs of 
ketone 11 generated from cholest-4-en-3-one (19), 3-benzyloxy-cholestan-4-one 24, was used as a model 
to test the methylation reaction (Scheme 2.5). Unlike ketone mixture 11, intermediates 23 easily and 
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cleanly epimerized to the desired ketone 23b when refluxed in methanolic NaOH. The methylenation of 
the ketone mixture 23 gave a similar mixture of the 4-methylene products observed with ketone 15. The 
same reaction with the pure ketone 23b also gave a mixture. However, an improved yield of the desired 
product 22 (87%) was obtained compared to the 79% yield observed with the ketone mixture. The Wittig 
reaction with the pure ketone suggested that some epimerization took place before formation of the Wittig 
products. 
 
To achieve the final product 17, the Wittig product mixture 16 was debenzylated in near 
quantitative yield with a dissolving metal reduction (Li/NH3)13 at -78 oC. The traditional dissolving metal 
reduction of the benzyl ether mixture 16 without the -78 oC bath gave some over-reduced side products by 
also reducing the 4-methylene. The four products were separated by HPLC and characterized by NMR. 
The isolation of compound 16c, the more polar and desired product, from the Wittig product mixture 
using preparative TLC also provided a pure sample of 24-epiconicasterol 3 after the -78 oC dissolving 
metal (Li/NH3) reduction of the benzyl ether. Compound 25 was also debenzylated via the method 
described above to afford 4-methylenecholesterol14 (26).  
 
The NMR data of 24-epiconicasterol (3) was compared to the conicasterol NMR data reported by 
Kho et al.1 The 1H NMR assignments for C26, C27 and C28 were in disaccord. Since C26 and C27 are 
interchangeable by HSQC, HMBC and COSY analyses, C28 was chosen as the focus of the comparison 
(Table 2.2). Campesterol (24R-24-methylcholesterol) and 22-dehydrobrassicasterol (24S-24-
methylcholesterol), two natural sterols with similar side chains, were used as models to compare the C28 
1H chemical shifts. The Δ value of the C28 1H chemical shifts of 22-dehydrobrassicasterol (0.787 ppm) 
and 3 (0.788 ppm) was only -1 ppb. A similar Δ value, -1 ppb, was observed by comparing the C28 1H 
chemical shift of campesterol (0.776 ppm) with the signal reported by Kho et al1 as C26 (0.777 ppm), 
most likely a missassignment. Their 1H NMR assignment for C28, 0.851 ppm (d, J = 7.0 Hz), matched 
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the signal that was assigned as C26/C27 0.854 ppm (d, J = 6.9 Hz) by HSQC-DEPT and HMBC. A Δ 
value of -11 ppb was observed when the C28 1H signals of conicasterol and 24-epiconicasterol were 
directly compared. The 13C NMR spectral data of compound 3 matched the nuclear carbon signals of the 
natural product within Δ values of -120 to 60 ppb (Table 2.3). Some of the reported carbons were also 
missassigned (C1, C6, C15 and C16). The side chain carbons had higher Δ values as expected ranging 
from -840 ppb (C25) and +260 ppb (C20). The direct comparison of the 13C NMR data of conicasterol1 
and 3 allowed an easy assignment of the sp2 carbons.  
O
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H
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Scheme 2.5. Synthesis of (3β,5α)-4-methylene-cholestan-3-ol from cholest-4-en-3-one.  
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Table 2.2. 1H NMR comparison of conicasterol 1 and its 24-epiner 3. a) Literature1 1H NMR chemical 
shifts in ppm. b) Measured 1H NMR chemical shifts in ppm. 
 
Compound C18 C19 C28 =CH2 =CH2 
1a 0.836 0.588 0.851 5.073 4.631 
3b 0.838 0.592 0.786 5.076 4.633 
∆ (ppb) -2 -4 +65 -3 -2 
 
The 1H and 13C NMR data of the 24–epimer of theonellasterol synthesized from stigmasterol via a 
similar method are reported in the experimental section. The 1H NMR data of theonellasterol and 24-
epitheonellasterol are compared in Table 2.4. The Δ values for the side chain 1H signals varied from -4 to 
+5 pbb. C29 was the only carbon with a positive Δ value, +5 ppb. A positive Δ value was also observed 
between the C28 1H signals of conicasterol and its 24-epimer. The 1H NMR data of 24R-24-
ethylcholesterol and 24S-24-ethylcholesterol were compared to make sense of the small differences in 
chemical shift (Δδ) observed between the side chain signals of theonellasterol and its 24-epimer. A +8 
ppb Δδ value was observed for the C29 methyl 1H NMR signals of the two 24-ethylcholesterol isomers. 
This small Δδ value was similar that observed between the C29 1H NMR signals of theonellasterol and its 
24-epimer. A more useful comparison was the Δδ between C29 and the most upfield methyl doublet 
(C26/C27) of the side chain isopropyl group. Using this comparison, a 32 ppb Δδ value was observed for 
both 24-epiconicasterol and 24R-24-ethylcholesterol, whereas Δδ values of 43 and 45 ppb were observed 
between the same the side chain 1H NMR signals for theonellasterol and 24S-24-ethylcholesterol, 
respectively. The similarity between these Δδ values between the two 24R and the two 24S sterols 
confirmed the stereochemical difference between the theonellasterol and its synthetic 24-epimer. The 1H 
NMR data for 24-desmethylconicasterol, a synthetic analogue of those marine sterols, is also reported in 
the experimental section. 
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Table 2.3. 13C NMR data for conicasterol and 24-epiconicasterol. Bolded carbon numbers are different 
from reported assignments1. */+ Assignments may be reversed. 
Conicasterol1 24-Epiconicasterol 
   Carbon # (ppm) Carbon # (ppm) ∆-value (ppb) 
1 34.55 20 34.81 
 
260 
 2 33.16 2 33.21 
 
50 
 3 73.37 3 73.40 
 
30 
 4 153.11 4 153.17 
 
60 
 +5 49.49 5 49.48 
 
-10 
 6 27.05 16 27.04 
 
-10 
 7 29.37 7 29.38 
 
10 
 8 125.69 8 125.69 
 
0 
 +9 49.28 9 49.27 
 
-10 
 10 40.00 10 40.01 
 
10 
 11 20.45 11 20.48 
 
30 
 *12 37.38 12 37.35 
 
-30 
 13 42.76 13 42.75 
 
-10 
 14 142.93 14 142.94 
 
10 
 15 24.68 6 24.68 
 
0 
 16 25.80 15 25.82 
 
20 
 17 56.90 17 56.78 
 
-120 
 18 18.22 18 18.20 
 
-20 
 19 13.20 19 13.20 
 
0 
 20 36.77 1 36.75 
 
-20 
 21 19.10 21 19.28 
 
180 
 22 33.55 22 33.56 
 
10 
 23 30.21 23 30.43 
 
220 
 24 38.95 24 39.13 
 
180 
 25 32.39 25 31.55 
 
-840 
 *26 20.21 26/27 20.44 
 
230 
 27 18.22 26/27 17.65 
 
-570 
 28 15.39 28 15.45 
 
60 
 29 102.82 29 102.77 
 
-50 
  
 
 
 
 
23 
 
 
Table 2.4. 1H NMR comparison of theonellasterol 2 and its 24-epimer 4. a) Literature1 1H NMR chemical 
shifts in ppm. b) Measured 1H NMR chemical shifts in ppm. 
 
Compound  C18 C19 C29 =CH2 =CH2 
2a 0.836 0.588 0.856 5.073 4.629 
4b 0.840 0.591 0.851 5.075 4.632 
∆ (ppb) -4 -3 +5 -2 -3 
 
 
2.3 Conclusions 
 
Ultimately, the synthesis of the 24-epiconicasterol was completed from ergosterol in a 10-step 
sequence and a 13% overall yield. The NMR data for 24-epiconiscasterol confirmed the reported 
stereochemistry at C24 (24R) for the natural product conicasterol. High ∆ values were observed between 
the side chain 13C NMR signals of conicasterol and 24-epiconicaterol and a +65 ppb difference was 
measured between their C28 1H signals. A +5 ppb ∆ value was also measured between the C29 1H signals 
of 24-epitheonellasterol and theonellasterol to also confirm the reported stereochemistry of the natural 
sterol. We were hesitant to confirm the stereochemistry of theonellasterol because of the relatively small 
Δδ value measured between its C29 1H NMR signal and that of its 24-epimer. However, comparing the 
larger Δδ values between C29 and the most upfield methyl doublet (C26/C27) 1H signals of the side chain 
isopropyl groups allowed correlations to be made between of theonellasterol and 24S-24-
ethhylcholesterol, and 24-epitheonellasterol and 24S-24-ethhylcholesterol that confirmed the 
stereochemical assignment by Kho et al1.  
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This synthesis also provided samples for biological studies. Natural analogs of both, conicasterol 
and theonellasterol have been identified as ligands to the FXR and PXR nuclear receptor.3 Bioactivity of 
the synthetic epimers would be of great significance as they could be an alternative source of ligands with 
pharmaceutical interests for the nuclear receptors PXR and FXR. 
 
2.4 Experimental  
 
General Procedures. NMR spectra were obtained in CDCl3 on a Bruker 600 MHz spectrometer (1H at 
600 MHz and 13C at 151 MHz). HPLC was performed using a Waters 6000A pump, Waters 410 
differential refractometer, and two Altex Ultrasphere ODS columns (5 µm, 10 x 250 mm) in series at a 
flow rate of 3 mL/min with MeOH.  Preparative TLC were done with Sorbent Technologies 
(SORBTECH) silica gel HL TLC plates (20 x 20 cm2, 250 µm thick with glass backed support). All 
solvents were from commercial sources. 
(3β,5α,8α,22E)-Epidioxyergosta-6,22-dien-3-ol (18). A solution of ergosterol (1.04 g, 2.62 mmol) and 
methylene blue (0.01 g) in 80 mL of CH2Cl2 was stirred in an open flask at 0 oC. The solution was 
irradiated with a 90 W tungsten lamp placed 15 cm away, at a 45-degree angle to the surface of the liquid. 
After 3.5 h, the mixture was filtered through silica gel and eluted with 1:1 hexanes/EtOAc. The crude 
product was purified by silica gel chromatography with 2:1-1:1 hexanes/EtOAc to give 0.77 g of 6 as a 
white solid (69% yield).  1H NMR  (600 MHz): 6.502 (1H, d, J =  8.5 Hz), 6.240 (1H, d, J =  8.5 Hz), 
5.223 (1H, dd, J =  7.7, 15.3 Hz), 5.147 (1H, dd, J =  8.4, 15.3 Hz ), 3.970 (1H, tt, J =  5.0, 11.5 Hz), 
2.109 (1H, ddd, J =  1.9, 5.0, 13.8 Hz), 1.693 (1H, dt, J =  3.5, 13.4 Hz), 0.999 (3H, d, J =  6.7 Hz), 
0.909 (3H, d, J =  6.9 Hz), 0.884 (3H, s), 0.834 (3H, d, J =  6.8 Hz), 0.817 (3H, d, J =  6.8 Hz),  0.817 
(3H, s). 
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(3β,5α)-Ergost-8(14)-ene-3,5-diol (9c). A solution of 18 (468.3 mg, 1.12 mmol) and PtO2 (141.2 mg) in 
10 mL of 4:2:1 EtOAc/acetic acid/dichloromethane was stirred at atmospheric pressure under a hydrogen 
atmosphere. The reaction was monitored by NMR until completion (5 days).  After filtration, the solvent 
was removed under reduced pressure and the product was purified by silica gel chromatography with 2:1 
hexanes/EtOAc to yield 737.4 mg of 7 as an off-white solid. and 16.5 mg of ergost-8(14)-en-3β-ol. An 
early fraction containing the 3-acetates of both compounds was deacetylated with 10% methanolic NAOH 
at reflux and purified by chromatography to give an additional 29.1 mg of 9c (72% total yield) and 16.5 
mg of ergost-8(14)-en-3β-ol. (3β,5α)-Ergost-8(14)-ene-3,5-diol: 1H NMR (600 MHz): 4.082 (1H, m), 
2.149 – 2.063 (1H, m), 1.996-1.929 (1H, m), 1.681-1.738 (1H, m), 0.935 (3H, d, J = 6.6 Hz), 0.875 (3H, 
s), 0.856 (3H, d, J = 6.8 Hz), 0.849 (3H, s), 0.786 (3H, d, J = 6.8 Hz), 0.783 (3H, d, J = 6.8 Hz). 13C 
NMR (151 MHz): 143.4, 125.1, 75.2, 67.2, 56.7, 44.2, 42.8, 41.2, 40.1, 39.1, 37.4, 34.9, 34.6, 33.5, 31.6, 
31.2, 30.7, 30.5, 27.0, 25.8, 24.2, 20.5, 20.1, 19.2, 18.3, 17.7, 17.4, 15.5. (3β)-Ergost-8(14)-en-3-ol: 1H 
NMR (600 MHz): 3.619(1H, m), 0.935 (3H, d, J = 6.7 Hz), 0.855 (3H, d, J = 6.8 Hz), 0.841 (3H, s), 
0.785 (3H, d, J = 6.9 Hz), 0.783 (3H, d, J = 6.9 Hz), 0.690 (3H, s).  
(5α)-Ergost-8(14)-en-5-hydroxy-3-one (10). A solution of 7 (268 mg, 0.64 mmol) and PCC (518.3 mg, 
2.4 mmol) in 10 mL of CH2Cl2 was stirred for 1 h. Hexanes (20 mL) was added to reaction and the 
resulting mixture was filtered through silica gel and eluted with 2:1 hexanes/EtOAc to yield 244.6 mg 
(92% yield) of desired product as white solid. 1H NMR (600 MHz): 2.696 (1H, d, J = 15.1 Hz), 2.151 
(1H, d, J = 15.4 Hz), 1.077 (3H, s), 0.946 (3H, d, J = 6.6 Hz), 0.885 (3H, s), 0.860 (3H, d, J = 6.8 Hz), 
0.789 (3H, d, J = 6.8 Hz). 13C NMR (151 MHz): 210.8, 143.9, 124.5, 77.8, 56.8, 52.0, 42.8, 41.3, 40.6, 
39.1, 38.1, 37.3, 34.8, 34.6, 33.6, 30.5, 31.6, 30.5, 27.0, 25.9, 24.4, 20.5, 20.1, 19.3, 18.4, 17.7, 16.7, 15.5. 
Ergosta-4,8(14)-dien-3-one (11). Triethylamine (2 mL) was added to a stirred solution of 10 (242.8 mg, 
0.61mmol) in 8 mL of anhydrous CH2Cl2 at 0 oC. After 10 min, 0.8 mL of MsCl in 1 mL of anhydrous 
CH2Cl2 was added dropwise and the resulting mixture was stirred at that temperature for 30 min. The 
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reaction was quenched with saturated sodium bicarbonate and extracted with 4:1 hexanes/EtOAc. The 
organic layer was dried over Na2SO4 and evaporated under reduced pressure. The crude product was 
purified via silica gel chromatography with 19:1 hexanes/EtOAc to yield 194.2 mg of an off-white solid 
(83%). 1H NMR (600 MHz): 5.756 (1H, br s), 2.525 (1H, ddd, J = 2.8, 5.9, 13.9 Hz), 2.061-1.984 (2H, 
m), 1.088 (3H, s), 0.949 (3H, d, J = 6.7 Hz), 0.902 (3H, s), 0.858 (3H, d, J = 6.9 Hz), 0.788 (3H, d, J = 
6.9Hz). 13C NMR (151 MHz): 199.6, 171.6, 144.9, 123.9, 123.3, 56.7, 47.4, 42.9, 40.0, 39.1, 37.3, 34.8, 
34.5, 34.1, 33.5, 32.6, 31.6, 30.4, 29.7, 27.0, 25.9, 20.5, 19.7, 19.2, 18.5, 18.3, 16.6, 15.5. 
Ergosta-4,8(14)-dien-3-ol (11). A solution of LAH (89.3 mg, 2.35 mmol) in 2 mL of anhydrous ether 
was added dropwise to a stirred mixture of 10 (194.2 mg, 0.490 mmol) in 4 mL of anhydrous ether. After 
30 min, the reaction was quenched by slow addition of 5 mL of brine. The resulting mixture was diluted 
with 10% hydrochloric acid until acidic and extracted with 4:1 hexanes/EtOAc. The organic layer was 
washed with saturated sodium bicarbonate, dried over Na2SO4, filtered through silica and evaporated 
under reduced pressure to give 189.3 mg (97%) of a 2.6:1 Ergosta-4,8(14)-dien-3β-ol (10b)/Ergosta-
4,8(14)-dien-3α-ol (10a) mixture. A sample of the product was separated via HPLC for NMR analysis of 
the two products. 11a 1H NMR  (600 MHz): 5.463 (1H, dd, J =  1.3, 4.3 Hz), 4.116 (1H, m), 2.448 (1H, 
ddd, J =  2.0, 5.6, 13.5 Hz), 2.056 (1H, ddd, J =  1.9, 5.5, 13.5 Hz), 1.970 (1H, dt, J =  3.5, 12.5 Hz), 
0.945 ( 3H, d, J =  6.6 Hz), 0.900 (3H, s), 0.876 (3H, s), 0.859 (3H, d, J =  6.8 Hz), 0.789 (3H, d, J =  6.8 
Hz), 0.787 (3H, d, J =  6.8 Hz). 11b 1H NMR (600 MHz): 5.330 (1H, br s), 4.189 (1H,  m), 2.45 (1H, 
ddd, J =  2.0, 5.5, 13.8 Hz), 2.047 (1H, ddd, J =  1.9, 5.5, 13.4 Hz), 0.965( 3H, s), 0.941 (3H, d, J =  6.7 
Hz), 0.871 (3H, s), 0.857 (3H, d, J =  6.9 Hz), 0.786 (3H, d, J =  6.8 Hz), 0.785 (3H, d, J =  6.8 Hz). 
3-Benzyloxy-ergosta-4,8(14)-diene (12). Benzyl bromide (70 µL, 0.6 mmol) was added to a solution of 
10 (162 mg, 0.4 mmol) dissolved in 5 mL of dry THF in a 25-mL flask equipped with a reflux condenser. 
NaH (102.1 mg), washed in hexanes, was transferred in 3 mL of anhydrous THF to the reaction mixture 
before heating the resulting solution at reflux under a N2 atmosphere. After 16 h, the reaction was cooled 
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to rt, filtered through silica gel and eluted with 4:1 hexanes/EtOAc. The crude product was evaporated 
under reduced pressure.  Flash chromatography using 79:1-39:1 hexanes/EtOAc gave (196.8 mg, 99%) of 
an inseparable 2.6/1 β/α mixture of 12 as a colourless oil.  1H NMR (600 MHz) (mixture): 5.487 (α) (1H, 
br d, J =  4.3 Hz), 5.436 (β) (2.6H, br s), 4.634-4.527(α/β) (3.6H , m), 3.977(β) (2.6H, m), 3.846(α) (1H, 
m), 0.974(β) (7.8H, s), 0.947(α) (3H, d, J =  6.4 Hz), 0.943(β) (7.8H, d, J =  6.6 Hz), 0.897(α) (3H, s), 
0.872(β) (7.8H, s), 0.861(β) (7.8H, d, J =  6.8 Hz), 0.790(β) (7.8H, d, J =  6.8 Hz). 
3-Benzyloxy-cholest-4-ene (21).  1H NMR (600 MHz) (21a): 5.455 (1H, m), 4.594 (1H, d, J = 12.2 Hz), 
4.519 (1H, d, J = 12.2 Hz), 3.771 (1H, m), 2.205 (1H, m), 0.977 (3H, s), 0.904 (3H, d, J = 6.6 Hz), 0.867 
(3H, d, J = 6.6 Hz), 0.863 (3H, d, J = 6.6 Hz), 0.680 (1H, s). 13C NMR (151 MHz): 150.6, 139.4, 128.3 (2 
C), 127.7 (2 C), 127.3, 118.7, 70.9, 70.0, 56.2, 56.1, 53.5, 42.5, 39.9, 39.5, 37.6, 36.2, 35.9, 35.8, 32.7, 
32.5, 32.1, 28.2, 28.1, 24.3, 24.2, 23.8, 22.8, 22.6, 21.5, 18.7, 18.2, 12.0.  1H NMR (600 MHz) (21b): 
5.389 (1H, m), 4.601 (1H, d, J = 11.9 Hz), 4.561 (1H, d, J = 11.9 Hz), 3.944 (1H, m), 2.200 (1H, m), 
1.813 (1H, m), 1.052 (3H, s), 0.901 (3H, d, J = 6.6 Hz), 0.866 (3H, d, J = 6.6 Hz), 0.861 (3H, d, J = 6.6 
Hz), 0.677 (1H, s). 13C NMR (151 MHz): 148.0, 139.1, 128.3 (2 C), 127.7 (2 C), 127.3, 120.9, 74.7, 69.8, 
56.2 (2 C), 54.5, 42.5, 39.9, 39.5, 37.6, 36.2, 36.0, 35.8, 35.4, 33.1, 32.3, 28.2, 28.0, 25.8, 24.2, 23.8, 
22.8, 22.5, 21.0., 18.8, 18.7, 12.0. 
3-Benzyloxy-ergost-8(14)-en-3,4-diol (14). A solution of 13 (165.3 mg, 0.3 mmol) in 4 mL of anhydrous 
THF was stirred at 0 oC under a N2 atmosphere for 10 min before adding 0.6 mL of 2 M borane-dimethyl 
sulfide slowly via a gas-tight syringe. After 15 min, the reaction was removed from the ice bath and 
stirred at room temperature for 4 h before adding 1 mL of 6 M NaOH dropwise. After 15 min, 1 mL of 
30% H2O2 was added dropwise and the reaction mixture was stirred vigorously at 50 oC for 16 h.  The 
reaction was allowed to cool to room temperature, quenched with water and extracted with 4:1 
hexanes/EtOAc. The organic layer was washed with brine and sodium bicarbonate, dried over Na2SO4 
and evaporated under reduced pressure. Silica gel chromatography with 19:1 hexanes/ EtOAc yielded 
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81.6 mg of an inseparable 2.6:1 (3β,4α,5α/3α,4β,5β) of 14 (48% yield).  1H NMR  (600 MHz) (mixture): 
4.715 (3α) (1H, d, J =  11.5 Hz), 4.711 (3β) (1H, d, J =  11.6 Hz), 4.496 (3α) (1H, d, J =  11.5 Hz), 
4.487(3β) (1H, d, J =  11.7 Hz), , 3.970(3α) (1H, dd, J =  8.9, 10.8 Hz), 3.417(3β) (1H, dd, J =  8.8, 10.3 
Hz), 3.293-3.193(3𝛼𝛼/3𝛽𝛽) (2H, m), 2.433(3β) (1H, ddd, J =  2.1, 4.5, 14.1 Hz), 0.932(3β) (3H, d, J =  6.6 
Hz), 0.857(3α) ( 3H, d, J =  7.0 Hz), 0.855(3β) (3H, d, J =  7.0 Hz), 0.835(3β) (3H, s), 0.829 (3α) (3H, s), 
0.784 (3β) (3H, d, J =  6.8 Hz), 0.782 (3β) (3H, d, J =  6.8), 0.732 (3β) (3H, s). 
3-Benzyloxy-cholestan-3,4-diol (22).  1H NMR  (600 MHz) (mixture): 4.703 (3α,5β) (1H, d, J = 11.5 
Hz), 4.699 (3β,5α) (1H, d, J = 11.6 Hz), 4.476 (3α,5β) (1H, d, J = 11.5 Hz), 4.476 (3β,5α) (1H, d, J = 
11.6 Hz), 3.864 (3α,5β) (1H, m), 3.415 (3β,5α) (1H, m), 3.228 (3α,5β) (1H, m), 3.180 (3β,5α) (1H, m), 
2.519 (3α,5β) (1H, d, J = 1.4 Hz), 2.481 (3β,5α) (1H, d, J = 1.4 Hz), 0.898 (3β,5α) (3H, d, J = 6.6 Hz), 
0.866 (3β,5α) (3H, d, J = 6.6 Hz), 0.861 (3β,5α) (3H, d, J = 6.6 Hz), 0.840 (3β,5α) (3H, s), 0.648 (3β,5α) 
(3H, s).         
3-Benzyloxy-ergost-8(14)-en-4-one (15). To a solution of 14 (81.6 mg, 0.16 mmol) in 5 mL of CH2Cl2 
was added PCC (132.6 mg, 0.61 mmol). The mixture was stirred for 1 h. Hexanes (5 mL) was added to 
the mixture before filtering it through silica gel. The crude product was eluted with 4:1 hexanes/EtOAc to 
yield a 2.6:1 (3β,5α/3α,5β) mixture of 15 as a white solid (71.2 mg, 95% yield). (3α,5R)-3-Benzyloxy-
ergost-8(14)-en-4-one (15a) 1H NMR (600 MHz): 4.872 (1H, d, J = 11.8 Hz), 4.500 (1H, d, J = 11.9 
Hz), 3.892 (1H, m), 0.953(3H, s), 0.917 (3H, d, J = 6.7 Hz), 0.855 (3H, d, J = 6.8 Hz), 0.814 (3H, s), 
0.784 (3H, d, J = 6.8 Hz), 0.780 (3H, d, J = 6.8 Hz). (3β,5S)-3-Benzyloxy-ergost-8(14)-en-4-one (15b) 
1H NMR (600 MHz): 4.852 (1H, d, J = 11.9 Hz), 4.475 (1H, d, J = 12.0 Hz), 3.971 (1H, m), 2.469 (1H, 
ddd, J = 1.4, 5.0, 13.6 Hz), 0.932 (3H, d, J = 6.6 Hz), 0.855 (3H, d, J = 6.8 Hz), 0.826 (3H, s), 0.785 
(3H, d, J =  6.8 Hz), 0.782 (3H, d, J = 6.8 Hz), 0.642, (3H, s). 
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3-Benzyloxy-cholestan-4-one (23). 1H NMR (600 MHz) (mixture): 4.861 (1H, d, J = 12.1 Hz), 4.846 
(1H, d, J = 12.0 Hz), 4.490 (1H, d, J = 12.0 Hz), 4.464 (1H, d, J = 12.0 Hz), 3.937 (1H, dd, J = 7.4, 12.0 
Hz), 3.828 (1H, dd, J = 6.6, 12.3 Hz), 0.899  (3H, d, J = 6.5 Hz), 0.866 (3H, d, J = 6.6 Hz), 0.862 (3H, d, 
J = 6.6 Hz), 0.747 (3H, s), 0.648 (3H, s), 0.626 (3H, s).  
(3β,5S)-3-Benzyloxy-cholestan-4-one (23b). A solution of 3-benzyloxy-cholestan-4-one 20 (585.3 mg, 
1.2 mmol) in 10 mL of 10% methanolic NaOH was heated at reflux for 1 h. The solvent was removed 
under reduce pressure before extraction of the product with 5% hydrochloric acid and 2:1 hexane/EtOAc. 
The organic layer was washed with brine, dried over Na2SO4 and evaporated under reduced pressured to 
afford 21 as a white solid (580.8 mg, 99% yield). 1H NMR (600 MHz): 4.845 (1H, d, J = 12.0 Hz), 4.464 
(1H, d, J = 12.0 Hz), 3.936 (1H, dd, J = 7.3, 12.1 Hz), 2.252 (1H, m), 2.079 (1H, dd, J = 2.8, 12.1 Hz), 
0.898 (3H, d, J = 6.5 Hz), 0.866 (3H, d, J = 6.6 Hz), 0.861 (3H, d, J = 6.6 Hz), 0.746 (3H, s), 0.647 (3H, 
s). 13C NMR (151 MHz): 210.5, 138.2, 128.4 (2 C), 127.8 (2 C), 127.6, 81.3 71.8, 57.5, 56.3, 56.2, 54.5, 
43.0, 42.6, 39.9, 39.5, 36.4, 36.1, 35.7, 34.9, 30.4, 28.2, 28.0, 24.1, 23.8, 22.8, 22.5, 21.7, 20.3, 18.7, 13.6, 
12.0. 
3β-Benzyloxy-ergost-8(14)-en-4-methylene (16). A solution of methyltriphenylphosphonium bromide 
(103.6 mg, 0.26 mmol) and potassium tert-butoxide (28.4 mg, 0.24 mmol) in 500 µL of anhydrous THF 
was heated at reflux under a N2 atmosphere for 30 min. A solution of 15 (20.2 mg, 0.04 mmol) in 1 mL of 
anhydrous THF was transferred to the generated ylide via a gas-tight syringe. The reaction was refluxed 
under a N2 atmosphere for an additional 14 h. The reaction was cooled to rt, quenched with water and 
extracted with 4:1 hexane/EtOAc. The organic layer was washed with brine, dried over Na2SO4 and 
evaporated under reduced pressure. Silica chromatography with 39/:1 hexanes/EtOAc yielded a mixture 
of 4 products 14 (18.8 mg, 93% yield): desired product 14c 79%, 6% 14a, 7% 14b and 8% 14d. The 
desired product was isolated by preparative TLC with 39:1 hexanes/EtOAc.  (5S)-3β-Benzyloxy-ergost-
8(14)-en-4-methylene (16c) 1H NMR (600 MHz): 5.214 (1H, br d, J = 1.3 Hz), 4. 699 (1H, d, J = 12.2 
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Hz), 4.647 (1H, br d, J = 1.4 Hz), 4.566 (1H, d, J = 12.1 Hz), 3.719 (1H, dd, J =  5.0, 11.7 Hz), 2.475 
(1H, ddd, J = 2.2, 4.1, 13.9 Hz), 1.938 (1H, dt, J = 3.4, 12.4 Hz), 0.937 (3H, d, J = 6.6 Hz), 0.858 (3H, d, 
J = 6.9 Hz), 0.835 (3H, s), 0.788 (3H, d, J = 6.8 Hz), 0.786 (3H, d, J = 6.8 Hz), 0.607, (3H, s). 
3β-Benzyloxy-4-methylenecholestane (25). 1H NMR (600 MHz): 5.191 (1H, br d, J = 1.2 Hz), 4.697 
(1H, d, J = 12.1 Hz), 4.651 (1H, br d, J = 1.3 Hz), 4.558 (1H, d, J = 12.2 Hz), 3.689 (1H, dd, J = 5.2, 
11.7 Hz), 0.909 (3H, , d, J = 6.5 Hz), 0.874 (3H, d, J = 6.6 Hz), 0.870 (3H, d, J = 6.6 Hz), 0.708 (3H, d, J 
= 6.6 Hz), 0.708, (3H, s), 0.659 (3H, s). 13C NMR (151 MHz): 1502.1, 139.2, 128.3 (2 C), 127.3 (3 C), 
103.4, 80.6, 71.1, 56.34, 56.33, 54.6, 50.3, 42.6, 40.1, 39.5, 38.9, 37.5, 36.2, 35.8, 35.3, 31.7, 30.6, 28.3, 
28.0, 24.3, 24.2, 23.8, 22.8, 22.6, 21.8, 18.7, 12.9, 12.1. 
4-Methylene-ergost-8(14)-en-3-ol (17). To a solution of 0.5 cm of Li wire in 2.5 mL of condensed NH3 
at -78 oC (acetone/dry ice bath) was added 16 (10.2 mg. 0.02 mmol) in 2.5 mL of Et2O. The reaction was 
stirred at -78 oC for 10 min and quenched with 1 mL of MeOH. The reaction was warmed to rt, diluted in 
10% hydrochloric acid and extracted with 2:1 hexane/EtOAc. The organic layer was washed with brine, 
dried over Na2SO4 and evaporated under a flow of N2. The crude products were purified by preparative 
TLC to obtain a mixture of 17 as a solid (8.2 mg, 98% yield). The 4 alcohols were separated by high-
performance liquid chromatography with MeOH. (3α,5R)-4-Methylene-ergost-8(14)-en-3-ol (17a). 1H 
NMR (600 MHz): 4.968 (1H, m), 4.604 (1H, m), 4.294 (1H, m), 0.941 (C21) (3H, d, J = 6.6 Hz), 0.858 
(C26/27) (3H, d, J = 6.8 Hz), 0.839 (C18) (3H, s), 0.788(C26/27) (3H, d, J = 6.9 Hz), 0.785 (C28) (3H, 
d, J = 6.8 Hz), 0.580 (C19) (3H, s). (3α,5S)-4-Methylene-ergost-8(14)-en-3-ol (17b). 1H NMR (600 
MHz): 5.296 (1H, br s), 4.987 (1H, br s), 4.006 (1H, m), 0.925 (C21) (3H, d, J = 6.6 Hz), 0.880 (C19) 
(3H, s), 0.855 (C26/27) (3H, d, J = 6.8 Hz), 0.827 (C18) (3H, s), 0.784 (C26/27) (3H, d, J = 6.8 Hz), 
0.782 (C28) (3H, d, J = 6.8 Hz).  (3β,5R)-4-Methylene-ergost-8(14)-en-3-ol (17c or 3). 1H NMR (600 
MHz): 5.076 (1H, s), 4.633 (1H, s), 4.023 (1H, m), 0.939 (C21) (3H, d, J = 6.6 Hz), 0.853 (C26/27) (3H, 
d, J = 6.8 Hz), 0.838 (C18) (3H, s), 0.786 (C26/27) (3H, d, J = 6.9 Hz), 0.786(C28) (3H, d, J = 6.8 Hz), 
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0.592 (C19) (3H, s). (3β,5S)-8(14)-4-Methylene-ergost-8(14)-en-3-ol (17d) 1H NMR (600 MHz): 5.154 
(1H, m), 4.938 (1H, m), 4.304 (1H, m), 2.435 (1H, dd, J = 2.3, 4.6 Hz) 0.928(C21) (3H, d, J = 6.7 Hz), 
0.911 (C19) (3H, s), 0.854 (C26/27) (3H, d, J = 6.9 Hz), 0.833 (C18) (3H, s), 0.783 (C26/27) (3H, d, J =  
6.8 Hz), 0.782 (C28) (3H, d, J =  6.8 Hz).  
24-epitheonellasterol (4): 1H NMR (600 MHz): 5.075 (1H, br s), 4.632 (1H, br s), 4.019 (1H, m), 2.478 
(1H, ddd, J =  2.4, 4.4, 13.9 Hz), 0.941 (C21) (3H, d, J =  6.6 Hz),  0.851 (C29) (3H, d, J =  7.4 Hz), 
0.840 (C18) (3H, s), 0.840 (C26/27) (3H, d, J =  6.8 Hz), 0.818 (C26/27) (3H, d, J =  6.9 Hz), 0.591 
(C19) (3H, s). 13C NMR (151 MHz): 153.2, 143.0, 125.7, 102.8, 73.4, 56.8, 49.5, 49.3, 46.0, 42.8, 40.0, 
37.4, 36.8, 34.8, 33.8, 33.2, 29.4, 29.2, 27.1, 26.0, 25.8, 24.7, 23.1, 20.4, 19.8, 19.2, 19.1, 18.2, 13.2, 12.0. 
24-desmethylconicasterol: 1H NMR (600 MHz): 5.075 (1H, m), 4.633 (1H, br s), 0.934 (C21) (3H, d, J 
= 6.7 Hz), 0.870 (C26/C27) (3H, d, J = 6.6 Hz), 0.866 (C26/C27) (3H, d, J = 6.6 Hz), 0.839 (C18) (1H, 
s), 0.591 (C19) (3H, s). 
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CHAPTER 3 
 
Synthesis of Pfiesterol and its 23-Epimer from 16-Dehydropregnenolone 
Acetate 
 
Abstract 
 
Pfiesterol, (23R)-4α,23-dimethylergost-17(20),24(28)-dien-3β-ol, a sterol from the heterotrophic 
dinoflagellate Pfiesteria picicida, was synthesized from 16-dehydropregnenolone acetate. This compound 
is a potential biomarker for the species Pfiesteria. Two different routes to the pfiesterol from intermediate 
18b, (23R)-23-methylergost-4,17(20),24(28)-trien-3-one, were used differing in the approach to 
stereoselectively monomethylate at C4. The 4α-(13C-methyl) pfiesterol was also synthesized via a 
reductive methylation with labeled methyl iodide. The labeled product was prepared for metabolic studies 
in copepods. Pfiesterol is also potential precursor of 4-methylandrosterone, an androgenic sex hormone 
that may affect invertebrate reproduction.  
 
3.1 Introduction 
 
Many sterols have been used as biomarkers for marine and terrestrial organisms including 
dinoflagellates.1-3 Dinoflagellates are an important and diverse group of motile marine and fresh water 
phytoplankton with the ability to produce potent toxins harmful to fish, shellfish and human health.4,5,8c,11 
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Dinosterol, 4α-methyl sterols, 23-methylsterols, and some steroid ketones  are considered biomarkers for 
dinoflagellates.3,6-7 Brevesterol, an unusual sterol from the harmful dinoflagellate K. brevis, has been 
proposed as biomarker for the species.9 A new sterol isolated from two strains of the toxic dinoflagellate 
Pfiesteria piscicida12, pfiesterol ((23R)-4α,23-dimethylergost-17(20),24(28)-dien-3β-ol) (1), was 
identified as a potential biomarker for that species.8c A published analysis of the sterols in Pfiesteria 
piscicida did not report that compound even though not all the isolated sterols were identified.11. The 
unusual ∆17(20) functionality in pfiesterol has been previously observed in the dinoflagellate sterol 
peridinosterol ((23R,24R)-4a,23,24-trimethyl-cholest-l7(20)-en-3β-ol).8b,13 The stereochemistry 
assignments in the nucleus and side chain of pfiesterol were achieved by chemical correlation through 
heterogenous catalytic hydrogenation of pfiesterol to give 20-epidihydrodinosterol, (20S,23R,24R)-4α,23-
trimethyl-cholestan-3β-ol, as the major product.13a The side chain of pfiesterol is not terribly stable. A 
sample of pfiesterol stored in a freezer in CDCl3 decomposed to give 4α-methylandrosterone, an 
androgenic steroid hormone.8c In vivo and in vitro experiments demonstrated that vertebrate related 
steroids like androgens directly and indirectly affect reproduction in marine molluscs through biological 
effects that include induction of sex reversal.14 Two methods of synthesizing pfiesterol from the 
commercially available steroid 16-dehydropregnenolone acetate, differing in the introduction of the 4α-
methyl group, were established. The 23-epimer of pfiesterol (3) and 4α-(13C-methyl) pfiesterol (1*) were 
also synthesized and characterized by NMR (Figure 3.1). The label in compound 1* was strategically 
added to the nucleus to allow an easy and unambiguous identification of the side chain decomposition 
product, 4α-13C-methyl androsterone.  
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HO HO
13CH3
HO
Pfiesterol (1) 4a−13CH3
 
pfiesterol (1*)
23-epipfiesterol (3)
O
HO
4a-methylandrosterone  
 
Figure 3.1. Pfiesterol (1), its 23-epimer (3), 4α-13C-methyl-pfiesterol (1*) and 4α-methylandrosterone. 
 
3.2 Results and Discussion 
 
The synthesis started with the saponification of 16-dehydropregnenolone acetate (4) to obtain 16-
dehydropregnenolone 515-16 and the Michael-addition product 617 in a 3:2 mixture favoring compound 5 
(Scheme 3.1). The use of tBuOH, a more hindered alcohol, has been reported not to give the Michael-
addition product15. We decided to move forward with the mixture because the formation of more 
Michael-addition products was expected in the following step due the methanolic NaOH treatment 
involved in the i-methyl ether formation. The alcohol mixture was subsequently protected to its respective 
i-methyl sterols in a two-step procedure to afford a 2:3 mixture of compounds 716,18 and 8. The mixture of 
i-methyl sterols was converted in high yield to the epoxide 9 upon treatment with methanolic tBuOOK at 
room tempature.19 This reaction successfully converted the starting mixture into one product, the epoxide 
9, by regenerating the ∆16 in the Michael-addition product via a retro-Michael addition of the methoxy 
group before its subsequent epoxidation. The keto-epoxide 9 was reduced with LAH to afford a mixture 
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of diols 10a and 10b followed by a Swern oxidation20 to obtain the keto-alcohol 1121 in an 85% yield. A 
better yield was obtained with Dess-Martin Periodinane (DMP), however, that reaction would be too 
expensive to do on a large scale. Oxidation with PCC mainly gave the oxidative cleavage product, 6β-
methoxy-3α,5α-cycloandrostan-17-one22. The keto-alcohol 11 was converted to the tertiary allylic alcohol 
12 via a Wittig reaction. Some minor side products interpreted as the methylenated acyloin 
rearrangement23 products were observed from that reaction. Introduction of 13C-label via the Wittig 
reaction gave compound 12*, an intermediate in a sequence to (23R)-(22-13C23)-methylergost-
17(20),24(28)-dien-3β-ol (17b*).  
 
 
NaOH/MeOH
MeOH
1) MsCl/TEA
2) TEA/MeOH
7
O
8
O
OMe
+
OMe OMe
tBuOOK
9
O
OMe
O
LAH
10a
10b
HO
OMe
OH
Swern
11
O
OMe
OH
Wittig
12
12*
OMe
OH
O O
OMe
+
HO HO
O
AcO
4 5 6
 
 
Scheme 3.1. Synthesis of intermediate 12 from 16-dehydroprenenolone.  
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As shown in Scheme 3.2, the allylic alcohol 12 was converted to the desired E-allylic chloride 13 
as the major product with thionyl chloride and lutidine in DCM.23 The product was not further purified 
due to its observed instability to exposure to silica gel and alumina. The crude product was stable when 
stored in benzene at -20 oC. That reaction was important in this sequence because it provided the ∆17(20) 
functionality in the desired product and activated the substrate for a facile SN2 reaction in the next step. 
The remaining carbons in the side chain of the target compound were added via the alkylation of the 
lithium enolate of (E)-3,4-dimethyl-2-pentenoate with the i-methyl ether chloride 13 at -78 oC.24 The 
resulting esters 14a and 14b were poorly separated on silica gel, thus, they were reduced with LAH to get 
a mixture of the alcohols 15a and 15b that were easier to separate by chromatography. The two alcohols 
were isolated and carried separately through the rest of the sequence. The separation of alcohols 15b and 
15a allowed a direct synthesis of pfiesterol and 23-epipfiesterol, respectively. 
 
13
13*
OMe
LAH
14a
14b
CO2Et
OMe
15a
15a*
15b
15b*
+
OMe OMe
OH OH
O
OEt
Cl
SOCl2/lutidine
DCM
12
12*
OMe
OH
LDA
 
 
Scheme 3.2. Synthesis of the alcohols 15a and 15b from compound 12.  
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The alcohol i-methyl ethers 15a and 15b were deoxygenated via the reduction of their respective 
mesylates to afford compounds 16a and 16b (Scheme 3.3). Minor starting alcohols were recovered from 
the LAH reduction of the mesylates from undesired S-O cleavage. With the desired side chains in place, 
the i-methyl ethers 16a (23S) and 16b (23R) were deprotected to obtain their corresponding sterols. The 
sterols 17a and 17b were converted to the enones 18a and 18b in good yield using the Oppenauer 
oxidation25.  
 
 
1) MsCl/TEA
15a
OMe
OH
 
2) LAH
 
1) 1% TFA
16a
OMe
 
2) TEA/MeOH
Oppenauer
17a
HO
15b
15b*
16b
16b*
17b
17b*
18a
18b
O
 
 
Scheme 3.3. Synthesis of the enones 18a and 18b from the alcohols 15a and 15b.  
 
The enones were used in two different methods to generate pfiesterol and 23-epipfiesterol 
(Scheme 3.4). The first method to pfiesterol and its 23-epimer from their corresponding enone involved 
the Kirk-Petrow reaction.26 This method was previously in our lab to make pfiesterol from the ∆5 isomer 
of the enone 18b.9a The phenylthiomethyl intermediates 21a and 21b were easily converted to 23-
epipfiesterol and pfiesterol via a dissolving metal reduction (Li/NH3), respectively.9a The second method 
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involved a reductive methylation.27 The reductive methylation of both enones gave a mixture of their 
respective desired monomethylated ketone (19a/19b) and the dimethylated product (20a/20b) in a 2:1 
ratio favoring the monomethylated product. The unsaturated ketone and the fully reduced starting material 
were observed as minor side products. That reaction was almost impossible to run predictably and 
successfully in the summer due to the high sensitivity of the enolate to humidity. Dry solvents and 
reagents and oven dry glassware were crucial in getting the reaction to work. However, the reaction still 
did not work at high humidity. The reductive alkylation was not that selective, however, it allowed a 
relatively cheap and easy method to introduce the 13C-methyl in 1* at a late stage in the synthesis. The 
labeled product (19b*) was generated using this method with 13CH3I. Pfiesterol (1), 23-epipfiesterol (3), 
and 4α-(13C-methyl) pfiesterol (1*) were generated as the exclusive products from 19a, 19b and 19b* via 
a reductive metal reduction (Li/NH3), respectively.27 Hydride reduction of the 4α-methyl ketone gives 
21% of the undesired 3α-hydroxy product. 
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1) Li/NH3
18a
18b
 
2) MeI, HMPA
O
 
Li/NH3
19a
19b
19b*
O
3
1
1*
HO
20a
20b
20b*
O
 
Li/NH3
21a
21b
O
3
1
HO
SPh
PhSH, TEA, Formalin
 
 
Scheme 3.4. Synthesis of 23-epipfiesterol 3 and pfiesterol 1 from the enones 18a and 18b.  
 
3.3 Summary 
 
Pfiesterol and its 23-epimer were successfully synthesized from 16-dehydroprenolone acetate. 
Two different methods were used to generate the 4α-methyl nucleus from the ∆4-enone intermediates 18a 
and 18b. The structure of the synthesized pfiesterol was confirmed by 1H NMR comparison with the 
natural product and a sample previously prepared in our lab.8b The labeled product was synthesized via a 
reductive methylation of intermediate 18b with 13CH3I. Introducing the label this late in the synthesis 
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provided an economic method compound 1*. The synthesized 4α-(13C-methyl) pfiesterol provided 
samples for metabolic studies to verify the in vivo formation of the hormone 4α-13C-methylandrosterone 
in invertebrates from the side chain degradation of 4α-(13C-methyl) pfiesterol. This steroid hormone may 
negatively affect reproduction in invertebrates. A sample of pfiesterol stored in the freezer in benzene for 
over 2.5 years was found unchanged by 1H NMR analysis.  
 
3.4 Experimental 
General Procedures. NMR spectra were obtained in CDCl3 on a Bruker 600 MHz spectrometer (1H at 
600 MHz and 13C at 151 MHz). HPLC was performed using a Waters 6000A pump, Waters 410 
differential refractometer, and two Altex Ultrasphere ODS columns (5 µm, 10 x 250 mm) in series at a 
flow rate of 3 mL/min with MeOH. Preparative thin layer chromatography (TLC) purifications were done 
with Sorbent Technologies (SORBTECH) silica gel HL thin TLC plates (20 x 20 cm2, 250 µm thick with 
glass backed support). All solvents were from commercial sources. 
16-Dehydropregnenolone (5) and 16-α-methoxypregnenolone (6). To a solution of of 4 (15.1 g, 42.4 
mmol) in 50 mL of 4:1 MeOH/THF was added 20 mL of 10% methanolic NaOH. The mixture was heated 
at reflux for 1 h. The reaction was cooled to rt before removing the solvent under reduced pressure. The 
crude product was extracted with saturated sodium bicarbonate and 2:1 hexanes/EtOAc. The organic layer 
was washed with brine, dried over Na2SO4 and filtered through silica gel before removing the solvent 
under reduced pressure. A 3:2 mixture of compound 5 and 6, respectively, was obtained as a white solid 
(12.13g, 88% yield). 16-Dehydropregnenolone (5). 1H NMR (600 MHz): 6.703 (1H, dd, J = 1.85, 3.16 
Hz), 5.362 (1H, m), 3.525 (1H, m), 2.260 (3H, s), 1. 049 (3H, s), 0.923 (3H, s). 13C NMR (151 MHz): 
196.8, 155.4, 144.4, 141.4, 121.1, 71.7, 56.5, 50.5, 46.1, 42.3, 37.1, 36.7, 34.7, 32.3, 31.7, 31.6, 30.2, 
27.1, 20.7, 19.3, 15.7. 16α-Methoxypregnenolone (6). 1H NMR (600 MHz): 5.353 (1H, m), 4.355 (1H, 
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m), 3.535 (1H, m), 3.217 (3H, s), 2.179 (3H, s), 1.005 (3H, s), 0.639 (3H, s). 13C NMR (151 MHz): 208.1, 
140.7, 121.3, 81.5, 71.7, 71.6, 57.2, 54.5, 49.9, 44.4, 42.2, 38.8, 37.1, 36.5, 32.0, 31.7, 31.6 (2 C), 31.5, 
20.8, 19.4, 14.5. 
6β-Methoxy-3α,5-cyclo-pregn-16-en-3-one (7) and 6β,16α-Dimethoxy-3α,5α-cyclo-pregnan-20-one 
(8). To a solution of 13.12 g of a 3:2 mixture of compounds 5 (23.1 mmol) and 6 (14.0 mmol) in 150 mL 
of dry DCM was added 12 mL of TEA. The mixture was stirred at 0 oC for 10 min before adding 9 mL of 
1:1 DCM/MsCl dropwise over 15 min. The mixture was stirred for an additional 45 min before extracting 
the reaction with saturated sodium bicarbonate and 9:1 hexanes/EtOAc. The organic layer was with brine, 
dried over Na2SO4 and filtered through silica gel before removing the solvent under reduced pressure. The 
crude mixture of the mesylates (14.9 g) was redissolved in 200 mL of 3:1 MeOH/DCM and 25 mL of 
10% methanolic NaOH and stirred at reflux for 2 h. The reaction was cooled to rt before extraction with 
10% HCl and 4:1 hexanes/EtOAc. The combined organic layers were washed with saturated sodium 
bicarbonate, then brine, and dried over Na2SO4 and concentrated in vacuo. The crude product was purified 
by flash silica gel chromatography with 9:1 hexanes/EtOAc to afford of a 2:3 mixture of compounds 7 
and 8, respectively (12.81 g, 84% yield for the two steps).  6β-Methoxy-3α,5α-cyclo-pregn-16-en-3-one 
(7). 1H NMR (600 MHz): 6.691 (1H, dd, J = 1.85, 3.30 Hz), 3.355 (3H, s), 2.804 (1H, t, J = 2.8 Hz), 
2.254 (3H, s), 1. 057 (3H, s), 0.947 (3H, s), 0.677 (1H, dd, J = 4.1 ,4.8), 0.456 (1H, dd, J = 5.2, 8.0 Hz). 
13C NMR (151 MHz): 196.8, 155.6, 144.3, 82.2, 56.7, 56.5, 48.5, 46.4, 43.6, 35.4, 35.2, 35.1, 33.1, 32.2, 
28.9, 27.1, 24.9, 22.3, 21.3, 19.2, 16.2, 13.2. 6β,16α-Dimethoxy-3α,5α-cyclo-pregnan-20-one (8). 1H 
NMR (600 MHz): 4.347 (1H, m), 3.323 (3H, s), 3.208 (3H, s), 2.779 (1H, t, J = 2.8 Hz), 2.543 (1H, d, J = 
6.2 Hz), 2.168 (3H, s), 1.016 (3H, s), 0.668 (3H, s), 0.451 (1H, dd, J = 5.1, 8.0 Hz). 13C NMR (151 MHz): 
208.1, 82.1, 81.5, 71.8, 57.1, 56.6, 54.3, 47.9, 44.9, 43.4, 39.4, 35.1, 35.0, 33.3, 31.9, 31.7, 30.1, 24.9, 
22.4, 21.4, 19.2, 14.9, 13.1.  
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(16R,17R)-6β-Methoxy-3α,5α-cyclo-16,17-epoxy-pregnan-20-one (9). To a solution of 13.5 g of a 
mixture of compounds 7 (16.4 mmol) and 8 (22.4 mmol) in 50 mL of 4:1 MeOH/THF and 6.5 mL of 70% 
tBuOOH in foil-wrapped flask was added 46.8 mL of 6 M KOH over 20 min. Reaction was checked by 
NMR until no starting material was observed. After 42 h, the reaction was extracted with water and 2:1 
hexanes/EtOAc. The combined organic layers were washed with brine, dried over Na2SO4 and filtered 
through a small pad of silica gel. The crude product was isolated as a white solid after removing the 
solvent under reduced pressure (13.03 g, 96% pure by NMR). 1H NMR (600 MHz): 3.669 (1H, s), 3.331 
(3H, s), 2.778 (1H, t, J = 2.8 Hz), 2.028 (3H, s), 1.081 (3H, s), 1.034 (3H, s), 0.667 (1H, m), 0.447 (1H, 
dd, J = 5.2, 8.0 Hz).  13C NMR (151 MHz): 204.9, 82.1, 71.1, 60.6, 56.7, 48.4, 45.4, 43.6, 42.0, 35.1, 
35.0, 33.2, 31.8, 28.2, 27.4. 26.0, 24.9, 22.0, 21.2, 19.2, 15.6, 13.2. 
(17R)-6β-Methoxy-3α,5α-cyclo-pregnan-17,20-diol (10). To a solution of the epoxy-ketone 9 (13.0 g, 
37.7 mmol) in 100 mL of anhydrous Et2O was added 2.86 g of LAH dissolved in 25 mL of Et2O via an 
addition funnel over 10 min. The reaction was stirred for 2 h before extraction with 10% hydrochloric 
acid and 2:1 hexanes/EtOAc. The combined organic layers were washed with brine, dried over Na2SO4 
and filtered through a small pad of silica gel. The crude product of 2.8:1 of 10a/10b was isolated as a 
white solid after removing the solvent mixture under reduced pressure (13.02 g, 99% crude yield). A 
sample of the mixture was separated by preparative TLC with 4:1 hexanes/EtOAc to provide the 
compounds 10a (major and less polar product) and 10b. (17R)-6β-Methoxy-3α,5α-cyclo-pregnan-17,20-
diol (10a). 1H NMR (600 MHz): 4.040 (1H, dd, J = 6.2, 12.5 Hz), 3.321 (3H. s), 2.766 (1H, t, J = 2.7 Hz), 
1.167 (3H, d, J = 6.3 Hz), 1.026 (3H, s), 0.850 (3H, s), 0.645 (1H, m), 0.430 (1H, dd, J = 5.2, 7.9 Hz). 13C 
NMR (151 MHz): 85.2, 82.3, 70.4, 56.6, 50.2, 47.7, 47.5, 43.4, 35.2, 35.17, 33.9, 33.4, 32.8, 30.6, 24.9, 
23.7, 22.4, 21.4, 19.3, 18.6, 15.5, 13.1. (17R)-6β-Methoxy-3α,5α-cyclo-pregnan-17,20-diol (10b). 1H 
NMR (600 MHz): 3.857 (1H, m), 3.332 (3H, s), 2.781 (1H, t, J = 2.7 Hz), 1.192 (3H, d, J = 6.4 Hz), 
1.030 (3H, s), 0.789 (3H, s), 0.654 (1H, m), 0.443 (1H, dd, J = 5.1, 7.9 Hz). 13C NMR (151 MHz): 85.6, 
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82.3, 72.4, 56.6, 51.1, 47.6, 46.1, 43.4, 37.7, 35.2, 35.1, 33.4, 31.6, 30.4, 24.9, 23.3, 22.2, 21.5, 19.2, 18.6, 
14.4, 13.1. 
(17R)-17-Hydroxy-6β-methoxy-3α,5-cyclo-pregnan-20-one (11). To a solution of oxalyl chloride (3.20 
mL, 36.3 mmol) in 60 mL of anhydrous DCM at -78 oC under a N2 atmosphere was added a mixture of 
DMSO (3 mL, 41.8 mmol) in 7 mL of DCM dropwise over 10 min. After 15 min, a mixture of the glycols 
10a and 10b (6.07g, 17.4 mmol) in 10 mL of anhydrous DCM was added dropwise to the reaction. After 
1h, TEA (12.2 mL, 87.0 mmol) was added dropwise and the reaction was allowed to warm slowly to 
room temperature before extraction with saturated sodium bicarbonate and 4:1 hexanes/EtOAc. The 
combined organic layers were washed with brine, dried over Na2SO4 and filtered through a silica gel.  The 
product was isolated as an off-white solid after removal of the solvent mixture in vacuo (5.6 g, 92% pure 
by NMR, 85% overall yield). 1H NMR (600 MHz): 3.339 (3H, s), 2.786 (1H, t, J = 2.8 Hz), 2.775 (1H, s), 
2.670 (1H, s), 2.276 (3H, s), 1.032 (1H, s), 0.786 (3H, s), 0.663 (1H, m), 0.453 (1H, dd, J = 5.2, 8.0 Hz). 
13C NMR (151 MHz): 211.8, 90.0, 82.2, 56.6, 50.6, 48.8, 47.6, 43.4, 35.3, 35.2, 33.6, 33.4, 30.5, 30.4, 
27.9, 24.9, 24.0, 22.2, 21.4, 19.3, 15.8, 13.2. 
(17R)-17-Hydroxy-6β-methoxy-20-methylene-3α,5-cyclo-pregnane (12 and 12*). A solution of Wittig 
reagent was prepared by heating a mixture of methyltriphenylphosphonium bromide (11.63 g, 32.60 
mmol) and of potassium tert-butoxide (3.13 g, 27.9 mmol) in 30 mL of dry THF at reflux for 45 min 
under a N2 atmosphere. A solution of keto-alcohol 11 (4.14 g, 11.9 mmol) in 15 mL of dry THF was 
added via a gas-tight syringe to the generated ylide. The resulting mixture was heated at reflux under a N2 
atmosphere for an additional 1.5 h. The reaction was allowed to cool to room temperature before 
extraction with water and 4:1 hexanes/EtOAc. The combined organic layers were washed with brine, 
dried over Na2SO4, filtered through a silica gel and concentrated under reduced pressure. The product 12 
was isolated as white solid after silica gel chromatography with 39:1-19:1 hexanes/EtOAc (2.93 g, 71% 
yield). 1H NMR (600 MHz): 4.994 (1H, br s), 4.918 (1H, m), 3.334 (3H, s), 2.782 (1H, t, J = 2.8 Hz), 
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2.422 (1H, m), 1.840 (3H, br s), 1.031 (3H, s), 0.669 (3H, s), 0.655 (1H, m), 0.441 (1H, dd, J = 5.2, 8.0 
Hz). 13C NMR (151 MHz): 148.1, 112.6, 86.4, 82.4, 56.6, 50.4, 47.7, 47.4, 43.4, 35.3, 35.2, 35.1, 33.4, 
31.5, 31.0, 25.0, 23.1, 22.6, 21.5, 21.1, 19.3, 15.7, 13.1. (17R)-(22-13C)-17-Hydroxy-6β-methoxy-20-
methylene-3α,5α-cyclo-pregnane (12*). This compound was made from the keto-alcohol 11 and 
Ph3P13CH2 as described above. 1H NMR (600 MHz): 4.992 (1H, d, J = 155.3 Hz), 4.917 (1H, d, J = 155.4 
Hz), 3.335 (3H, s), 2.782 (1H, t, J = 2.8 Hz), 2.422 (1H, m), 1.840 (3H, br s), 1.031 (3H, s), 0.669 (3H, s), 
0.655 (1H, m), 0.441 (1H, dd, J = 5.2, 8.0 Hz). 13C NMR (151 MHz): 112.6 (C22). 
(E)-22-Chloride-20-methyl-6β-methoxy-3α,5α-cyclo-pregn-17(20)-ene (13 and 13*). To solution of 
the allylic alcohol 12 (1.29 g, 3.80 mmol) and 2,6-lutidine (7.0 mL, 56.3 mmol) in 20 mL of dry DCM at 
0 oC under a N2 atmosphere was added SOCl2 (940 µL, 13.0 mmol) dropwise. The reaction was stirred for 
1 h before extraction with 5% hydrochloric acid and hexanes. The combined organic layers were washed 
with sodium bicarbonate and brine, dried over Na2SO4 and concentrated under reduced pressure. The 
crude product was quickly filtered through alumina with 19:1 hexane/EtOAc to obtain 13 as light-yellow 
oil (1.32 g, crude). 22-Chloride-20-methyl-6β-methoxy-3α,5α-cyclo-pregn-17(20)-ene (13). 1H NMR 
(600 MHz): 4.015 (2H, m), 3.342 (3H, s), 2.797 (1H, t, J = 2.8 Hz), 1.815 (3H, m), 1.035 (3H, s), 0.915 
(3H, s), 0.665 (1H, m), 0.452 (1H, dd, J = 5.2, 7.9 Hz). (22-13C)22-Chloride-20-methyl-6β-methoxy-
3α,5α-cyclo-pregn-17(20)-ene (13*). 1H NMR (600 MHz): 4.014 (2H, m, JHC= 150.8 Hz), 3.342 (3H, s), 
2.797 (1H, t, J = 2.8 Hz), 1.815 (3H, m), 1.035 (3H, s), 0.916 (3H, s), 0.664 (1H, m), 0.451 (1H, dd, J = 
5.3, 7.8 Hz). 13C NMR (151 MHz): 50.2 (C22). 
(23ξ)-Ethyl-6β-methoxy-3α,5α-cyclo-23-homoergost-17(20),24(28)-dien-23-oate (14a and 14b). To a 
solution of diisopropylamine (630 µL, 4.5 mmol) in 5 mL of anhydrous THF at 0 oC under a N2 
atmosphere was added and 1.6 mL of 2.81 M of n-BuLi in hexane. After 10 min, the mixture was cooled 
to -78 oC before adding ethyl (E)-3,4-dimethyl-2-pentenoate (800 µL, 4.6 mmol) dropwise. After 1 h, a 
solution of the crude 13 (1.32 g) in 4 mL of anhydrous THF was added dropwise over 5 min at -78 oC. 
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HMPA (250 µL) was then added before allowing the reaction to slowly warm up to rt. After 16 h, the 
reaction was extracted in 5% hydrochloric acid and 4:1 hexanes/EtOAc. The combined organic layers 
were washed with sodium bicarbonate and then brine, dried over Na2SO4 and concentrated under reduced 
pressure. The mixture of 14a and 14b was isolated as clear oil after silica gel chromatography with 39:1-
19:1 hexanes/EtOAc (1.24 g, 69% yield from 12a). A sample of the mixture was separated by preparative 
TLC with 19:1 hexanes/EtOAc to isolate pure samples of 14a and 14b. (23S)-Ethyl-6β-methoxy-3α,5α-
cyclo-23-homoergost-17(20),24(28)-dien-23-oate (14a). 1H NMR (600 MHz): 5.057 (1H, s), 4.940 (1H, 
s), 4.085 (2H, m), 3.335 (3H, s), 3.183 (1H, dd, J = 5.5, 9.8 Hz), 2.787 (1H, t, J = 2.7 Hz), 1.692 (3H, m), 
1.230 (3H, t, J = 7.1 Hz), 1.061 (3H, d, J = 6.8 Hz), 1.043 (3H, d, J = 6.8 Hz), 1.027 (3H, s), 0.885 (3H, 
s), 0.654 (1H, m), 0.440 (1H, dd, J = 5.2, 8.0 Hz). 13C NMR (151 MHz): 174.2, 154.0, 146.0, 121.2, 
108.9, 82.4, 60.2, 56.6, 56.4, 48.0, 47.9, 44.8, 43.4, 40.0, 38.1, 35.3, 35.0, 34.5, 33.3, 30.0, 29.6, 25.0, 
24.3, 23.1, 22.0, 21.5, 19.2, 17.6, 16.5, 14.2, 13.1. (23R)-Ethyl-6β-methoxy-3α,5α-cyclo-23-
homoergost-17(20),24(28)-dien-23-oate (14b). 1H NMR (600 MHz): 5.051 (1H, s), 4.938 (1H, s), 4.082 
(2H, m), 3.334 (3H, s), 3.164 (1H, dd, J = 6.5, 8.7 Hz), 2.789 (1H, t, J = 2.7 Hz), 1.690 (3H, m), 1.225 
(3H, t, J = 7.2 Hz), 1.057 (3H, d, J = 6.8 Hz), 1.039 (3H, d, J = 6.8 Hz), 1.027 (3H, s), 0.868 (3H, s), 
0.655 (1H, m), 0.441 (1H, dd, J = 5.1, 8.0 Hz). 13C NMR (151 MHz): 174.4, 153.9, 146.0, 121.5, 109.0, 
82.4, 60.3, 56.6, 56.4, 48.2, 47.9, 44.9, 43.4, 39.8, 37.9, 35.3, 35.0, 34.4, 33.3, 30.0, 29.8, 25.0, 24.3, 23.1, 
22.1, 22.0, 21.4, 19.2, 17.5, 16.7, 14.1, 13.1. 
(23ξ)-6β-Methoxy-3α,5α-cyclo-23-homoergost-17(20),24(28)-dien-23-ol (15a,15b). The esters 14a and 
14b (1.18 g, 2.4 mmol) were reduced with 209.1 mg of LAH as a mixture as described above (10) to 
afford 1. 04 g of 15a and 15b (1.04 g, 96% yield). The two alcohols were isolated by silica gel 
chromatography with 19:1-9:1 hexanes/EtOAc. (23S)-6β-Methoxy-3α,5α-cyclo-23-homoergost-
17(20),24(28)-dien-29-ol (15a). 1H NMR (600 MHz): 4.951 (1H, s), 4.815 (1H, s), 3.557 (2H, m), 3.339 
(3H, s), 2.790 (1H, t, J = 2.8 Hz), 1.743 (3H, m), 1.059 (3H, d, J = 6.8 Hz), 1.056 (3H, d, J = 6.8 Hz) 
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,1.028 (3H, s), 0.898 (3H, s), 0.655 (1H, m), 0.441 (1H, dd, J = 5.2, 8.0 Hz). 13C NMR (151 MHz): 157.9, 
145.8, 122.8, 107.2, 82.4, 65.4, 56.6, 56.5, 47.8, 44.9, 44.4, 43.4, 40.5, 38.2, 35.2, 35.0, 34.3, 33.3, 30.03, 
30.01, 25.0, 24.3, 23.1, 22.2, 21.4, 19.2, 18.0, 16.5, 13.1. (23S)-6β-Methoxy-3α,5α-cyclo-(22-13C)-23-
homoergost-17(20),24(28)-dien-29-ol (15a*). 1H NMR (600 MHz): 4.954 (1H, s), 4.817 (1H, s), 3.564 
(2H, m), 3.337 (3H, s), 2.792 (1H, t, J = 2.8 Hz), 1.745 (3H, m), 1.061 (3H, d, J = 6.8 Hz), 1.058 (3H, d, J 
= 6.8 Hz) ,1.030 (3H, s), 0.900 (3H, s), 0.657 (1H, m), 0.443 (1H, dd, J = 5.2, 8.0 Hz). (23R)-6β-
Methoxy-3α,5α-cyclo-23-homoergost-17(20),24(28)-dien-23-ol (15b). 1H NMR (600 MHz): 4.963 (1H, 
s), 4.830 (1H, s), 3.562 (2H, m), 3.339 (3H, s), 2.792 (1H, t, J = 2.8 Hz), 1.728 (3H, m), 1.062 (3H, d, J = 
6.8 Hz), 1.056 (3H, d, J = 6.8 Hz) ,1.031 (3H, s), 0.902 (3H, s), 0.659 (1H, m), 0.444 (1H, dd, J = 5.2, 8.0 
Hz). 13C NMR (151 MHz): 157.8, 145.6, 122.6, 107.4, 82.4, 65.2, 56.6, 56.3, 47.9, 45.0, 44.9, 43.4, 39.9, 
37.9, 35.2, 35.1, 34.1, 33.3, 30.0, 29.9, 25.0, 24.3, 23.1, 22.3, 21.4, 19.2, 17.7, 16.8, 13.1. (23R)-6β-
Methoxy-3α,5α-cyclo-(22-13C)-23-homoergost-17(20),24(28)-dien-29-ol (15b*). 1H NMR (600 MHz): 
4.963 (1H, s), 4.830 (1H, s), 3.562 (2H, m), 3.339 (3H, s), 2.793 (1H, t, J = 2.8 Hz), 1.728 (3H, m), 1.062 
(3H, d, J = 6.8 Hz), 1.056 (3H, d, J = 6.8 Hz) ,1.031 (3H, s), 0.902 (3H, s), 0.658 (1H, m), 0.445 (1H, dd, 
J = 5.2, 8.0 Hz). 13C NMR (151 MHz): 39.9 (C22). 
(23R)-6β-Methoxy-3α,5α-cyclo-23-methylergost-17(20),24(28)-diene (16b). To a solution of the 
alcohol 15b (749.8 mg, 1.700 mmol) and TEA (1.2 mL, 8.7 mmol) in 10 mL anhydrous DCM at 0 oC was 
added MsCl (300 µL, 3.9 mmol) dropwise. The resulting solution was stirred for 30 min before extraction 
with 5% HCl and 4:1 hexanes/EtOAc. The combined organic layers were washed with sodium 
bicarbonate and then brine, dried over Na2SO4 and concentrated under reduced pressure to provide 830.8 
mg of the mesylate 24b (omitted in the scheme). (23R)-23-[(Methylsulfonyl)oxy]methyl]-6β-methoxy-
3α,5α-cyclo-ergost-17(20),24(28)-diene (24b). 1H NMR (600 MHz): 4.962 (1H, s), 4.856 (1H, s), 4.127 
(2H, m), 3.333 (3H, s), 2.959 (3H, s), 2.788 (1H, t, J = 2.7 Hz), 1.711 (3H, m), 1.042 (3H, d, J = 6.8 Hz), 
1.039 (3H, d, J = 6.8 Hz) ,1.027 (3H, s), 0.895 (3H, s), 0.654 (1H, m), 0.441 (1H, dd, J = 5.1, 8.0 Hz). 13C 
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NMR (151 MHz): 155.9, 146.0, 121.4, 108.2, 8.3, 72.5, 56.6, 56.3, 47.8, 45.0, 43.4, 41.5, 39.7, 37.9, 37.4, 
35.2, 35.0, 34.6, 33.3, 30.0, 24.9, 24.3, 23.1, 22.0, 21.8, 21.4, 19.2, 17.9, 16.7, 13.1. The mesylate was 
reduced with 253.2 mg of LAH as described above (see compound 10) to afford 598.5 mg (83% yield 
from of 16b, 85% yield based on recovered starting material). (23R)-6β-Methoxy-3α,5α-cyclo-23-
methylergost-17(20),24(28)-diene (16b). 1H NMR (600 MHz):  4.757 (1H, br s), 4.753 (1H, br s), 3.341 
(3H, s), 2.794 (1H, t, J = 2.8 Hz), 1.690 (3H, m), 1.040 (3H, d, J = 6.8 Hz),1.034 (3H, s), 1.029 (3H, d, J 
= 6.8 Hz), 0.984 (3H, d, J = 6.9 Hz), 0.908 (3H, s), 0.658 (1H, m), 0.443 (1H, dd, J = 5.2, 8.0 Hz). 13C 
NMR (151 MHz): 162.6, 144.7, 123.3, 104.5, 82.4, 56.6, 56.4, 47.9, 44.9, 44.0, 43.4, 38.0, 36.8, 35.2, 
35.1, 33.5, 33.3, 30.0, 29.9, 25.0, 24.3, 23.1, 22.8, 22.5, 21.4, 20.0, 19.2, 17.6, 16.8. 13.1. 
(23R)-6β-Methoxy-3α,5α-cyclo-(22-13C)-23-methylergost-17(20),24(28)-diene (16b*). This compound 
was obtained as described above from 15b* and its respective mesylate 22b*(omitted in schemes). (23R)-
23-[(Methylsulfonyl)oxy]methyl]-6β-methoxy-3α,5α-cyclo-(22-13C)Cergost-17(20),24(28)-diene 
(22b*). 1H NMR (600 MHz): 4.964 (1H, s), 4.858 (1H, s), 4.127 (2H, m), 3.335 (3H, s), 2.961 (3H, s), 
2.790 (1H, t, J = 2.7 Hz), 1.713 (3H, m), 1.044 (3H, d, J = 6.8 Hz), 1.041 (3H, d, J = 6.8 Hz) ,1.028 (3H, 
s), 0.897 (3H, s), 0.657 (1H, m), 0.443 (1H, dd, J = 5.2, 8.0 Hz). 13C NMR (151 MHz): 39.7 (C22). (23R)-
6β-Methoxy-3α,5α-cyclo-(22-13C)-23-methylergost-17(20),24(28)-diene (16b*). 1H NMR (600 MHz):  
4.758 (1H, br s), 4.754(1H, br s), 3.341 (3H, s), 2.796 (1H, t, J = 2.8 Hz), 1.692 (3H, m), 1.042 (3H, d, J 
= 6.8 Hz),1.036 (3H, s), 1.029 (3H, d, J = 6.8 Hz), 0.984 (3H, d, J = 6.9 Hz), 0.908 (3H, s), 0.6598 (1H, 
m), 0.443 (1H, dd, J = 5.2, 8.0 Hz). 13C NMR (151 MHz):44.0 (C22). 
(23S)-6β-Methoxy-3α,5α-cyclo-23-methylergost-17(20),24(28)-diene (16a). This compound was 
obtained as described above from 15a and its respective mesylate 24a (omitted in scheme). (23S)-23-
[(Methylsulfonyl)oxy]methyl]-6β-methoxy-3α,5α-cyclo-ergost-17(20),24(28)-diene (22a). 1H NMR 
(600 MHz): 4.967 (1H, s), 4.861 (1H, s), 4.137 (2H, d, J = 6.7 Hz), 3.334 (3H, s), 2.956 (3H, s), 2.792 
(1H, t, J = 2.8 Hz), 1.715 (3H, m), 1.044 (3H, d, J = 6.8 Hz), 1.043 (3H, d, J = 6.8 Hz) ,1.027 (3H, s), 
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0.885 (3H, s), 0.655 (1H, m), 0.442 (1H, dd, J = 5.2, 8.0 Hz). 13C NMR (151 MHz): 156.2, 146.2, 121.3, 
108.0, 82.4, 72.1, 56.6, 56.4, 47.7, 44.9, 43.4, 41.1, 40.0, 38.0, 37.4, 35.2, 35.0, 34.6, 33.3, 30.01, 30.0, 
24.9, 24.3, 23.1, 21.9, 21.7, 21.4, 19.2, 18.0, 16.5, 13.1. (23S)-6β-Methoxy-3α,5α-cyclo-23-
methylergosta-17(20),24(28)-diene (16a). 1H NMR (600 MHz):  4.761 (1H, br s), 4.752 (1H, s), 3.338 
(3H, s), 2.792 (1H, t, J = 2.8 Hz), 1.691 (3H, m), 1.040 (3H, d, J = 6.8 Hz),1.035 (3H, s), 1.031 (3H, d, J 
= 6.8 Hz), 0.966 (3H, d, J = 6.9 Hz), 0.905 (3H, s), 0.656 (1H, m), 0.443 (1H, dd, J = 5.2, 8.0 Hz). 13C 
NMR (151 MHz):162.7, 144.8, 123.1, 104.4, 82.4, 56.6, 56.59, 47.9, 44.8, 44.3, 43.4, 38.2, 36.3, 35.3, 
35.0, 33.6, 33.3, 30.04, 33.0, 25.0, 24.3, 23.1, 22.7, 22.4, 21.4, 19.5, 19.2, 17.9, 16.6, 13.1. 
(23R)-23-Methylergost-17(20),24(28)-dien-3β-ol (17b). To a solution of 16b (344.2 mg, 0.81 mmol) in 
5 mL of anhydrous DCM was added 105 µL of TFA. The resulting solution was stirred at room 
temperature for 30 min before adding 3 mL of 4:1 MeOH/TEA dropwise. The mixture was heated at 45 
oC for 1h before removing the solvent under reduced pressure. The obtained crude solid was purified via 
silica gel chromatography with 9:1 hexanes/EtOAc to afford the desired product 17b as a white crystal 
(250.7 mg, 75% yield). 1H NMR (600 MHz):  5.367 (1H, m), 4.756 (2H, m), 3.527 (1H, m), 1.695 (3H, 
m), 1.036 (3H, d, J = 6.7 Hz), 1.025 (3H, d, J = 6.7 Hz), 1.019 (3H, s), 0.984 (3H, d, J = 6.9 Hz), 0.876 
(3H, s). 13C NMR (151 MHz): 162.6, 144.5, 140.8, 123.7, 121.6, 104.6, 71.8, 56.6, 50.0, 44.0, 42.3, 37.5, 
37.2, 36.8, 36.5, 33.5, 31.8, 31.7, 31.4, 29.9, 24.5, 22.7, 22.5, 21.5, 20.0, 19.4, 17.6, 16.4. 
(23R)-(22-13C)23-methylergost-17(20),24(28)-dien-3β-ol (17b*) from 16b*. 1H NMR (600 MHz):  
5.367 (1H, m), 4.756 (2H, br s), 3.527 (1H, m), 1.695 (3H, m), 1.036 (3H, d, J = 6.7 Hz), 1.025 (3H, d, J 
= 6.7 Hz), 1.019 (3H, s), 0.983 (3H, dd, J = 4.7 (JCH), 6.9 Hz), 0.876 (3H, s). 13C NMR (151 MHz): 44.0 
(C22).  
(23S)-23-Methylergost-17(20),24(28)-dien-3β-ol (17a) from 16a. 1H NMR (600 MHz):  5.367 (1H, m), 
4.761 (1H, m), 4.752 (1H, m), 3.529 (1H, m), 1.696 (3H, m), 1.038 (3H, d, J = 6.7 Hz), 1.029 (3H, d, J = 
 
 
 
51 
 
6.8 Hz), 1.020 (3H, s), 0.966 (3H, d, J = 6.9 Hz), 0.871 (3H, s).13C NMR (151 MHz): 162.7, 144.6, 140.8, 
123.5, 121.6, 104.4, 71.8, 56.8, 50.0, 44.4, 44.3, 42.3, 37.7, 37.2, 36.5, 36.3, 33.6, 31.8, 31.7, 31.3, 30.0, 
24.5, 22.7, 22.4, 21.5, 19.6, 19.3, 18.0, 16.1. 
(23R)-23-Methylergost-4,17(20),24(28)-trien-3-one (18b). To a solution of the alcohol 17b (200.5 mg, 
0.490 mmol) and Al(iPrO)3 (400.8 mg, 1.960 mmol) of in 10 mL of anhydrous toluene was added 
anhydrous 3-methyl-2-butanone (2.5 mL, 23.3 mmol). The mixture was stirred at reflux under a N2 
atmosphere for 16 h. The reaction was cooled to room temperature before extraction with 10% 
hydrochloric acid. The combined organic layers were washed with sodium bicarbonate and then brine, 
dried over Na2SO4 and concentrated under reduced pressure. The desired product was obtained as white 
solid after purification with silica gel chromatography with 19:1 hexanes/EtOAc (169.1 mg, 85% yield). 
1H NMR (600 MHz): 5.731 (1H, s), 4.760 (1H, br s), 4.751 (1H, br s), 1.690 (3H, m), 1.191 (3H, s), 1.034 
(3H, d, J = 6.5 Hz), 1.024 (3H, d, J = 6.5 Hz), 0.984 (3H, d, J = 6.9 Hz), 0.903 (3H, s). 13C NMR (151 
MHz): 199.6, 171.5, 162.5, 144.0, 124.0, 123.8, 104.6, 55.7, 53.6, 44.4, 44.0, 38.6, 37.4, 36.8, 35.6, 35.1, 
34.0, 33.5, 32.9, 31.9, 29.8, 24.3, 22.7, 22.5, 21.4, 20.1, 17.6, 17.3, 16.5.  
(23S)-23-Methylergost-4,17(20),24(28)-trien-3-one (18a) from 17a. 1H NMR (600 MHz): 5.731 (1H, 
s), 4.763 (1H, s), 4.750 (1H, s), 1.691 (3H, m), 1.192 (3H, s), 1.038 (3H, d, J = 6.5 Hz), 1.029 (3H, d, J = 
6.5 Hz), 0.961 (3H, d, J = 6.9 Hz), 0.898 (3H, s). 13C NMR (151 MHz): 199.6, 171.5, 162.6, 144.0, 123.8 
(2C), 104.5, 55.9, 53.6, 44.4, 44.3, 8.6, 37.6, 36.3, 35.7, 35.1, 34.0, 33.6, 32.9, 31.9, 29.9, 24.3, 22.7, 
22.4, 21.4, 19.6, 17.9, 17.3, 16.3. 
(23S)-4α,23-Dimethylergost-17(20),24(28)-dien-3-one (19a) and (23S)-2α,4α,23-trimethylergost-
17(20),24(28)-dien-3-one 20a. To a solution of Li (190.3 mg, 27.6 mmol) in 15 mL of NH3 in an oven-
dry two-neck flask equipped with a drying tube was added dropwise the dissolved enone 18a (171.1 mg, 
0.42 mmol) in 7 mL of dry anhydrous THF. After 1.5 h, 450 µL of anhydrous isoprene was slowly added 
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followed 250 µL of anhydrous HMPA. The mixture was cooled to -78 oC before the dropwise addition of 
MeI (250 µL, 4.0 mmol). The NH3 was allowed to evaporate overnight through a drying tube. The 
reaction was extracted with 10% hydrochloride and 4:1 hexanes/EtOAc. The combined organic layers 
were washed with sodium bicarbonate and then brine, dried over Na2SO4 and concentrated under reduced 
pressure. The crude product was purified by silica gel chromatography with 39:1 hexanes/EtOAc to 
afford of the desired product 19a (78.3 mg, 44% yield) and 32.8 mg of 20a. Both products were obtained 
as a white solid. (23S)-4α,23-Dimethylergost-17(20),24(28)-dien-3-one (19a). 1H NMR (600 MHz): 
4.759 (1H, br s), 4.748 (1H, br s), 2.441(1H, m), 1.682 (3H, m), 1.076 (3H, s), 1.036 (3H, d, J = 6.7 Hz), 
1.027 (3H, d, J = 6.8 Hz), 0.981 (3H, d, J = 6.5 Hz), 0.960 (3H, d, J = 6.9 Hz), 0.864 (3H, s). 13C NMR 
(151 MHz): 213.6, 162.7, 144.5, 123.4, 104.4, 56.3, 53.9, 53.6, 45.1, 44.5, 44.4, 39.2, 38.0, 37.9, 36.4, 
36.3, 34.3, 33.6, 31.8, 30.0, 26.5, 24.3, 22.7, 22.4, 21.8, 19.6, 17.9, 16.4, 12.6, 11.5. (23S)-2α,4α,23-
Trimethylergost-17(20),24(28)-dien-3-one 20a. 1H NMR (600 MHz): 4.759 (1H, s), 4.748 (1H, s), 
2.522 (1H, s), 1,682 (3H, br s), 1.126 (3H, s), 1.036 (3H, d, J = 6.5 Hz), 1.027 (3H, d, J = 6.5 Hz), 1.001 
(3H, d, J = 6.5 Hz), 0.956 (6H, d, J = 6.5 Hz), 0.864 (3H, s). 
(23R)-4α,23-Dimethylergost-17(20),24(28)-dien-3-one (19b) and (23R)-2α,4α,23-trimethylergost-
17(20),24(28)-dien-3-one (20b) from 18b. 1H NMR (600 MHz): 4.756 (1H, br s), 4.749 (1H, br s), 
2.441(1H, m), 1.681 (3H, m), 1.074 (3H, s), 1.034 (3H, d, J = 6.7 Hz), 1.023 (3H, d, J = 6.7 Hz), 0.981 
(6H, d, J = 6.7 Hz), 0.864 (3H, s). 13C NMR (151 MHz): 213.7, 162.5, 144.5, 123.6, 104.6, 56.1, 53.9, 
53.6, 45.1, 44.6, 44.0, 39.2, 38.0, 37.7, 36.8, 36.4, 34.3, 33.5, 31.8, 29.9, 25.6, 24.3, 22.7, 22.5, 21.8, 20.0, 
17.6, 16.6, 12.7, 11.5. (23R)-2α,4α,23-trimethylergost-17(20),24(28)-dien-3-one (20b).  1H NMR (600 
MHz): 4.756 (1H, s), 4.749 (1H, s), 2.520 (1H, s), 1,680 (3H, br s), 1.124 (3H, s), 1.033 (3H, d, J = 6.6 
Hz), 1.022 (3H, d, J = 6.6 Hz), 0.999 (3H, d, J = 6.5 Hz), 0.979 (3H, d, J = 6.9 Hz), 0.961 (6H, d, J = 6.6 
Hz), 0.868 (3H, s). 13C NMR (151 MHz): 214.7, 162.5, 144.5, 123.6, 104.6, 56.1, 54.6, 54.0, 49.2, 44.7, 
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44.6, 44.0, 40.7, 37.7, 36.8, 36.78, 34.3, 33.5, 31.9, 29.9, 25.5, 24.3, 22.7, 22.5, 21.8, 20.0, 17.6, 16.6, 
14.9, 13.6, 11.5.  
(23R)-4α(13C-Methyl)-23-methylergost-17(20),24(28)-dien-3-one (19b*) and (23R)-2α,4α(13C-
dimethyl)-23-methylergost-17(20),24(28)-dien-3-one (20b*) from 18b. 1H NMR (600 MHz): 4.755 
(1H, br s), 4.748 (1H, br s), 2.441(1H, m), 1.682 (3H, br s), 1.074 (3H, s), 1.034 (3H, d, J = 6.7 Hz), 
1.023 (3H, d, J = 6.7 Hz), 0.980 (3H, d, J = 6.8 Hz),0.980 (3H, dd, J = 6.5, 126.1 (JCH) Hz), 0.869 (3H, s). 
13C NMR (151 MHz): 11.5 (4α-Me). (23R)-2α,4α -13C-dimethyl-23-methylergost-17(20),24(28)-dien-3-
one (20b*). 1H NMR (600 MHz): 4.756 (1H, s), 4.749 (1H, s), 2.518 (1H, s), 1,680 (3H, m), 1.123 (3H, 
s), 1.033 (3H, d, J = 6.6 Hz), 1.022 (3H, d, J = 6.6 Hz), 0.998 (3H, dd, J = 6.5, 126.8 (JCH) Hz), 0.979 
(3H, d, J = 6.9 Hz), 0.960 (6H, d, J = 6.5, 127.0 (JCH) Hz), 0.868 (3H, s). 13C NMR (151 MHz): 14.9 (2α-
Me), 11.5 (4α-Me). 
(23S)-4α,23-Dimethylergost-17(20),24(28)-dien-3β-ol (23-epipfiesterol, 3). To a solution of Li (70.5 
mg, 10.2 mmol) in 10 mL of NH3 was added of 19a (73.3 mg, 0.17 mmol) in 2 mL of Et2O. After 1 h, 
250 µL of tBuOH was added. After allowing the NH3 to evaporate at room temperature, the reaction was 
extracted with 10% hydrochloric acid and 4:1 hexanes/EtOAc. The combined organic layers were washed 
with sodium bicarbonate and then brine, dried over Na2SO4 and concentrated under reduced pressure. The 
crude product was purified by silica gel chromatography with 9:1 hexanes/EtOAc to afford compound 3 
as a white solid (52.6 mg, 76% yield). 1H NMR (600 MHz): 4.756 (1H, br s), 4.747 (1H, br s), 3.084 (1H, 
m), 1.679 (3H, m), 1.036 (3H, d, J = 6.7 Hz), 1.026 (3H, d, J = 6.7 Hz), 0.962 (3H, d, J = 6.9 Hz), 0.955 
(3H, d, J = 6.4 Hz), 0.836 (6H, s). 13C NMR (151 MHz): 162.7, 144.8, 123.2, 104.4, 76.6, 56.6, 54.4, 
51.0, 44.5, 44.4, 39.2, 38.0, 36.8, 36.3, 36.0, 34.3, 33.6, 23.1, 31.1, 30.0, 24.3, 24.2, 22.7, 22.4, 21.5, 19.6, 
17.9, 16.4, 15.1, 13.3. 
 
 
 
54 
 
(23R)-4α,23-Dimethylergost-17(20),24(28)-dien-3β-ol (Pfiesterol, 1) from 19b. 1H NMR (600 MHz): 
4.754 (1H, br s), 4.749 (1H, br s), 3.083 (1H, m), 1.678 (3H, m), 1.034 (3H, d, J = 6.8 Hz), 1.023 (3H, d, 
J = 6.8 Hz), 0.977 (3H, d, J = 6.9 Hz), 0.955 (3H, d, J = 6.4 Hz), 0.840 (3H, s), 0.836 (3H, s). 13C NMR 
(151 MHz): 162.6, 144.7, 123.4, 104.5, 76.6, 56.3, 54.4, 50.9, 44.6, 44.0, 39.2, 37.8, 36.8, 36.7, 36.0, 
34.3, 33.5, 32.1, 31.1, 29.9, 24.3, 24.2, 22.7, 22.5, 21.5, 20.0, 17.5, 16.6, 15.1, 13.3. 
(23R)-4α-(13C-Methyl)-23-methylergost-17(20),24(28)-dien-3β-ol (1*) from 19b*. 1H NMR (600 
MHz): 4.755 (1H, br s), 4.751 (1H, br s), 3.084 (1H, m), 1.679 (3H, m), 1.036 (3H, d, J = 6.8 Hz), 1.024 
(3H, d, J = 6.8 Hz), 0.978 (3H, d, J = 6.9 Hz), 0.954 (3H, dd, J = 6.4, 125.1 (JCH) Hz), 0.840 (3H, s), 
0.836 (3H, s). 13C NMR (151 MHz): 15.1 (4α-Me). 
(23S)-4-Phenylthiomethyl-23-methylergost-4,17(20),24(28)-trien-3-one (21a). To a solution of 18a 
(25.8 mg, 0.0600 mmol) in 700 µL of MeOH in a stretched glass culture tube was added 150 µL of 
thiophenol, 250 µL of formalin (37% formaldehyde w/w) and 37 µL of TEA. The tube was flame sealed 
and the mixture was heated at 120 oC for 19 h. The reaction was allowed to cool to room temperature 
before extraction with 9:1 hexanes/EtOAc. The combined organic layers were washed with sodium 
bicarbonate and then brine, dried over Na2SO4 and concentrated under reduced pressure. The crude 
product was purified via silica gel chromatography with 19:1 hexanes/EtOAc to obtain compound 21a 
(17.2 mg, 51% yield). 1H NMR (600 MHz): 7.387 (2H, m), 7.187 (1H, m), 4.764 (1H, br s), 4.751 (1H, br 
s), 3.881 (2H, br s), 2.722 (1H, m), 1.687 (3H, m), 1.165 (3H, s), 1.038 (3H, d, J = 6.8 Hz), 1.029 (3H, d, 
J = 6.8 Hz), 0.963 (3H, d, J = 6.9 Hz), 0.885 (3H, s). 13C NMR (151 MHz): 197.0, 168.2, 162.6, 144.0, 
136.6, 131.0 (2 C), 128.7 (2 C), 128.3, 126.5, 123.8, 104.5, 55.9, 54.0, 44.4, 44.3, 39.5, 37.6, 36.3, 34.8, 
34.6, 33.7, 33.6, 32.0, 29.9, 28.9, 28.2, 24.3, 22.7, 22.4, 21.4, 19.7, 17.9, 17.85, 16.3. 
(23R)-4-Phenylthiomethyl-23-methylergost-4,17(20),24(28)-trien-3-one (21b) from 18b. 1H NMR 
(600 MHz): 7.386 (2H, m), 7.188 (1H, m), 4.760 (1H, br s), 4.751 (1H, br s), 3.877 (2H, s), 2.722 (1H, 
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m), 1.682 (3H, br s), 1.160 (3H, s), 1.035 (3H, d, J = 6.8 Hz), 1.024 (3H, d, J = 6.8 Hz), 0.982 (H, d, J = 
6.9 Hz), 0.886 (3H, s). 13C NMR (151 MHz): 197.0, 168.2, 162.5, 143.9, 136.5, 131.0 (2 C), 128.7 (2 C), 
128.2, 126.5, 123.9, 104.6, 55.6, 54.0, 44.4, 44.0, 37.4, 36.8, 34.7, 34.6, 33.6, 33.5, 31.9, 29.8, 28.9, 28.2, 
24.2, 22.7, 22.5, 21.4, 20.1, 17.8, 17.5, 16.5. 
Pfiesterol (1) from 21b. To a solution of Li (61.2 mg, 8.80 mmol) of in 15 mL of NH3 was added 
compound 21b (12.6 mg, 0.0200 mmol) of in 2 mL of Et2O. The mixture was stirred for 30 min before 
adding 400 µL of MeOH dropwise. After 45 min, additional Li (35.1 mg, 5.1 mmol) was added to the 
reaction. After 1 h, NH3 (5 mL) was added and the reaction was left to stir overnight. The residue 
obtained after the NH3 slowly evaporated overnight was extracted with 4:1 hexanes/EtOAc and 10% 
hydrochloric acid. The combined organic layers were washed with sodium bicarbonate and then brine, 
dried over Na2SO4 and concentrated under reduced pressure. The product 1 was purified via preparative 
TLC with 4:1 hexanes/EtOAc (8.1 mg, 80% yield).  
 
References: 
 
1. Volkman, J. K. Org. Geochem. 1986, 9, 83-99. 
2. Volkman, J. K., Sterols in Microalgae. In The Physiology of Microalgae; Borowitzka, M. A., 
Bearadall, J., Raven, J., ED.; Springer, Dordrecht, 2006; p 485. 
3. Volkman, J. K., Barrett, S. M., Blackburn, S. I., Mansour, M. P., Sikes, E. L., Gelin, F. Org. 
Geochem. 1998, 29, 1163-1179. 
4. Hackett, J. D., Anderson, D. M., Erdner, D. L., Bhattacharya, D. Am. J. Bot. 2004, 91, 1523-1534. 
 
 
 
56 
 
5. a) Wang, D.-Z. Mar. Drugs 2008, 6, 349-371. b) Burkholder, J. M., Noga, E. J., Hobbs, C. H., 
Glasgow, H. B. J. Nature 1992, 358, 407-410. c) Noga, E. J., Khoo, L., Stevens, J. B., Fan, Z., 
Burkholder, J. M. Mar. Pollut. Bull. 1996, 32, 219-224. 
6. Leblond, J. D., Anderson, B., Kofink, D., Logares, R., Rengefors, K., Kremp, A. Eur. J. Phycol. 
2006, 41, 303–311. 
7. Giner, J.-L. Chem. Rev. 1993, 93, 1735-1152. 
8. a) Giner, J.-L., Boyer, G. L. Phytochemistry 1998, 48, 475-477. b) Giner, J.-L., Li, X., Boyer, G. L. 
Phytochemistry 2001, 57, 787-789. c) Zhao, H. Analysis, Synthesis and Metabolic Studies of Sterols 
from Harmful Algae and Fungi. Ph.D. Dissertation, State University of New York – College of 
Environmental Science and Forestry, Syracuse, NY, 2006. 
9. Giner, J.-L., Faraldos, J. A., Boyer, G. L. J. Phycol. 2003, 39, 1-6. 
10.  Giner, J.-L., Zhao, H., Boyer, G. L., Satchwell, M. F., Andersen, R. A. Chem. Biodivers. 2009, 6, 
111-130. 
11. Leblond, J. D., Chapman, P. J. J. Phycol. 2004, 40, 104–111. 
12. Steidinger, K. A., Burkholder, J. M., Glasgow, H. B., Hobbs, C. W., Garrett, J. K., Truby, E. W., 
Noga, E. J., Smith, S. A. J. Phycol. 1996, 32, 157–164. 
13. a) Zielinski, J., Kokke, W. C. M. C., Tam Ha, T. B., Shu, A. Y. L., Duax, W. L., Djerassi, C. J. Org. 
Chem. 1983, 48, 3471-3477. b) Giner, J. L., Djerassi, C. L. J. Org. Chem. 1991, 56, 2357-2363.  
14. Lafont, R., Mathieu, M. Ecotoxicology 2007, 16, 109-130. 
15. Shingate, B. B., Hazra, B. G., Pore, V. S., Gonnade, R. G., Bhadbhade, M. M. Tetrahedron 2007, 63, 
5622-5635. 
16. Cheng, S.-L., Jiang, X.-L., Shi, Y., Tian, W.-S. Org. Lett. 2015, 17, 2346-2349. 
 
 
 
57 
 
17. Terada, S., Hayashi, K., Mitsuhashi, H. Tetrahedron Lett. 1978, 23, 1995-1998. 
18. Julian, P. L., Meyer, E. W., Ryde, I. J. Am. Chem. Soc. 1950, 72, 367-370.  
19. Schweiger, E. J., Joullié, M. M., Weisz, P. B. Tetrahedron Lett. 1997, 38, 6127-6130. 
20. a) Freerksen, R. W., Raggio, M. L., Thoms, C. A., Watt, D. S.  J. Org. Chem. 1979, 44, 702-710. b) 
Kasal, A., Pokorna, J., Zajicek, J. Czech. Chem. Commun. 1991, 56, 1340-1347.  
21. Brown, F. J., Djerassi, C. J. Org. Chem. 1981, 46, 954-963. b) Schmuff, N. R., Trost, B. M. J. Org. 
Chem. 1983, 48, 1404-1412. 
22. a) Bischofberger, N., and Walker, K. A. M. J. Org. Chem. 1985, 50, 3604-3609. b) Paquette, L. A., 
Hofferberth, J. E., Org. React. 2003, 62, 477-567. 
23. Loughhead, D. G. J. Org. Chem. 1985, 50, 3931-3934. 
24. Stoilov, I., Kolaczkowska, E., Watt, D. S. J. Org. Chem. 1993, 58, 3444-3454. 
25. a) Oppenauer. R. V. Org. Synth. 1941, 21, 18. b) Djerassi, C. Org. React. 1951, 6, 207. 
26. Kirk, D. N.; Petrow, V. Proc. Chem. Soc. 1961, 114. 
27. Schmidt, A. W., Doert, T., Goutal, S., Gruner, M., Mende, F., Kurzchalia, T. V., Knölker, H.-J. Eur. 
J. Org. Chem. 2006, 48, 3471-3477. 
 
 
 
 
 
 
 
 
58 
 
CHAPTER 4 
 
Synthesis and NMR Characterization of 4-Methylcholestane-3β,4β-diol, a 
Pavlovol, from Cholestenone 
 
Abstract:  
 
The synthesis of 4-methylcholestane-3β,4β-diol, a synthetic pavlovol, from cholestenone in a 
seven-step sequence and a 38% overall yield is reported. Pavlovols in cultured Pavlova spp. were found 
to behave as analogs of the hormone ecdysone in northern bay scallop larvae (Argopecten irradians 
irradians). Another route to 4-methylcholestane-3β,4β-diol from 4-methylenecholestanol is also 
described. All the products were characterized by NMR. The NMR characterization of (24R)-4-
methylstigmastane-3β,4β-diol and (24R)-4-methylsigmast-22-en-3β,4β-diol are also reported. These 
sterols provided reference compounds and samples for biological testing of their effects on the growth 
and development of scallop larvae. 
 
4.1 Introduction 
 
Pavlovols, 3β,β4-dihydroxy-4-methylsterols, are natural sterols that have been exclusively 
isolated in microalgae belonging to the genera Pavlova and Diacronema.1-2Both genera are part of the 
family Pavlovaceae and the order Pavlovales, hence the name of those dihydroxy sterols that are also 
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considered biomarkers for that order.3 Four natural pavlovols have been reported to date: methylpavlovol 
(1), ethylpavlovol (2), 22-dehydromethylpavlovol (3) and 22-dehydroethylpavlovol (4) (Figure 4.1).1-3 
 
HO
HHO
1R
4R
2R
6R
7R
R
3R
5R
 
 
Figure 4.1. The natural pavlovols (1-4) and the reported synthetic pavlovols (5-7). 
 
Microalgae, including some Pavlova species, have been extensively used in aquaculture as live 
foods for bivalves because of their high content of essential nutrients.1,2,4 Microalgae are the primary 
source of sterols for marine invertebrates and shellfishes, as they are either no longer able to synthesize or 
transform their own essential sterols or do so poorly.5-7 Pavlovols in cultured Pavlova spp. were found to 
behave as analogs of the hormone ecdysone by inducing early metamorphosis in northern bay scallop 
(Argopecten irradians irradians) larvae and to be responsible for settlement induction.8 A pavlovol with 
the cholesterol side chain (5) was made in a seven-step sequence from cholestenone with a 38% overall 
yield. Two other synthetic pavlovols made from stigmasterol, (24R)-4-methylstigmastane-3β,4β-diol (6) 
and (24R)-4-methylsigmast-22-en-3β,4β-diol (7), are also described. These sterols offer new material for 
testing on the effects of pavlovols on bivalves. Another method to 4-methylcholestane-3β,4β-diol from 4-
methylenecholestanol is also described. 
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4.2 Results and Discussion 
 
The synthesis of 4-methylcholestane-3β,4β-diol (5) from cholestenone is summarized in Scheme 
4.1. Cholestenone (8), which is commercially available and can easily be made from cholesterol 9, was 
reduced with LAH to obtain a 7:1 mixture of the allylic alcohols 10 favoring the 3β product in near 
quantitative yield. The mixture of alcohols was benzylated with benzyl bromide and the product mixture 
10 was converted to the mixture of alcohols 11 via a hydroboration-oxidation reaction10. Heating the 
oxidation reaction at 50 oC overnight was increased the reaction yield, but still the yield was only a 
modest 59 %. A 7:1 mixture of the alcohols 11b/11a, was obtained from the reaction.  
O
LAH
HO
BnCl/NaH
BnO
59%
1) BMS
2)NaOH, H2O2
BnO
89%
OH
H1:7 a/b
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H
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H
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10 11
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b: 3b
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O
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MeMgI
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HO HO
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Scheme 4.1. Synthesis of compound 5 from cholestenone 8. 
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The mixture of alcohols 11a and 11b from the hydroboration-oxidation step were oxidized to 
their corresponding ketones 12 with PCC in good yield (89%). It was found that the mixture of the 
ketones 12a and 12b could be isomerized with methanolic NaOH at reflux to obtain the pure desired 
ketone 12b in near quantitatively yield. The epimerization of the ketone mixture to one product 12b 
boosted the sequence overall yield by salvaging the undesired isomer 12a which originated from cholest-
4-en-3α-ol (9a), the minor product of the LAH reduction of cholestenone in the very first step of the 
sequence. The conversion of the ketone mixture to one product 12b also provided a direct path to the final 
product 5 without the need for purification by chromatography. The ketone 12b was selectively alkylated 
with methylmagnesium iodide to afford only compound 13 in a 98% yield. The selectivity the alkylation 
reaction can be attributed to steric hindrance over the top face of the carbonyl by the benzyl ether at C3 
and the methyl group at C10. The desired synthetic pavlovol, 4-methylcholestane-3β,4β-diol 5, was 
obtained from the deprotection of the benzyl ether via catalytic hydrogenation in an 89 % yield from 
intermediate 12, and a 38% overall yield from cholestenone.  
 
The final product, 4-methylcholestane-3β,4β-diol (5), was confirmed as a pavlovol by comparing 
its NMR data with the 1H and 13C data1b reported for methylpavlovol (1) and ethylpavlovol (2) (Table 
4.1). Comparison of the nuclear 1H and 13C signals of compound 5 and methylpavlovol and ethylpavlovol 
indicated that all three compounds have a similar nucleus. Only minor differences (under 10 ppb) were 
observed between the signals of the nucleus. The side chain 1H and 13C chemical shifts for the three 
compounds only had similar values for C20 and C21. The NMR data for compounds 6 and 7 are reported 
in the experimental section.  
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Table 4.1. 1H and 13C chemical shifts (ppm) for compounds 11b, 21b and 5. *30: 4-methyl carbon. 
 
 
13C shifts 
 
1H shifts 
Carbon # 1 2 5 
 
1 2 5 
1 36.68 36.61 36.64 
    2 27.21 27.17 27.17 
    3 75.69 75.65 75.66 
 
3.249 3.250 3.247 
4 74.18 74.17 74.16 
    5 53.00 52.92 52.95 
    6 20.62 20.60 20.59 
    7 32.52 32.48 32.49 
    8 34.96 34.90 34.91 
    9 55.67 55.59 55.62 
 
0.59 0.59 0.581 
10 36.26 36.22 36.22 
    11 20.64 20.60 20.61 
    12 40.02 39.97 40.00 
    13 42.58 42.53 42.55 
    14 56.66 56.61 56.64 
    15 24.21 24.19 24.17 
    16 28.25 28.28 28.27 
    17 56.16 56.12 56.27 
    18 12.10 12.07 12.07 
 
0.643 0.646 0.646 
19 13.99 13.97 13.97 
 
1.006 1.009 1.009 
20 36.21 36.28 36.186 
    21 18.86 18.77 18.66 
 
0.899 0.906 0.895 
22 33.76 33.89 35.78 
    23 30.65 26.37 23.84 
    24 39.13 46.05 39.52 
    25 31.52 28.93 28.00 
    26 17.64 19.60 22.55 
 
0.779 0.828 0.863 
27 20.51 13.97 22.80 
 
0.771 0.807 0.859 
28 15.48 26.37 
     29 
 
12.32 
     *30 25.37 25.36 25.35 
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Scheme 4.2. Synthesis of intermediates 17a and 17b from 4-methylenecholestanol 15. 
 
In the second method, compound 5 was made from the known sterol 4-methylenecholestanol 
1412. The starting material 14 was easily and cleanly converted to the epoxide 1512b-13 with mCPBA 
(Scheme 4.2). The oxygen was added exclusively to the bottom face of the exo-methylene. The hydroxyl 
group in this case did not participate in the stereodirection of the epoxidation.12b The epoxy-alcohol was 
treated with phenyl isocyanate and pyridine in DCM to afford the epoxy-phenylcarbamate 16.14 The 
treatment of intermediate 16 with a 2% TFA solution in anhydrous DCM gave a 2:3 mixture of the cyclic 
carbonates 17a and 17b in 42% yield.15,16 Multiple side products were observed from this reaction, but 
they were not characterized. The desired product 17b was only obtained in a 25% yield. A proposed 
mechanism for the formation of the cyclic carbonates is illustrated in Scheme 4.3. In the anhydrous 2% 
TFA/DCM solution, the phenyl carbamate and the epoxide in compound 15 rearranged to the resonance 
stabilized iminium hydroxymethyl intermediate A that reacted intermolecularly to give the mixture of 
imines B. The cyclic carbonates 17a and 17b are readily obtained from the hydrolysis of the imine 
mixture B. 
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Scheme 4.3. Mechanism for the formation of the cyclic carbonates 17a and 17b. 
 
With the desired stereochemistry already in at C4, intermediate 17b was converted to its 
corresponding ethoxymethyl ether 18 with chloromethyl ethyl ether (Scheme 4.4).15b,17 Compound 19 was 
obtained by transesterification of the cyclic carbonate with methanolic NaOH at reflux.18 The 4α-
hydroxymethyl was selectively deoxygenated in a two-step procedure to obtained compound 20.19 To 
achieve the final product 5, the 3β-hydroxyl was deprotected with catalytic sulfuric acid in a 4:1 
MeOH/H2O at reflux in a 90% yield. This method was originally considered harsh with the tertiary 
alcohol at C4. However, no noticeable dehydration product was observed in the crude mixture. The final 
product was spectrally identical to the pavlovol generated by the original method. 
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Scheme 4.4. Synthesis of compound 3 from intermediate 16b. 
 
4.3 Summary 
 
The synthesis of the unnatural pavlovol, 4-methylcholestane-3β,4β-diol (5), was successfully 
accomplished from cholestenone in seven steps and a 38% overall yield. The final product was 
characterized by 1H and 13C NMR. Its structure was confirmed by comparison to NMR data for the 
natural sterols methylpavlovol (1) and ethylpavlovol (2).  Another seven-step sequence was used to make 
compound 3 from 4-methylenechlestanol. The second sequence was less effective as only an 8% yield 
overall yield was observed. The TFA catalyzed reaction only gave the desired cyclocarbonate in a 25% 
yield. Two new synthetic pavlovols synthesized from stigmasta-5,22-dien-3-one, (24R)-4-
methylstigmastane-3β,4β-diol (6) and (24R)-4-methylsigmast-22-en-3β,4β-diol (7), are also reported. 
These sterols are 24 epimers of the natural pavlovols 2 and 4. All three pavlovols were made available for 
studies of their biological effects on bivalve growth and development. Pavlovols behave as natural 
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analogs of ecdysone, a natural invertebrate hormone that is also involved in life-history transitions in 
bivalve molluscs.8  
 
4.4 Experimental 
 
General Procedures. NMR spectra were obtained in CDCl3 on a Bruker 600 MHz spectrometer (1H at 
600 MHz and 13C at 151 MHz). Preparative thin layer chromatography (TLC) purifications were done 
with Sorbent Technologies (SORBTECH) silica gel HL thin TLC plates (20 x 20 cm2, 250 µm thick with 
glass backed support). All solvents were from commercial sources.  
Cholest-4-en-3-ol (9). A solution of LAH (400.6 mg, 10.5 mmol) in 10 mL of anhydrous ether was added 
dropwise to a stirring mixture of 8 (2.63 g, 6.84 mmol) in 4 mL of anhydrous ether. After 30 min, the 
reaction was quenched by slow addition brine. The resulting mixture was diluted with 10% Hydrochloric 
acid and extracted with 4:1 hexanes/EtOAc. The organic layer was washed with saturated sodium 
bicarbonate, dried over Na2SO4, filtered through silica and evaporated under reduced pressure to give of a 
6.7:1 mixture of favoring the 3β-product 9b (2.56 g, 97% yield). 
3-Benzyloxy-cholest-4-ene (10). Benzyl bromide (3.8 mL, 31.9 mmol) was added to a solution of 9 (8.1 
g, 20.9 mmol) dissolved in 5 mL of dry THF in a 25-mL flask equipped with a reflux condenser. NaH 
(4.0 g) was transferred in 3 mL of anhydrous THF to the reaction mixture before heating the resulting 
solution at reflux under a N2 atmosphere. After 16 h, the reaction was cooled to rt, filtered through silica 
gel and eluted with 4:1 hexanes/EtOAc. The crude product was evaporated under reduced pressure.  Flash 
chromatography using 79:1-39:1 hexanes/EtOAc gave a 6.7:1 β/α mixture of 10 (8.65 g, 87%). A sample 
of the mixture was separated by preparative TLC with 39:1 hexanes/EtOAc. 3α-Benzyloxy-cholest-4-ene 
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(10a).  1H NMR (600 MHz): 5.455 (1H, m), 4.594 (1H, d, J = 12.2 Hz), 4.519 (1H, d, J = 12.2 Hz), 3.771 
(1H, m), 2.205 (1H, m), 0.977 (3H, s), 0.904 (3H, d, J = 6.6 Hz), 0.867 (3H, d, J = 6.6 Hz), 0.863 (3H, d, 
J = 6.6 Hz), 0.680 (1H, s). 13C NMR (151 MHz) (3-α product): 150.6, 139.4, 128.3 (2 C), 127.7 (2 C), 
127.3, 118.7, 70.9, 70.0, 56.2, 56.1, 53.5, 42.5, 39.9, 39.5, 37.6, 36.2, 35.9, 35.8, 32.7, 32.5, 32.1, 28.2, 
28.1, 24.3, 24.2, 23.8, 22.8, 22.6, 21.5, 18.7, 18.2, 12.0. 3β-Benzyloxy-cholest-4-ene (10b).  1H NMR 
(600 MHz): 5.389 (1H, m), 4.601 (1H, d, J = 11.9 Hz), 4.561 (1H, d, J = 11.9 Hz), 3.944 (1H, m), 2.200 
(1H, m), 1.813 (1H, m), 1.052 (3H, s), 0.901 (3H, d, J = 6.6 Hz), 0.866 (3H, d, J = 6.6 Hz), 0.861 (3H, d, 
J = 6.6 Hz), 0.677 (1H, s). 13C NMR (151 MHz) (3-β product): 148.0, 139.1, 128.3 (2 C), 127.7 (2 C), 
127.3, 120.9, 74.7, 69.8, 56.2 (2 C), 54.5, 42.5, 39.9, 39.5, 37.6, 36.2, 36.0, 35.8, 35.4, 33.1, 32.3, 28.2, 
28.0, 25.8, 24.2, 23.8, 22.8, 22.5, 21.0., 18.8, 18.7, 12.0. 
3-Benzyloxy-cholestane-3,4-diol (11).  Borane-dimethyl sulfide (45 mL of a 2 M solution in THF) was 
added to compound 10 (8.65 g, 18.1 mmol) at 0 oC under a N2 atmosphere over 10 min. After 30 min of 
stirring, the reaction was removed from the ice bath and stirred at room temperature for 3 h before adding 
3 mL of 6 M NaOH dropwise. After an additional 15 min, 3 mL of 30% H2O2 was added dropwise and 
the resulting mixture was stirred vigorously at 50 oC for 16 h.  The reaction was allowed to cool to room 
temperature, quenched with water and extracted with 4:1 hexanes/EtOAc. The organic layer was washed 
with brine and then sodium bicarbonate, dried over Na2SO4 and evaporated under reduced pressure. Silica 
gel chromatography with 19:1 hexanes/ EtOAc yielded a 6.7: 1 mixture of 3β,4α,5α/3α,4β,5β 11 as a 
white solid (5.27g, 59% yield).  1H NMR (600 MHz) (mixture): 1H NMR (600 MHz) (mixture): 
4.703(3α,5β) (1H, d, J = 11.5 Hz), 4.699(3β,5α) (1H, d, J = 11.6 Hz), 4.476(3α,5β) (1H, d, J = 11.5 Hz), 
4.476(3β,5α) (1H, d, J = 11.6 Hz), 3.864(3α,5β) (1H, m), 3.415(3β,5α) (1H, m), 3.228(3α,5β) (1H, m), 
3.180(3β,5α) (1H, m), 2.519(3α,5β) (1H, d, J = 1.4 Hz), 2.481(3β,5α) (1H, d, J = 1.4 Hz), 0.898(3β,5α) 
(3H, d, J = 6.6 Hz), 0.866(3β,5α) (3H, d, J = 6.6 Hz), 0.861(3β,5α) (3H, d, J = 6.6 Hz), 0.840(3β,5α) 
(3H, s), 0.648(3β,5α) (3H, s).         
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(3ξ,5ξ)-3-Benzyloxy-cholestan-4-one (12). To a solution of 11 (4.97 g, 10.4 mmol) in 25 mL of DCM 
was added PCC (10.4 g, 48.4 mmol). The mixture was stirred for 16 h. Hexanes (25 mL) was added to the 
mixture before filtering it through silica gel.  The product was eluted with 4:1 hexanes/EtOAc to yield 
71.2 mg of 7: 1 (3β,5α/3α,5β) mixture of 12 as a white solid (4.40 g, 89% yield). 1H NMR (600 MHz) : 
4.861 (1H, d, J = 12.1 Hz), 4.846 (1H, d, J = 12.0 Hz), 4.490 (1H, d, J = 12.0 Hz), 4.464 (1H, d, J = 12.0 
Hz), 3.937 (1H, dd, J = 7.4, 12.0 Hz), 3.828 (1H, dd, J = 6.6, 12.3 Hz), 0.899  (3H, d, J = 6.5 Hz), 0.866 
(3H, d, J = 6.6 Hz), 0.862 (3H, d, J = 6.6 Hz), 0.747 (3H, s), 0.648 (3H, s), 0.626 (3H, s). 
 5α-3β-Benzyloxy-cholestan-4-one (12b). To a solution of 12 (4.08 g, 8.30 mmol) in 100 mL of 10% 
methanolic NaOH was added 50 mL of EtOH. The mixture was heated at reflux for 1 h. The solvent was 
removed under reduced pressure before extraction of the product with 5% hydrochloric acid and 2:1 
hexane/EtOAc. The organic layer was washed with brine, dried over Na2SO4 and evaporated under 
reduced pressured to afford 12b as a white solid (4.01 g, 98% yield). 1H NMR (600 MHz): 4.845 (1H, d, J 
= 12.0 Hz), 4.464 (1H, d, J = 12.0 Hz), 3.936 (1H, dd, J = 7.3, 12.1 Hz), 2.252 (1H, m), 2.079 (1H, dd, J 
= 2.8, 12.1 Hz), 0.898 (3H, d, J = 6.5 Hz), 0.866 (3H, d, J = 6.6 Hz), 0.861 (3H, d, J = 6.6 Hz), 0.746 
(3H, s), 0.647 (3H, s). 13C NMR (151 MHz): 210.5, 138.2, 128.4 (2 C), 127.8 (2 C), 127.6, 81.3 71.8, 
57.5, 56.3, 56.2, 54.5, 43.0, 42.6, 39.9, 39.5, 36.4, 36.1, 35.7, 34.9, 30.4, 28.2, 28.0, 24.1, 23.8, 22.849, 
22.5, 21.7, 20.3, 18.7, 13.6, 12.0. 
3β-Benzyloxy-4-methylcholestane-4β-ol (13). To a mixture of Mg (568.9 mg, 23.5 mmol) and I2 (28.6 
mg, 0.11 mmol) in 5 mL of anhydrous Et2O was added a solution of MeI (1.1 mL, 17.5 mmol) in 3.9 mL 
of Et2O dropwise under a N2 atmosphere over 20 min. After 15 min, a solution of 12 (815.7 mg, 1.7 
mmol) in 60 mL of Et2O was added dropwise over 30 min. After an additional 5 min, the reaction was 
cooled on ice before extraction with cold saturated aqueous NH4Cl and 2:1 hexanes/EtOAc. The organic 
layer was washed with brine, dried over Na2SO4 and evaporated under reduced pressured. The crude 
product was purified by flash chromatography with 19:1 hexanes/EtOAc to afford 13 as a white solid 
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(829.8 g, 98% yield). 1H NMR (600 MHz):  7.348 (4H, d, J = 4.3 Hz), 7.292 (1H, m), 4.701 (1H, d, J = 
11.6 Hz), 4.500 (1H, d, J = 11.6 Hz), 3.038 (1H, dd, J = 4.6, 11.4 Hz), 1.219 (3H, s), 1.048 (3H, s), 0.900 
(3H, d, J = 6.6 Hz), 0.869 (3H, d, J = 6.6 Hz), 0.865 (3H, d, J = 6.6 Hz), 0.652 (3H, s), 0.555 (1H, m). 13C 
NMR (151 MHz): 138.7, 128.3 (2C), 127.8 (2C), 127.6, 82.9, 74.1, 71.2, 56.7, 56.3, 55.8, 53.3, 42.6, 
40.1, 39.5, 36.7, 36.24, 36.20, 35.8, 35.0, 32.6, 28.3, 28.0, 25.7, 24.2, 23.8, 22.8, 22.7, 22.6, 20.73, 20.70, 
18.7, 14.1, 12.1. 
4-Methylcholestane-3β,4β-diol (3). To a solution of 13 (779.9 mg, 1.5 mmol) in 15 mL of EtOAc was 
added 133.3 mg of 10% Pd/C. The mixture was stirred under H2 for 1.5 h. The crude product was filtered 
through silica gel to afford 3 (570.8 mg, 89% yield). 1H NMR (600 MHz): 3.244 (1H, m), 1.224 (3H, s), 
1.009 (3H, s), 0.895 (3H, d, J = 6.6 Hz), 0.863 (3H, d, J = 6.6 Hz), 0.859 (3H, d, J = 6.6 Hz), 0.646 (3H, 
s), 0.581 (1H, m). 13C NMR (151 MHz): 75.7, 74.2, 56.6, 56.3, 55.6, 52.9, 42.5, 40.0, 39.5, 36.6, 36.2, 
36.19, 35.8, 34.9, 32.5, 28.3, 28.0, 27.2, 25.4, 24.2, 23.8, 22.8, 22.5, 20.6, 20.59, 18.7, 14.0, 12.1.  
(24R)-4-methylsigmast-22-en-3β,4β-diol (6) from stigmasterol. 1H NMR (600 MHz): 5.144 (1H, m), 
5.012 (1H, m), 3.247 (1H, m), 1.226 (3H, s), 1.013 (3H, s), 1.004 (3H, d, J = 6.6 Hz), 0.846 (3H, d, J = 
6.4 Hz), 0.804 (3H, t, J = 7.4 Hz), 0.786 (3H, d, J = 6.4 Hz), 0.668 (3H, s), 0.590 (1H, m). 13C NMR (151 
MHz): 138.4, 129.2, 75.7, 74.2, 56.7, 56.1, 55.7, 52.9, 51.2, 42.4, 40.5, 39.9, 36.6, 36.2, 34.9, 32.5, 31.9, 
29.0, 27.2, 25.4, 25.36, 24.2, 21.2, 21.1, 20.6, 20.57, 19.0, 14.0, 12.3, 12.2. 
(24R)-4-methylstigmastane-3β,4β-diol (7) from stigmasterol. 1H NMR (600 MHz): 3.247 (1H, m), 
1.227 (3H, s), 1.011 (3H, s), 0.904 (3H, d, J = 6.5 Hz), 0.845 (3H, t, J = 7.4 Hz), 0.834 (3H, d, J = 6.8 
Hz), 0.813 (3H, d, J = 6.8 Hz), 0.649 (3H, s), 0.584 (1H, m). 13C NMR (151 MHz): 75.7, 74.2, 56.6, 56.2, 
55.6, 52.9, 45.9, 42.5, 40.0, 36.6, 36.2, 36.15, 34.9, 34.0, 32.5, 29.2, 28.3, 27.2, 26.1, 25.4, 24.2, 23.1, 
20.6, 20.58, 19.8, 19.0, 18.7, 14.0, 12.1, 12.0. 
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(4R)-Spiro(oxirane-2,4’-5α-cholestan-3β-ol (15). To a solution of 14 (100.2 mg, 0.2500 mmol) in 3 mL 
of DCM was added 70% mCPBA (50.6 mg, 0.26 mmol). The mixture was stirred for 30 min before 
extraction with saturated aqueous sodium bicarbonate and 4:1 hexanes/EtOAc. The organic layer was 
washed with brine, dried over Na2SO4 and filtered through alumina. The solvent was removed under 
reduced pressure to afford 15 (93.9 mg, 90% yield). 
(4R)-3-N-phenylcarbamate-spiro(oxirane-2,4’-5α-cholestan-3β-ol (16). To a solution of 15 (61.2 mg, 
0.150 mmol) in 3 mL of anhydrous DCM and 100 µL of pyridine was added of phenyl isocyanate (100 
µL, 0.92 mmol) under a N2 atmosphere. The mixture was stirred at room temperature for 16 h before 
extraction with 10% hydrochloric acid and 2:1 hexanes/EtOAc. The organic layer was washed with brine, 
dried over Na2SO4 and evaporated under reduced pressure. The crude product was purified by silica gel 
chromatography with 9:1 hexanes/EtOAc to provide 16 (72.0 mg, 92% yield, 99% yield based on 
recovered starting material). 1H NMR (600 MHz): 7.044 (1H, t, J = 7.3 Hz), 6.560 (1H, s), 4.986 (1H, dd, 
J = 5.2, 12.1 Hz), 2.911 (1H, d, J = 4.4 Hz), 2.652 (1H, d, J = 5.0 Hz), 0.907 (3H, d, J = 6.6 Hz), 0.870 
(3H, d, J = 6.6 Hz), 0.868 (3H, s), 0.865 (3H, d, J = 6.6 Hz), 0.653 (3H, s). 13C NMR (151 MHz): 152.6, 
137.8, 129.0, 123.4, 118.8, 72.1, 59.8, 56.3, 56.1, 54.6, 47.8, 45.7, 42.5, 39.9, 39.5, 38.4, 36.5, 36.1, 35.8, 
35.3, 31.1, 28.2, 28.0, 27.4, 24.2, 23.8, 22.8, 22.5, 21.2, 19.3, 18.7, 13.6, 12.0. 
(4ξ)-Cholestan-3β-ol-4-cyclic carbonate (17). A solution of 16 (72.0 mg, 0.13 mmol) in 5 mL of 2% 
TFA in anhydrous DCM was stirred at room temperature for 2 h. The reaction was quenched with 200 µL 
of pyridine and the solvent was evaporated under a flow of N2. The residue was extracted with 10% 
hydrochloric acid and 2:1 hexanes/EtOAc. The organic layer was washed with brine, dried over Na2SO4 
and evaporated under reduced pressure. The crude product was purified by silica gel chromatography 
with 9:1-1:1 hexanes/EtOAc to provide a 1/1.5 17a:17b mixture (29.2 mg, 42% yield). (4R)-Cholestan-
3β-ol-4-cyclic carbonate (17a). 1H NMR (600 MHz): 4.469 (1H, d, J = 8.3 Hz), 4.224 (1H, d, J = 8.3 
Hz), 3.771 (1H, m), 0.894 (3H, d, J = 6.6 Hz), 0.866 (3H, d, J = 6.6 Hz), 0.861 (3H, d, J = 6.6 Hz),0.722 
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(3H, s), 0.642 (3H, s). 13C NMR (151 MHz): 154.8, 88.6, 74.4, 64.8, 56.2, 56.19, 54.9, 50.1, 42.4, 39.7, 
39.5, 37.6, 36.1, 35.9, 35.8, 35.1, 31.3, 28.2, 28.0, 26.7, 24.2, 23.8, 22.8, 22.5, 20.8, 20.0, 18.7, 13.3, 12.0. 
(4S)-Cholestan-3β-ol-4-cyclic carbonate (17b). 1H NMR (600 MHz): 4.469 (1H, d, J = 8.3 Hz), 4.224 
(1H, d, J = 8.3 Hz), 3.771 (1H, m), 0.894 (3H, d, J = 6.6 Hz), 0.866 (3H, d, J = 6.6 Hz), 0.861 (3H, d, J = 
6.6 Hz),0.722 (3H, s), 0.642 (3H, s). 13C NMR (151 MHz): 155.1, 86.1, 72.7, 69.8, 56.4, 56.2, 55.1, 51.7, 
42.6 ,39.8, 39.5, 36.9, 36.16, 36.15, 35.7, 35.0, 31.8, 28.2, 28.0, 27.6, 24.1, 23.8, 22.8, 22.5, 20.8, 20.1, 
18.7, 14.2, 12.1. 
(4S)- 3β-Ethoxymethoxy-cholestan-4-cyclic carbonate (18). To a solution of 17b (5.9 mg, 0.013 mmol) 
and 150 µL of iPr2EtN in 0.5 mL of anhydrous THF was added chloromethyl ethyl ether (20 µL, 0.22 
mmol). The mixture was heated at reflux under a N2 atmosphere for 3 h. The reaction was extracted at 
room temperature with 10% hydrochloric acid and 4:1 hexanes/EtOAc. The organic layer was washed 
with brine, dried over Na2SO4 and evaporated under reduced pressure. The crude product was purified via 
preparative TLC with 4:1 hexanes/EtOAc to give 18 (5.4 mg, 81% yield). 1H NMR (600 MHz): 4.811 
(1H, d, J = 7.3 Hz), 4.680 (1H, d, J = 7.3 Hz), 4.292 (1H, d, J = 8.0 Hz), 4.180 (1H, d, J = 7.9 Hz), 3.686 
(1H, m), 3.588 (1H, m), 3.306 (1H, dd, J = 5.2, 11.8 Hz), 1.208 (3H, t, J = 7.1 Hz), 1.030 (3H, s), 0.894 
(3H, d, J = 6.5 Hz), 0.863 (3H, d, J = 6.6 Hz), 0.859 (3H, d, J = 6.6 Hz), 0.654 (3H, s), 0.621 (1H, m). 13C 
NMR (151 MHz): 155.2, 93.4, 85.3, 78.6, 69.9, 64.1, 56.4, 56.2, 55.2, 51.4, 42.6, 39.8, 39.5, 37.0, 36.2, 
35.8, 35.7, 35.0, 31.8, 28.2, 28.0, 24.1, 23.8, 23.5, 22.8, 22.5, 20.8, 20.2, 18.6, 15.0, 14.3, 12.1. 
(4S)-3β-Ethoxymethoxy-4-hydroxymethyl-cholestan-4-ol (19). A solution of 18 (5.4 mg, 0.01 mmol) 
in 1 mL of 10% methanolic NAOH was heated at reflux for 2 h. The solvent was evaporated under a flow 
of N2 and the residue was extracted with 10% hydrochloric acid and 4:1 hexanes/EtOAc. The organic 
layer was washed with brine, dried over Na2SO4 and evaporated under reduced pressure to obtain 19 (4.5 
mg, 88% yield). 1H NMR (600 MHz): 4.791(1H, d, J = 6.6 Hz), 4.703 (1H, d, J = 6.6 Hz), 3.672 (1H, m), 
3.617-3.537 (3H, m), 3.493 (1H, d, J = 7.2 Hz), 1.231 (3H, t, J = 7.1 Hz), 1.066 (3H, s), 0.894 (3H, d, J = 
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6.5 Hz), 0.864 (3H, d, J = 6.6 Hz), 0.859 (3H, d, J = 6.6 Hz), 0.646 (3H, s), 0.623 (1H, m). 13C NMR (151 
MHz): 93.8, 78.2, 75.3, 64.2, 64.0, 56.6, 56.3, 55.6, 47.5, 42.5, 40.0, 39.5, 36.6, 36.2 (2 C), 35.8, 34.9, 
32.3, 28.3, 28.0, 24.1, 23.8, 23.0, 22.8, 22.6, 20.7, 20.5, 18.7, 15.0, 14.6, 12.1. 
(4S)-3β-Ethoxymethoxy-4-methylcholestan-4-ol (20). To a solution of 19 (4.5g, 0.009 mmol) and TEA 
(25 µL, 0.18 mmol) in 1 mL of DCM at 0 oC was added methanesulfonic acid (6 µL, 0.09 mmol). The 
mixture was stirred for 30 min and extracted with 10% hydrochloric acid and 4:1 hexanes/EtOAc. The 
organic layer was washed with brine, dried over Na2SO4 and evaporated under reduced pressure to obtain 
the desired mesylate. 1H NMR (600 MHz): 4.826 (1H, d, J = 6.9 Hz), 4.748 (1H, d, J = 6.9 Hz), 4.075 
(2H, dd, J = 9.3, 16.4 Hz), 3.658-3.597 (2H, m), 3.576 (1H, dd, 5.1, 11.3 Hz), 3.006 (3H, s), 1.221 (3H, t, 
J = 7.1 Hz), 1.055 (3H, s), 0.896 (3H, d, J = 6.5 Hz), 0.865 (3H, d, J = 6.6 Hz), 0.861 (3H, d, J = 6.9 Hz), 
0.648 (3H,s). In a solution of the mesylate in 1.5 mL of Et2O was added 6.5 mg of LAH. The mixture was 
stirred for 45 min and extracted with 10% hydrochloric acid and 4:1 hexanes/EtOAc. The organic layer 
was washed with brine, dried over Na2SO4 and evaporated under reduced pressure. The crude product was 
purified via preparative TLC with 4:1 hexanes/EtOAc to give 20 (2.9 mg, 67% yield from 19). 1H NMR 
(600 MHz): 4.836 (1H, d, J = 7.0 Hz), 4.836 (1H, d, J = 7.0 Hz), 4.698 (1H, d, J = 7.0 Hz), 3.645 (2H, q, J 
= 7.1 Hz), 3.230 (1H, m), 1.212 (3H, t, J = 7.1 Hz), 1.194 (3H, s), 1.037 (3H, s), 0.895 (3H, d, J = 6.5 
Hz), 0.864 (3H, d, J = 6.6 Hz), 0.860 (3H, d, J = 6.6 Hz), 0.647 (3H, s), 0.561 (1H, m). 13C NMR (151 
MHz): 93.8, 81.4, 74.1, 63.5, 56.7, 56.3, 55.7, 53.2, 42.6, 40.1, 39.5, 36.7, 36.2, 35.8, 35.0, 32.6, 29.7, 
28.3, 23.5, 22.8, 22.6, 20.72, 20.70, 18.7, 15.1, 14.1, 12.1 
4-Methylcholestane-3β,4β-diol (3) from 20. To a solution of 20 (2.9 mg, 0.006 mmol) in 1mL of 4:1 
MeOH/H2O was added a mixture of 200 µL 2% sulfuric acid in THF. The reaction was heated at reflux 
for 1 h before extraction at room temperature with saturated sodium bicarbonate and 2:1 hexanes/EtOAc. 
The organic layer was washed with brine, dried over Na2SO4 and evaporated under a flow of N2. The 
crude product was purified via preparative TLC with 2:1 hexanes/EtOAc to give 5 (2.3 mg, 90% yield). 
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CHAPTER 5 
 
Synthesis of Simple Analogs of Petrosterol and Potential Enzymatic Products 
 
Abstract  
 
The synthesis of two simple analogs of petrosterol and the possible products of enzymatic 
reactions via invertebrate phytosterol dealkylation are reported. All five reported sterols were generated 
from a common intermediate 6β-methoxy-3α,5α-cyclo-24-cyclopropylcholane-24-one. The two simple 
analogs, (24R)-24-cyclopropyl-24-methylchol-5-en-3β-ol and (24S)-24-cyclopropyl-24-methylchol-5-en-
3β-ol, were made as a mixture that was difficult to separate by HPLC. The possible enzymatic products, 
24-cyclopropyl-24-methylenechol-5-en-3β-ol and (24R)-24,25-epoxy-24-cyclopropyl-24-homochol-5-en-
3β-ol and (24S)-24,25-epoxy-24-cyclopropyl-24-homochol-5-en-3β-ol, were obtained directly from the 
intermediate ketone 24-cyclopropylchol-5-en-3β-ol-24-one. The epoxides were made as mixture that was 
inseparable by HPLC with MeOH. All the products including the mixtures were characterized by 600 
MHz NMR. Like petrosterol, all the reported products are potential inhibitors of invertebrate sterol 
metabolism. 
           
5.1 Introduction 
 
Petrosterol (1) and its natural analogs are 26,27-cyclopropyl sterols that have been isolated from 
many marine sponge species (Figure 5.1).1-13 Many oxygenated petrosterol analogs exhibit biological 
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activities that include anticancer and antifouling.8-13 The stereochemistry of the 24-methyl and side chain 
25,26-cycloprapane of petrosterol was established via X-ray crystallography of its p-bromobenzoate 
derivative.1b Marine invertebrates like crustaceans are unable to biosynthesize sterols and depend on their 
diet as a source of exogeneous sterols including cholesterol, an essential component for somatic and 
reproductive growth.14,15 As in insects, 24-alkyl phytosterols are converted to cholesterol in invertebrates 
via a well-known dealkylation process (Scheme 5.1).14,16-18 Like gorgosterol, petrosterol is a potential 
inhibitor of invertebrate sterol metabolism. The dealkylation of the 24-methyl in both sterols would lead 
to a highly reactive cyclopropylcarbinyl cation capable of disabling the dealkylating enzyme (Scheme 
5.2).19,20 
R
O
HO
R
R
R1
2
3
4
R
 
 
Figure 5.1. Petrosterol 1 and its analogs 2 and their possible metabolic products 3 and 4. 
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Scheme 5.1. Mechanism of dealkylation of phytosterols to cholesterol in insects. 
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Scheme 5.2. Carbocation intermediates from the dealkylation of gorgosterol and petrosterol. 
 
Two simple analogs of petrosterol, (24R)-24-cyclopropyl-24-methylchol-5-en-3β-ol and (24S)-
24-cyclopropyl-24-methylchol-5-en-3β-ol (2) were synthesized as a mixture as potential inhibitors of 
invertebrate sterol metabolism. Three possible metabolic products of the analogs 2, 24-cyclopropyl-24-
methylenechol-5-en-3β-ol 3 and -epoxy-24-cyclopropyl-24-homochol-5-en-3β-ol (4) (as a mixture of 
isomers), were also synthesized (Figure 5.1).  
 
5.2 Results and Discussion 
 
The 6β-methoxy-3α,5α-cyclo-24-cyclopropylcholane-24-one (6), a key intermediate in the 
synthesis, was made in near quantitative yield via the alkylation of methyl 3-cyclopropyl-3-oxopropionate 
with i-methyl ether 22-iodide followed by saponification and subsequent decarboxylation of the 
intermediate keto-ester (Scheme 5.3).21 A portion of the i-methyl ketone 6 was easily converted to 
intermediate 7 Wittig in a 85% yield. It was hoped that 24-cyclopropyl-24-methylenechol-5-en-3β-ol 4 
could readily be obtained from compound 7 by a simple deprotection of its i-methyl ether nucleus. 
However, the deprotection of intermediate 7 using TFA followed by subsequent transesterification with  
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Scheme 5.3. Synthesis of intermediate 7 from i-methyl ether 22-iodide (5). 
 
methanolic TEA gave mainly a mixture of the sterols 8a and 8b (Scheme 5.4). No stereochemical 
assignment for the side chain double bond of the sterols 8a and 8b was done as those compounds were 
not of interest. However, sterol 8b is suspected to be the 23-E isomer as it was the predominant product. 
Intermediate 7 was hydrogenated in the presence of PtO2 to reduce the 24-methylene double-bond. 
Deprotection gave a mixture of the compounds 922, 10 and 2 (Scheme 5.4). This method was found to be 
an inefficient route to synthesize compound 2, as the desired product yield was unfavorable and the 
mixture of compounds 9, 10 and 2 was not easily separable by preparative HPLC. An alternative method 
to reduce the double to had to be used because of the sensitivity of the cyclopropane to the hydrogenation 
reaction.  
7
OMe 1) PtO2/H2
2) 1%TFA
3) TEA/MeOH
1) 1%TFA
2) TEA/MeOH
8HO
HO HO HO9 10 2  
Scheme 5.4. Synthesis of compounds 8, 9, 10 and 2 from intermediate 7. 
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A different approach was used to make compound 2 from intermediate 7 (Scheme 5.5). 
Intermediate 7 was converted to the mixture of alcohols 11 through a hydroboration-oxidation reaction in 
an 84% yield.23 The mixture of alcohols 11 was characterized by NMR and moved forward in the 
sequence as a mixture, as the alcohols were could not be separated. The mixture of intermediates 11 was 
deoxygenated in a 2-step procedure to get a compound 12 as a mixture in a 74% yield.24 The i-methyl 
ethers 12 were deprotected in an 85% yield to afford a mixture of compound 2, the two simple analogs of 
petrosterol (24R)-24-cyclopropyl-24-methylchol-5-en-3β-ol and (24S)-24-cyclopropyl-24-methylchol-5-
en-3β-ol. The isomers could be separated in very small amounts by HPLC after multiple re-injections and 
were characterized by 1H NMR. The stereochemical assignment at C24 for the isomers was done 
chemically by hydrogenating each compound to the corresponding 24-methylcholestane-3β-ol.25 The 13C 
NMR data for the isomers was obtained as a mixture.  
 
7
OMe
1) BMS
2) NaOOH
11
OMe
OH
1) MsCl
2) LAH
12
OMe 1) 1%TFA
2) TEA/MeOH
HO 2
84% 74%
85%
 
Scheme 5.5. Synthesis of compound 2 from intermediate 7. 
 
To make compounds 3 and 4 the i-methyl ketone 6 from was deprotected to the corresponding 
sterol 13 in an 80% yield (Scheme 5.6). From intermediate 13, compounds 3 and 4 were readily attainable 
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in just one step. Compound 3 was obtained from intermediate 13 via a Wittig methylenation in an 89% 
yield. The epoxide mixture (4) was made from intermediate 13 using the Corey-Chaykovsky reaction in a 
95% yield.26 The mixture of epoxides (4) was be sensitive to silica gel and was not separable by HPLC 
with methanol.  
  
O
OMe
1) 1%TFA
2) TEA/MeOH
13HO
O
6
Ph3P CH2
3HO
(CH3)3SI
4HO
O
95%
80% 89%
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Scheme 5.6. Synthesis of compounds 3 and 4 from intermediate 6.  
 
5.3 Summary 
 
Two simple analogs (2) of petrosterol, (24R)-24-cyclopropyl-24-methylchol-5-en-3β-ol and 
(24S)-24-cyclopropyl-24-methylchol-5-en-3β-ol, were successfully synthesized as a mixture from the i-
methyl 22-iodide in a six-step sequence with a 43% overall yield. Since the purpose of the sequence was 
to synthesize those compounds as potential inhibitors of invertebrate sterol metabolism, producing them 
as a mixture was not an issue. The possible enzymatic products of compound (2), 24-cyclopropyl-24-
methylenechol-5-en-3β-ol (3) and (24R)-epoxy-24-cyclopropyl-24-hoochol-5-en-3β-ol and (24S)-24,25-
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epoxy-24-cyclopropyl-24-homochol-5-en-3β-ol (4), were also generated in good yield. Biological testing 
of those compounds has demonstrated their activity as inhibitors of the invertebrate phytosterol 
dealkylation. 
 
5.4 Experimental 
 
General Procedures. NMR spectra were obtained in CDCl3 on a Bruker 600 MHz spectrometer (1H at 
600 MHz and 13C at 151 MHz) and a Bruker 800 MHz spectrometer (1H at 800 MHz and 13C at 201 
MHz). HPLC was performed using a Waters 6000A pump, Waters 410 differential refractometer, and two 
Altex Ultrasphere ODS columns (5 µm, 10 x 250 mm) in series at a flow rate of 3 mL/min with MeOH. 
Preparative thin layer chromatography (TLC) purifications were done with Sorbent Technologies 
(SORBTECH) silica gel HL thin TLC plates (20 x 20 cm2, 250 µm thick with glass backed support). All 
solvents were from commercial sources. 
6β-Methoxy-3α,5α-cyclo-24-cyclopropylcholane-24-one (6). To a suspension of 63% of NaH (45.2 mg, 
1.10 mmol, washed with hexane) in 1 mL of DMF at 0 oC under a N2 atmosphere was added 300 µL of 
methyl 3-cyclopropyl-3-oxopropionate (2.30 mmol) dropwise. The mixture was brought to rt and stirred 
for 1 h before adding a solution of i-methyl ether 22-iodide (251.2 mg, 0.550 mmol) in 2 mL of DMF.  
The mixture was stirred at 100 oC for 30 min and cooled to room temperature. The reaction was extracted 
with 10% hydrochloric acid and 4:1 hexanes/EtOAc. The organic layer was washed with brine, dried over 
Na2SO4 and filtered through silica gel. The solvent was removed under reduced pressure to produce the 
crude keto-ester as a yellow oil (308 mg).  To a solution of the crude product in 1 mL of THF was added 
3 mL of 10% methanolic NaOH before heating the mixture at reflux for 30 min. The reaction was cooled 
before adding 10% hydrochloric acid until aqueous layer was acidic. The mixture was extracted with 4:1 
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hexanes/EtOAc and the organic layer was washed with brine and dried over Na2SO4. The crude product 
was purified by silica gel chromatography with 39:1-19:1 hexanes/EtOAc to yield 217.1 mg (96% yield). 
1H NMR (600 MHz): 3.315 (3H, s), 2.762 (1H, t, J = 2.8 Hz), 2.606-2.533 (1H, m), 2.483-2.413 (1H, m), 
1.016 (3H, s), 0.924 (3H, d, J = 6.6 Hz), 0.713 (3H, s), 0.640 (1H, m), 0.425 (1H, dd, J = 5.1, 8 Hz). 13C 
NMR (151 MHz): 211.7, 82.4, 56.53, 56.51, 56.1, 48.0, 43.4, 42.8, 40.5, 40.3, 35.4, 35.3, 35.0, 33.4, 30.5, 
30.0, 28.2, 25.0, 24.2, 22.8, 21.5, 20.3, 19.3, 18.5, 13.1, 12.3, 10.6, 10.5. 
6β-Methoxy-3α,5α-cyclo-24-cyclopropyl-24-methylenecholane (7). To a mixture of compound 6 (34.8 
mg, 0.084 mmol), methyltriphenylphosphonium iodide (67.3 mg, 0.19 mmol) and KtBuO (18.8 mg, 0.17 
mmol) was added 1 mL of anhydrous THF. The mixture was stirred under a N2 atmosphere at reflux for 1 
h.  The reaction was allowed to cool to room temperature before extraction with water and 4:1 
hexanes/EtOAc. The organic layer was dried over Na2SO4 and evaporated under reduce pressure. The 
crude product was purified via silica gel chromatography with 39:1-19:1 hexanes/EtOAc to afford 29.3 
mg of 7 (85% yield). 1H NMR (600 MHz): 4.603 (1H, m), 4.580 (1H, br), 3.322 (3H, s), 2.767 (1H, t, J = 
2.8 Hz), 1.024 (3H, s), 0.944 (3H, d, J = 6.6 Hz), 0.723 (3H, s), 0.661-0.601 (3H. m), 0.460-0.403 (3H, 
m). 13C NMR (151 MHz): 152.0, 105.5, 82.5, 56.5, 56.2, 48.1, 43.4, 42.8, 40.3, 35.7, 35.3, 35.1, 34.7, 
33.4, 32.6, 30.5, 28.3, 25.0, 24.2, 22.8, 21.5, 19.3, 18.6, 16.1, 13.1, 12.3, 6.3, 6.0. 
(24ξ)-6β-Methoxy-3α,5α-cyclo-24-cyclopropyl-24-hydroxymethyl-cholane (11). To a solution of 7 
(29.3 mg, 0.071 mmol) in 1.5 mL of THF was added 100 µL 2 M BMS dropwise under a N2 atmosphere. 
The reaction was stirred for 2 h before adding 10 drops of 10% methanolic NaOH dropwise, followed by 
10 drops of 30% H2O2. The reaction was stirred at room temperature for 3 h before extracting the product 
with water and 2:1 hexanes/EtOAc. The organic layer was washed with brine, dried over Na2SO4 and 
evaporated under a flow of N2. The crude product was purified by silica gel chromatography with 9:1-4:1 
hexanes/EtOAc to obtain 25.5 mg of the mixture 11 (84% yield). The two alcohols in the mixture could 
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not be separated by TLC or HPLC. 1H NMR (600 MHz): 3.657-3.573 (4H, m), 3.320 (6H, s), 2.764 (2H, 
t, J = 2.8 Hz), 1.021 (6H, s), 0.929 (6H, d, J = 6.6 Hz), 0.925 (6H, d, J = 6.6 Hz), 0.715 (6H, s), 0.644 
(2H, m), 0.566-0.408 (8H, m), 0.187-0.059 (4H, m). 13C NMR (151 MHz): 82.4, 67.3, 66.8, 56.5, 56.2, 
56.1, 48.0, 46.5, 46.4, 43.4, 42.8, 40.3, 36.01, 35.98, 35.3, 35.1, 33.4, 33.2, 33.1, 31.9, 29.7, 29.6, 29.3, 
28.34, 28.28, 28.1, 25.0, 24.2, 22.8, 22.7, 21.5, 19.3, 18.7, 18.6, 14.1, 13.5, 13.3, 132.3, 3.5, 3.3, 3.2, 2.8.  
(24ξ)-6β-Methoxy-3α,5α-cyclo-24-cyclopropyl-24-methylcholane (12). To a solution of 11 (22.2 mg, 
0.052 mmol) and TEA (100 µL, 0.72 mmol) of in 1 mL of dry DCM was added MsCl (10 µL, 0.13 mmol) 
at 0 oC. The mixture was stirred for 30 min at that temperature before sequential extractions with water 
and 4:1 hexanes/EtOAc. The organic layer was washed with 5% hydrochloric acid followed by a brine 
wash and dried over Na2SO4. The crude product was evaporated under a reduced pressure. A solution of 
the crude product (28.9 mg) in 1.5 mL of Et2O was treated with 8.6 mg of LAH. The mixture was stirred 
for 30 min at room temperature and the reaction was extracted with 10% hydrochloric acid and 4:1 
hexanes/EtOAc. The organic layer was washed with brine and dried over Na2SO4. The crude product was 
purified via silica gel chromatography with 39:1-19:1 hexanes/EtOAc to obtain 16.1 mg of the mixture 12 
(74% yield). 1H NMR (600 MHz): 3.323 (6H, s), 2.766 (2H, t, J = 2.8 Hz), 1.024 (6H, s), 0.928 (3H, J = 
6.7 Hz), 0.924 (3H, J = 6.7 Hz), 0.920 (3H, J = 6.5 Hz), 0.911 (3H, J = 6.5 Hz), 0.717 (6H, s), 0.646 (2H, 
m), 0.587 (2H, m), 0.506-0.305 (8H, m), 0.073 (2H, m), -0.011 (2H, m). 13C NMR (151 MHz): 82.5, 56.5, 
56.3, 56.2, 48.1, 43.4, 42.8, 40.3, 39.0, 38.9, 36.1, 35.8, 35.3, 35.1, 33.8, 33.5, 33.43, 33.37, 33.3, 31.9, 
30.5, 29.7, 29.4, 28.3, 28.2, 25.0, 24.2, 22.8, 22.7, 21.5, 20.1, 19.6, 19.3, 18.8, 18.6, 18.4, 18.0, 14.1, 13.1, 
12.3, 4.5, 4.3, 3.1, 2.8. 
(24ξ)-24-Cyclopropyl-24-methylchol-5-en-3β-ol (2). To a solution of 12 (34.2 mg, 0.082 mmol) in 1 
mL of dry DCM was added 10 µL of TFA. The mixture was stirred for 30 min before adding 1 mL of 
10% methanolic TEA. The resulting mixture was heated at 45 oC for 1 h before evaporating the solvent 
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under a flow of N2. The observed solid was purified via silica gel chromatography with 19:1-9:1 
hexanes/EtOAc to afford 23.3 mg of 2 (71% yield). The mixture was difficult to separate by HPLC with 
MeOH. It took multiple re-injections to isolate minor amounts of each isomer. Isomer 2a (24R)-24-
Cyclopropyl-24-methylchol-5-en-3β-ol. 1H NMR (600 MHz): 5.351 (1H, m), 3.524 (1H, m), 1.010 (3H, 
s), 0.923 (3H, d, J = 6.6 Hz), 0.918 (3H, d, J = 6.6 Hz), 0.681 (3H, s), 0.606-0.533 (1H, m), 0.509-0.426 
(1H, m), 0.426-0.332 (2H, m), 0.057 (1H, m), -0.003 (1H, m). Isomer 2b (24ξ)-24-Cyclopropyl-24-
methylchol-5-en-3β-ol). 1H NMR (600 MHz): 5.352 (1H, s), 3.523 (1H, s), 1.011 (3H, s), 0.927 (3H, d, J 
= 6.6 Hz), 0.926 (3H, d, J = 6.6 Hz), 0.682 (3H, s), 0.628-0.560 (1H, m), 0.498-0.431 (1H, m), 0.431-
0.374 (1H, m), 0.374-0.307 (1H, m).0.085 (1H, m), -0.020 (1H, m). Mixture 2. 13C NMR (151 MHz): 
140.8, 121.7, 71.8, 56.80, 56.77, 56.1, 56.0, 50.2, 42.3, 39.8, 39.0, 38.9, 37.3, 36.5, 36.0, 35.8, 33.8, 33.5, 
33.4, 33.3, 31.9, 31.7, 28.2, 28.1, 24.3, 21.1, 19.6, 19.4, 18.8, 18.7, 18.4, 18.3, 18.0, 17.6, 11.9, 4.5, 4.3, 
3.1, 2.7.  
24-Cyclopropyl-chol-5-en-3β-hydroxy-24-one (13). To a solution of 6 (110.3 mg, 0.270 mmol) in 3 mL 
of dry DCM was added 60 µL of TFA. The mixture was stirred for 30 min before adding 1.5 mL of 10% 
methanolic TEA. The resulting mixture was heated at 45 oC for 1 h before evaporating the solvent under a 
flow of N2. The observed solid was purified via silica gel chromatography with 19:1-9:1 hexanes/EtOAc 
to afford 85.6 mg of 13 (80% yield). 1H NMR (600 MHz): 5.345 (1H, m), 3.516 (1H, m), 2.611-2.535 
(1H, m), 2.486-2.413 (1H, m), 1.003 (3H, s), 0.929 (3H, d, J = 6.6 Hz), 0.677 (3H, s). 13C NMR (151 
MHz): 211.7, 140.8, 121.6, 71.8, 56.7, 55.9, 50.1, 42.4, 42.3, 40.5, 39.8, 37.3, 36.5, 35.4, 31.90, 31.87, 
31.7, 30.0, 28.1, 24.3, 21.1, 20.3, 19.4, 18.5, 11.9, 10.6, 10.5. 
24-Cyclopropyl-24-methylenechol-5-en-3β-ol (3). To a mixture of compound 13 (25.5 mg, 0.084 
mmol), Ph3PCH3I (60.8 mg, 0.17 mmol) and KtBuO (18.8 mg, 0.17 mmol) was added 1 mL of anhydrous 
THF. The mixture was stirred under a N2 atmosphere at reflux for 1 h.  The reaction was allowed to cool 
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to room temperature before extraction with water and 4:1 hexanes/EtOAc. The organic layer was dried 
over Na2SO4 and evaporated under reduce pressure. The crude product was purified via silica gel 
chromatography with 39:1-19:1 hexanes/EtOAc to afford 29.3 mg of 3 (89% yield). 1H NMR (600 MHz): 
5.349 (1H, m), 4.600 (1H, m), 4.578 (1H, br s), 3.520 (1H, m), 1.009 (3H, s), 0.948 (3H, d, J = 6.6 Hz), 
0.685 (3H, s), 0.652-0.583 (2H, s), 0.458-0.397 (2H, m). 13C NMR (151 MHz): 151.9, 140.8, 121.8, 
105.5, 71.8, 56.8, 56.0, 50.1, 42.4, 42.3, 39.8, 37.3, 36.5, 35.6, 34.7, 32.6, 31.91, 31.90, 31.7, 28.2, 24.3, 
21.1, 19.4, 18.6, 16.1, 11.9, 6.3, 6.0. 
(24ξ)-Epoxy-24-cyclopropyl-24-homochol-5-en-3β-ol (4). To a mixture of 13 (19.8 mg, 0.05 mmol) and 
trimethylsulfonium iodide (36.5 mg, 0.18 mmol) in 1 mL of Et2O at 0 oC was added 75 µL of 2.5M nBuLi 
in hexanes. The mixture was stirred for 1 h before quenching the reaction with saturated aqueous 
Na2S2O3. The mixture was extracted with 4:1 hexanes/EtOAc. The organic layer was washed with brine, 
dried over Na2SO4 and evaporated under a flow of N2. The crude product was purified by flash 
chromatography with alumina 9:1 hexanes/EtOAc to obtain 20.2 mg of the mixture 4 (99% yield, 96% 
pure by NMR). The mixture was not separable by HPLC. 1H NMR (600 MHz): 5.345(2H, m), 3.516 (2H, 
m), 1.005 (6H, s), 0.927 (6H, d, J = 6.6 Hz), 0.681 (6H, s), 0.470-0.398 (2H, m), 0.384-0.278 (4H, m), 
0.213-0.136 (2H, m). 13C NMR (151 MHz): 140.8, 121.6, 71.8, 59.3, 59.1, 56.8, 56.7, 55.9, 55.8, 51.64, 
51.57, 50.1, 42.33, 42.29, 39.8, 37.2, 36.5, 32.7, 32.5, 31.90, 31.88, 31.7, 31.0, 30.9, 28.1, 24.2, 21.1, 
19.4, 18.61, 18.59, 13.4, 13.3, 11.9, 2.0, 1.8, 0.63, 0.58.  
(23ξ)-24-Cyclopropyl-24-methylchol-5,23-dien-3β-ol (8). The two isomer 8a and 8b were isolated by 
HPLC in a mixture obtained from the PtO2 catalyzed hydrogenation of compound 7 followed by 
subsequent deprotection of the i-methyl ethers from the hydrogenation reaction. Isomer 8a (minor 
isomer). 1H NMR (600 MHz): 5.353 (1H. m), 5.237 (1H, m), 3.524 (1H, m), 1.413 (3H, m), 1.011 (3H, 
s), 0.946 (3H, d, J = 6.6 Hz), 0.694 (3H, s), 0.573 (2H, m), 0.517 (2H, m). Isomer 8b (major isomer). 1H 
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NMR (600 MHz): 5.352 (3H, m), 5.204 (1H, m), 3.523 (1H, m), 1.483 (3H, br s), 1.009 (3H, s), 0.895 
(3H, d, J = 6.6 Hz), 0.683 (3H, s), 0.526 (2H, m), 0.416 (2H, m). 
(24ξ)-24-methyl-24-propyl-cholan-3β-ol (10). The compounds 10 were isolated as a mixture by HPLC 
in a mixture obtained from the PtO2 catalyzed hydrogenation of compound 7 followed by subsequent 
deprotection of the i-methyl ethers from the hydrogenation reaction. 1H NMR (600 MHz): 0.532 (2H, m), 
3.524 (2H, m), 1.010 (6H, s), 0.912 (3H, d, J = 6.6 Hz), 0.908 (3H, d, J = 6.6 Hz), 0.876 (6H, t, J = 7.2 
Hz), 0.840 (3H, d, J = 6.6 Hz), 0.827 (3H, d, J = 6.6 Hz), 0.679 (2H, br s). 
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CHAPTER 6 
 
Structural Elucidation of Two Novel 24,25-Cyclopropyl Sterols From a 
Tropical Jewel Orchid 
 
Abstract:  
 
The structural elucidation by synthesis of two novel cyclopropyl sterols isolated in microgram 
quantities from a tropical jewel orchid is reported. Since only a minute amount of each sterol was 
isolated, in order to elucidate their stereochemical configurations, all the synthesized stereoisomers of the 
candidate structures were characterized by 800 MHz NMR. The determination of the stereochemistry of 
the side chain cyclopropanes was achieved through a series of correlations ultimately resting on (24R)-24-
ethyl-24-methylcholestanol, the structure of which rests on crystallography. These correlations included 
ones with isotopic labeling of prochiral groups. To our knowledge, this is the first report of sterols 
containing a side chain cyclopropane in higher plants.  
 
6.1 Introduction 
 
Sterols with cyclopropane-containing side chains are unusual in nature.  They have been 
predominantly observed in marine organisms like dinoflagellates and sea sponges1. Sterols with nuclear 
cyclopropanes, like cycloartane triterpenoids, are more common and have been isolated in algae and 
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higher plants2. To date, only three higher plant sterols with cyclopropane side chains have been reported: 
two cycloartane-type triterpenoids from Pandanus boninensis3 and a homocyclotirucallane from 
Spiranthes sinensis 4. Their structural elucidations were accomplished by spectroscopic methods and X-
ray crystallography.  
 
In the present study, two novel sterols from a tropical jewel orchid, 23-[(1R,2S)-(2-ethyl-1,2-
dimethylcyclopropyl)]-24-norchol-5-en-3β-ol (1) and 23-[(1S)-(2,2-diethyl-1-methylcyclopropyl)]-24-
norchol-5-en-3β-ol (2), are described and their structures were elucidated by 800 MHz 1H NMR.  
 
HO HO1 2
HO 3 HO 4
13CH3
 
 
Figure 6.1. Tropical jewel orchid sterols 1 and 2 and the model sterol used in stereochemistry 
assignments. 
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6.2 Results and Discussion 
 
The 1H NMR of the isolated sterols suggested the presence of a tetrasubstituted cyclopropane in 
both compounds based on the diagnostic non-equivalent methylene proton signals at δ 0.075 and δ -0.014 
for sterol 1 and at δ 0.036 and δ -0.006 for sterol 2. The possibility of having a nuclear cyclopropane was 
dismissed for both compounds as they both possess a typical ∆5 sterol nucleus with the olefinic C6-H δ 
5.35 at 3α-H at δ 3.52. The 1H NMR spectrum for sterol 1 showed the presence of four methyl singlets, a 
methyl doublet (d, J = 6.6 Hz) at δ 0.905, and a triplet (t, J = 7.4 Hz) at δ 0.919 indicating an ethyl group. 
The spectrum of sterol 2 showed three methyl singlets and a methyl doublet (d, J = 6.6 Hz) at δ 0.905 and 
two triplets (t, J = 7.4 Hz) at δ 0.889 and δ 0.864 for two ethyl groups. The methyl doublet at δ 0.905 (d, J 
= 6.6 Hz) in both spectra has similar coupling constant to the C21 methyl signal of sterols with the 
cholesterol side chain.  This observation suggested the cyclopropane is likely located toward the end of 
side chain in both molecules. Therefore, sterols 1 and 2 were suspected to be 24,25-cyclopropyl sterols 
containing an ethyl and two methyl groups, or two ethyl and one methyl groups, respectively (Figure 6.1).  
 
To confirm the structure and the absolute stereochemistry of each sterol, all the possible isomers 
of both sterols were synthesized and characterized by 800 MHz 1H NMR. As a reference, (24R)-24-ethyl-
24-methylcholestanol (3), a known sterol characterized by crystallography5, was used to assign the 
stereochemistry of the 24-ethyl cyclopropanes via a series of correlations. To assign the stereochemistry 
of the 24-methyl cyclopropyl sterols, isotopic labeling of prochiral groups was used for correlations with 
the known sterol (24R)-24-methyl-28(13C)-codisterol (4)6.  
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Because the other sterols in this orchid were mainly 24-ethyl sterols, 24-ethyl-24,25-cyclopropyl 
sterols intermediates were first synthesized as described in Scheme 6.1. Compound 7, which contributed 
the 24-ethyl substituent, was obtained from the 22-I i-methyl 5 via an acetoacetic ester synthesis to afford 
6, followed by the saponification of the ester and subsequent decarboxylation7. The Horner-Wadsworth-
Emmons (HWE) reaction was used to obtain a mixture of unsaturated esters 8 from 76. The selectivity of 
the HWE reaction was not important in this synthesis, as both E and Z isomers were desired. The esters 
were reduced as a mixture with LAH to the allylic alcohols 9a and 9b. Those alcohols were separated by 
silica gel chromatography and the Z-alcohol 9a was the less polar product. The 1,4-reduction product was 
also observed as a minor product. DIBAL was not a better option for this reduction; it was a much slower 
reaction and was incompatible with the i-methyl ether nucleus. Unequivocal assignment of 
stereochemistry of the two alcohols (9a and 9b) was based on 2D NMR analyses (COSY and ROESY) 
were used in the assignment of stereochemistry of the two alcohols. The signals of the methylene protons 
of the alcohol at δ 4.103 (2H, s) showed a correlation in the ROESY spectrum of 9b to a multiplet at δ 
2.082 (3H, m) that includes the methylene protons of the 24-ethyl substituent. The methylene protons of 
the ethyl group were determined through COSY correlation to the triplet (3H, t, 7.4 Hz) at δ 0.970. A 
sample of the mixture was acetylated and deoxygenated via a dissolving metal reduction (Li/NH3) to 
obtain the unsaturated i-methyl ether 106. The cyclopropane moiety was introduced as a 
dichlorocyclopropane via a dichlorocarbene reaction to get a nearly 1:1 mixture of compound 118. To 
render the mixture separable by HPLC, the i-methyl ethers were deprotected to obtain the respective 
normal sterol nucleus 12. After HPLC separation of the mixture, the first sterol to elute was put in the 
freezer and each sterol (12a and 12b) was handled individually and carefully through the rest of the 
synthetic sequence to avoid accidental mix-ups. The HPLC peaks were cut in 3 fractions as sterols 12a 
and 12b have similar retention times. The β-cyclopropane 12a eluted first and was obtained purely in the 
first fraction of the peak, 12b was pure in the third fraction. As described in Scheme 6.1, the 
dichlorocyclopropanes were reduced individually with a dissolving medal reduction (Li/NH3)5 to afford 
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the ethyl-dimethyl-cyclopropane sterols 13 and 15. The dechlorinated cyclopropane sterols showed a 
relatively better separation by HPLC than their precursors and the order of elution was the same. The 
cyclopropanes were opened via an overnight reaction with TFA. The crude reactions were treated with 
methanolic TEA to recover any TFA ester sterols generated. The obtained unsaturated sterols 14 and 16 
were hydrogenated to form (24R)-24-ethyl-24-methylcholestanol (3) and its 24-epimer (17), respectively. 
The stereochemistry of 3 at C24, which was established via correlation with a dichlorocyclopropane with 
X-ray crystallography5, permitted the characterization of cyclopropanes 13 and 12a as β-cyclopropanes. 
The stereochemistry at C24 for compounds 12b, 14, 15, 16 and 17 was also assigned based on reference 
compound 3. Unexpectedly, the NMR spectra of compounds 13 and 15 did not match the isolated sterol 
that has an ethyl and two methyl groups attached to the cyclopropane. That meant that there was a methyl 
group at C24 and that the ethyl group and the other methyl group were attached to the same center of the 
cyclopropane ring. 
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Scheme 6.1. Synthesis of compounds 3 and 17. 
 
 
Candidate structures for the orchid cyclopropyl sterol substituted with two ethyl and one methyl 
groups were synthesized from the intermediate allylic alcohols 9a and 9b (Scheme 6.2). The allylic 
alcohols were dichlorocyclopropanated individually and the product mixtures were separated by HPLC at 
separate times to avoid any accidental mix-ups. A much better separation was observed for the 
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dichlorocyclopropyl i-methyl alcohols compared to the normal sterols in Scheme 5.1. Again, the β-
cyclopropanes eluted first. The stereochemistry of those cyclopropanes was assigned by chemical 
correlation of alcohols 25b and 26b with compound 15 (Scheme 6.3). Partial reduction of the 
dichlorocyclopropanes was observed during the LAH reductions. That was not considered an issue as the 
dichlorocyclopropanes were ultimately reduced to achieve the reference structure 15.  
 
To generate the first 24-diethyl-25methyl-cyclopropyl sterol 33, the dichlorocyclopropyl alcohol 
26a was first dechlorinated by dissolving metal reduction (Li/NH3) to get compound 27 (Scheme 6.2). 
That alcohol was then converted to the unsaturated cyclopropyl i-methyl sterol 29 through a DMP 
oxidation and subsequent Wittig reaction at room temperature. Due to the observed sensitivity of the 
cyclopropane to catalytic hydrogenation with Pd/C and PtO25, a different approach was needed to convert 
compound 29 to the di-ethyl intermediate 32. Compound 29 was successfully reduced using a selective 
hydroboration and subsequent two-step deoxygenation9. After deprotection of the i-methyl ether of 
intermediate 32, compound 33 was obtained. The 1H NMR spectrum did not match that of the diethyl 
methyl cyclopropyl sterol.  
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Scheme 6.2. Synthesis of compounds 33. 
 
The remaining diastereomers of compound 33 were generated by a different and shorter method 
(Scheme 6.3). It was found that catalytic hydrogenation could be used if the chlorines were carried 
through the rest of sequence as a protecting group for the acid-labile cyclopropanes. Thus, compounds 37, 
38 and 39 were hydrogenated to the di-ethyl dichlorocyclopropanes 40, 41 and 42 which generated the 
sterols 43, 44 and 45 after deprotection of the nucleus. The 24,25-diethyl-cyclopropyl sterols 46, 47 and 
48 were obtained after dichlorination of the cyclopropanes. Again, their 1H NMR spectra did not match 
that of the natural diethyl-methyl-cyclopropyl sterol. Since none of the synthesized 24,25-diethyl-
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cyclopropyl sterols matched the isolated tropical orchid sterol 2, it was reasoned that sterol 2 was a 25,25-
diethyl-24-methyl-cypropropyl sterol.  
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Scheme 6.3. Synthesis of compounds 46, 47 and 48. Correlation by synthesis alcohols 27b and 28b to 
compound 15. 
 
In order to apply a similar logic to the synthesis of 24-methyl-cyclopropyl sterols, 
stereochemically defined references were needed. Trimethyl-cyclopropyl sterols 21 and 22 were 
synthesized in scheme similar to the one described in scheme 5.1 (Scheme 6.4). The final stereochemical 
assignments in this case rests on compound 4, (24R)-24-methyl-28(13C)-codisterol, which was 
characterized by NMR after preparation via a stereospecific enzymatic methylation of 24(13C)-
methyldesmosterol with SAM (S-adenosylmethionine)6. The stereochemistry of the cyclopropanes in 21 
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and 22 was the key to the stereochemical assignments of all the 24-methyl-cyclopropyls sterols generated. 
Just like in Scheme 6.1, the cyclopropanes were introduced to compound 18 using dichlorocarbene to 
obtain the mixture of i-methyl sterols 19. After the deprotection the i-methyl ethers, the sterols 20a and 
20b were separated by HPLC before the reduction of the dichlorocyclopropanes. The β-cyclopropane 20a 
eluted earlier, much like the 24-ethyl-β-dichlorocyclopropane 12b. Deuterated TFA was used in the 
cyclopropane ring opening reaction of compounds 21 and 22 to add chirality at C24 and allow the 
differentiation between the two geminal methyls in the products. Even though neat deuterated TFA and 
dry CDCl3 were used in the cyclopropane ring opening reactions, the sterols 23 and 24 were only 
observed as the minor products in a mixture of deuterated and non-deuterated products due to a kinetic 
isotope effect. Since the experiments were done on a microscale, it is possible that moisture affected the 
amount of deuterium available for the desired reactions to proceed, as water would promote proton-
deuterium exchange before the ring opening reaction could take place. The assignment of α and β methyls 
in both products 23 and 24 were based on the deuterium shifts observed in the 13C NMR spectra. HMBC 
and HSQC analyses were used to assign the side chain carbons in the unlabeled 24-dimethyl sterol. C23 
at δ 36.8, C24 at δ 38.0 and 24α-methyl at δ 27.5 in compound 23 were identified based on their 
deuterium shifts compared to the unlabeled product. Shifts of about 20 ppb were observed for C23 and the 
unlabeled 24-methyl and a shift of 70 ppb for C24 in compounds 23 and 24. Signals for the deuterated 24-
methyl of 23 and 24 had ∆δ values of 320 ppb (t, J = 19.2 Hz) and 318 ppb (t, J = 19.5 Hz) shifts to the 
right in their respective 13C-NMR spectrum. The final stereochemical assignments for compounds 24, 22 
and the other sterol in this sequence were assigned based on the monodeuterated methyl (24α) in 24 
matching the 13C methyl (24α) in the model compound 4 at δ 27.5.  
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Scheme 6.4. Synthesis of deuterated compounds 23 and 24. 
 
The synthesis of 25,25-diethyl-24-methyl-cyclopropyl sterols started with the condensation of 
triethyl 2-phosphonopropionate and ketone 49 to afford a nearly 1:1 mixture of the esters 50 (Scheme 
6.5).  The mixture of esters 50 was reduced to obtain mainly the allylic alcohols 51a and 51b. The 1,4-
reduction product was observed as a side product. Ketone 49 and triethyl 2-phosphonobutyrate were used 
in a similar method in Scheme 6.6 to produce the alcohols 74a and 74b. The two sets of alcohols were 
processed individually to make their respective dichlorocyclopropanes as previously described. The 
stereochemical assignments for the sterols generated in Scheme 6.5, including the compound that 
matched the natural sterol 1, are based on correlations by synthesis of alcohols 52b and 53b to compound 
22. The dichlorocyclopropyl i-methyl ethers 75a, 75b, 76a and 76b in Scheme 5.6 led only to two sterols 
including one that matched the natural sterol 2 due to the loss of chirality at C25 after the catalytic 
hydrogenation step. The stereochemical assignments of the sterols in that sequence were achieved through 
correlations by synthesis of the alcohols 75b and 76b to sterol 72 in Scheme 6.6. 
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Scheme 6.5. Synthesis of compounds 1, 70, 71 and 72. Correlation by synthesis alcohols 52b and 53b to 
compound 22. 
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Scheme 6.6. Synthesis of compounds 2 and 89. Correlation by synthesis alcohols 75b and 76b to 
compound 72. 
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6.3 Conclusions 
 
The two unusual cyclopropyl sterols from the tropical jewel orchid were identified as 23-
[(1R,2S)-(2-ethyl-1,2-dimethylcyclopropyl)]-24-norchol-5-en-3β-ol (1) and  23-[(1S)-(2,2-diethyl-1-
methylcyclopropyl)]-24-norchol-5-en-3β-ol  (2). Both unusual phytosterols and all their possible isomers 
were synthesized and characterized by 800 MHz 1H NMR as only minute amounts of both sterols were 
isolated. Access to an 800 MHz NMR was instrumental to the process of discovering and ultimately 
characterizing those sterols. To date, this is the first report of the isolation and characterization of sterols 
with a side chain cyclopropane in higher plants. The presence of those unusual sterols in the aerial parts 
of those plants could be as chemical defense against herbivorous insects. Those complex sterols may 
impede the dealkylation process used by insects to convert phytosterols to cholesterol, an essential 
component for growth and reproduction.10,11 Feeding experiments with those sterols would be necessary 
to verify this hypothesis. 
 
6.4 Experimental  
 
General Procedures. NMR spectra were obtained in CDCl3 on a Bruker 600 MHz spectrometer (1H at 
600 MHz and 13C at 151 MHz) and a Bruker 800 MHz spectrometer (1H at 800 MHz and 13C at 201 
MHz). HPLC was performed using a Waters 6000A pump, Waters 410 differential refractometer, and two 
Altex Ultrasphere ODS columns (5 µm, 10 x 250 mm) in series at a flow rate of 3 mL/min with MeOH. 
Preparative thin layer chromatography (TLC) purifications were done with Sorbent Technologies 
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(SORBTECH) silica gel HL thin TLC plates (20 x 20 cm2, 250 µm thick with glass backed support). All 
solvents were from commercial sources. 
6β-Methoxy-3α,5α-cyclo-27-norcholestan-24-one (7). To a suspension of 63% NaH (64.3 mg, 1.60 
mmol) in 1 mL of DMF at 0 oC under a N2 atmosphere was added 220 µL of methyl propionylacetate 
(1.76 mmol) dropwise. The mixture was brought to rt and stirred for 1h before adding a solution of i-
methyl ether 22-iodide (344.8 mg, 0.760 mmol) in 2 mL of DMF.  The mixture was stirred at 100 oC for 
30 min and cooled to room temperature. The reaction was extracted with 10% hydrochloric acid and 4:1 
hexanes/EtOAc. The organic layer was washed with brine, dried over Na2SO4 and filtered through silica 
gel. The solvent was removed under reduced pressure to afford a crude mixture of 6β-Methoxy-3α,5α-
cyclo-23(ξ)-carboxymethyl-27-norcholestan-24-one (6) (563.9mg). 1H NMR (600 MHz): 3.727 (3H, s), 
3.698 (3H, s) 3.572 (1H, dd, J = 4.4, 9.9 Hz), 3.551 (1H, dd, J = 3.1, 11.2 Hz), 3.314 (6H, s), 2.761 (2H, t, 
J = 2.7 Hz), 1.070 (3H, t, J = 7.3 Hz), 1.053 (3H, t, J = 7.2 Hz), 1.011 (3H, s), 1.008 (3H, s), 0.911 (3H, 
d, J = 6.4 Hz), 0.897 (3H, d, J = 6.6 Hz), 0.637 (2H, dd, J = 4.0, 4.8 Hz), 0.425 (2H, dd, J = 5.0, 7.9 Hz).  
The crude product (6) was treated with 3 mL of 10% methanolic NaOH and stirred at reflux for 30 min. 
The reaction was cooled before adding 10% hydrochloric acid until aqueous layer was acidic. The 
mixture was extracted with 4:1 hexanes/EtOAc and the organic layer was washed with brine and dried 
over Na2SO4. The crude product (7) was purified by silica gel chromatography with 19:1-9:1 
hexanes/EtOAc to yield 218.9 mg (72% for the two steps). 1H NMR (600 MHz): 3.318 (3H, s), 2.764 (1H, 
t, J = 2.8 Hz), 2.422 (3H, m), 2.311 (1H, m), 1.050 (3H, t, J = 7.4 Hz), 1.018 (3H, s), 0.905 (3H, d, J = 
6.5 Hz), 0.710 (3H, s), 0.643 (1H, dd, J = 4.0, 4.9 Hz), 0.428 (1H, dd, J = 5.0, 8.0 Hz). 13C NMR (151 
MHz): 212.3, 82.4, 56.5(4), 56.5(1), 56.1, 48.0, 43.4, 42.8, 40.3, 39.4, 35.8, 35.4, 35.3, 35.0, 33.4, 30.5, 
30.0, 28.2, 25.0, 24.1, 22.8, 21.5, 19.3, 18.5, 13.1, 12.3, 7.9. 
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6β-Methoxy-3α,5-cyclo-26,27-bisnorcholestan-24-one (49). 1H NMR (600 MHz): 3.322 (3H, s), 2.767 
(1H, t, J = 2.7 Hz), 2.453 (1H, m), 2.334 (1H, m), 1.022 (3H, s), 0.910 (3H, d, J = 6.6 Hz), 0.715 (3H, s), 
0.647 (1H, dd. J = 4.1, 5.0 Hz), 0.432 (1H, dd, J = 5.0, 8.0 Hz). 
General method for the Horner-Emmons-Wadsworth (HEW) reaction. To a suspension of NaH (2.4 
eq.) in 1 mL of dry THF in a stretched test tube was added dropwise the phosphonate ester (2.4 eq.) at 0 
oC. The mixture was stirred for 1h under a N2 atmosphere at rt before adding dropwise a solution of the 
keto-i-methyl ether (90.3-202.0 mg) in 1mL of THF. The tube was carefully flame sealed before heating 
the reaction at 85 oC for 18 h. The reaction was allowed to cool to room temperature before extraction 
with 10% hydrochloric acid and 4:1 hexanes/EtOAc. The pooled organic layers were washed with a brine 
and dried over Na2SO4. The crude product was concentrated under reduced pressure and purified via 
silica gel chromatography with 39:1-19:1 hexanes/EtOAc to obtain a mixture of the desired products and 
starting material.  
(24ξ)-Ethyl-6β-Methoxy-3α,5α-cyclo-stigmast-24-en-26-oate (8).  This product was generated via the 
HEW reaction of triethyl 2-phosphonopropionate with 6β-Methoxy-3α,5α-cyclo-27-norcholestan-24-one 
(43% yield). 1H NMR (600 MHz):4.179 (4 H, m), 3.325 (3H, s), 3.322 (3H, s), 2.770 (1H, t, J = 2.7 Hz), 
2.766 (1H, t, J = 2.7 Hz), 1.846 (3H, s), 1.840 (3H, s), 1.297 (3H, t, J = 7.2 Hz), 1.293 (3H, t, J = 7.2 Hz), 
1.024 (3H, s), 1.022 (3H, s), 0.985 (3H, d, J = 6.6 Hz), 0.957 (3H, d, J = 6.6 Hz), 0.728 (3H, s), 0.720 
(3H, s), 0.647 (2H, m), 0.431(2H, m). 
(24ξ)-Ethyl-6β-Methoxy-3α,5α-cyclo-ergost-24-en-26-oate (50). This product was generated via the 
HEW reaction of triethyl 2-phosphonopropionate with 6β-Methoxy-3α,5α-cyclo-26,27-dinorcholestan-
24-one (33% yield). 1H NMR (600 MHz): 4.180 (4 H, m), 3.323 (3H, s), 3.320 (3H, s), 2.769 (1H, t, J = 
2.6 Hz), 2.765 (1H, t, J = 2.7 Hz), 1.969 (3H, br s), 1.849 (3H, br s), 1.831 (3H, br s), 1.754 (3H, br 
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s),1.295 (3H, t, J = 7.2 Hz), 1.293 (3H, t, J = 7.2 Hz), 1.023 (3H, s), 1.020 (3H, s), 0.975 (3H, d, J = 6.6 
Hz), 0.949 (3H, d, J = 6.6 Hz), 0.724 (3H, s), 0.717 (3H, s), 0.645 (2H, m), 0.429 (2H, m). 
(24ξ)-Ethyl-6β-Methoxy-3α,5α-cyclo-27-homoergost-24-en-26-oate (73). This product was generated 
via the HEW reaction of triethyl 2-phosphonobutyrate with 49 (21%). The reaction was heated at 110 oC 
for 92 h. 1H NMR (600 MHz):4.194 (4 H, m), 3.326 (3H, s), 3.322 (3H, s), 2.771 (1H, t, J = 2.7 Hz), 
2.766 (1H, t, J = 2.7 Hz), 1.910 (3H, s), 1.756 (3H, s), 1.300 (6 H, t, J = 7.2 Hz), 1.026 (3H, s), 1.022 
(3H, s), 0.999 (3H, t, J = 7.4 Hz), 0.993 (3H, t, J = 7.4 Hz), 0.976 (3H, d, J = 6.6 Hz), 0.941 (3H, d, J = 
6.6 Hz), 0.728 (3H, s), 0.717 (3H, s), 0.649 (2H, m), 0.432 (2H, m). 
General method for the LAH reduction of the unsaturated i-methyl ether esters. The starting esters 
(less than 23 mg) were separately dissolved in 1 mL of anhydrous Et2O. An excess of LAH was added to 
each reaction in 1 mL of anhydrous Et2O. After 1 h of stirring, the reactions were worked up with 5 mL of 
10% of hydrochloric acid and extracted with 2:1 hexanes/EtOAc. The organic layers were washed with 
brine, dried over Na2SO4 and filtered through a small pad of silica gel before evaporating the solvents. 
Crude products were purified on a small scale via preparative TLC with 9:1 hexanes/EtOAc. The Z-
alcohols were less polar than their E-isomers for all the products.  
(24Z)-6β-Methoxy-3α,5α-cyclo-stigmast-24-en-26-ol (9a). 1H NMR (600 MHz): 4.093 (2H, s), 3.323 
(3H, s), 2.767 (1H, t, J = 2.7 Hz), 1.742 (3H, s), 1.023 (3H, s), 0.970 (3H, t, J = 7.4 Hz), 0.964 (3H, d, J = 
6.6 Hz), 0.717 (3H, s), 0.647 (1H, dd, J = 4.0, 4.8 Hz), 0.430 (1H, dd, J = 5.1, 8.0 Hz). 13C NMR (151 
MHz): 140.2, 127.1, 82.4, 63.8, 56.6, 56.5, 55.9, 48.0, 43.4, 42.8, 40.3, 36.3, 36.2, 35.3, 35.1, 33.4, 30.5, 
28.3, 28.2, 25.7, 25.0, 24.2, 22.8, 21.5, 19.3, 18.7, 15.8, 13.1, 12.8, 12.2. 
(24E)-6β-Methoxy-3α,5α-cyclo-stigmast-24-en-26-ol (9b). 1H NMR (600 MHz): 4.103 (2H, s), 3.325 
(3H, s), 2.769 (1H, t, J = 2.7 Hz), 1.738 (3H, s), 1.025 (3H, s), 0.976 (3H, d, J = 6.6 Hz), 0.970 (3H, t, J = 
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7.4 Hz), 0.725 (3H, s), 0.648 (1H, dd, J = 4.0, 4.9 Hz), 0.432 (1H, dd, J = 5.1, 8.0 Hz). 13C NMR (151 
MHz): 140.2, 127.1, 82.4, 63.8, 56.6, 56.5, 55.9, 48.0, 43.4, 42.8, 40.3, 36.3, 36.2, 35.3, 35.1, 33.4, 30.5, 
28.3, 28.2, 25.7, 25.0, 24.2, 22.8, 21.5, 19.3, 18.7, 15.8, 13.1, 12.8, 12.2. 
(24Z)-6β-Methoxy-3α,5α-cyclo-ergost-24-en-26-ol (51a). 1H NMR (600 MHz): 4.016 (2H, s), 3.323 
(3H, s), 2.767 (1H, t, J = 2.7 Hz), 1.737 (3H, s), 1.668 (3H, s),1.022 (3H, s), 0.957 (3H, d, J = 6.6 Hz), 
0.715 (3H, s), 0.646 (1H, dd, J = 4.0, 5.0 Hz), 0.430 (1H, dd, J = 5.0, 7.9 Hz).  
(24E)-6β-Methoxy-3α,5α-cyclo-ergost-24-en-26-ol (51b). 1H NMR (600 MHz): 4.114 (2H, s), 3.323 
(3H, s), 2.768 (1H, t, J = 2.7 Hz), 1.745 (3H, s), 1.714 (3H, s), 1.023 (3H, s), 0.967 (3H, d, J = 6.6 Hz), 
0.722 (3H, s), 0.646 (1H, dd, J = 4.0, 5.1 Hz), 0.431 (1H, dd, J = 5.1, 7.9 Hz). 
(24Z)-6β-Methoxy-3α,5α-cyclo-27-homoergost-24-en-26-ol (74a). 1H NMR (800 MHz): 4.119 (2H, m), 
3.324 (3H, s), 2.768 (1H, t, J = 2.8 Hz), 1.685 (3H, s), 1.025 (3H, s), 0.985 (3H, t, J = 7.5 Hz), 0.964 (3H, 
d, J = 6.6 Hz), 0.717 (3H, s), 0.648 (1H, dd, J = 4.0, 5.0 Hz), 0.432 (1H, dd, J = 5.1, 8.0 Hz). 13C NMR 
(201 MHz): 134.6, 133.9, 82.5, 61.7, 56.5, 55.9, 48.0, 43.4, 42.8, 40.3, 36.0, 35.5, 35.3, 35.1, 33.4, 30.8, 
30.5, 28.3, 25.0, 24.2, 23.8, 22.8, 21.5, 19.3, 18.8, 18.3, 13.3, 13.1, 12.2. 
(24E)-6β-Methoxy-3α,5α-cyclo-27-homoergost-24-en-26-ol (74b). 1H NMR (800 MHz): 4.133 (2H, s), 
3.327 (3H, s), 2.770 (1H, t, J = 2. 6 Hz), 1.730 (3H, s), 1.027 (3H, s), 1.005 (3H, t, J = 7.5 Hz), 0.972 
(3H, d, J = 6.6 Hz), 0.728 (3H, s), 0.650 (1H, dd, J = 4.1, 5.0 Hz), 0.434 (1H, dd, J = 5.1, 7.9 Hz). 13C 
NMR (201 MHz): 134.5, 133.8, 82.5, 62.1, 56.6, 56.5, 48.1, 43.4, 42.8, 40.3, 36.2, 35.3, 35.1, 34.8, 33.4, 
31.0, 30.5, 28.3, 25.0, 24.2, 23.5, 22.8, 21.5, 19.3, 18.8, 18.0, 13.9, 13.1, 12.3. 
(24ξ)-Ethyl-6β-Methoxy-3α,5α-cyclo-stigmast-24-en-26-acetate. A solution of (24ξ)-Ethyl-6β-
Methoxy-3α,5-cyclo-5a-stigmast-24-en-26-ol (21.3 mg, 0.05 mmol) in 1 mL of 2:1 pyridine/Ac2O and 
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heated overnight at 40 oC. The reaction was evaporated after 15 h under a flow of N2 and the crude 
product was filtered through silica gel to obtain 21.5 mg of the desired mixture (92% yield). 1H NMR 
(600 MHz):4.566 (1 H, s), 4.557 (1 H, s), 3.323 (3H, s), 3.320 (3H, s), 2.768 (1H, t, J = 2.7 Hz), 2.764 
(1H, t, J = 2.7 Hz), 2.060 (3H, s), 2.058 (3H, s), 1.682 (3H, s), 1.582 (3H, s), 1.023 (3H, s), 1.019 (3H, s), 
0.975 (3H, t, J = 7.4 Hz), 0.973 (3H, d, J = 6.5 Hz), 0.968 (3H, t, J = 7.4 Hz),1.024 (3H, s), 0.955 (3H, d, 
J = 6.5 Hz), 0.723 (3H, s), 0.712 (3H, s), 0.645 (2H, m), 0.428(2H, m). 
6β-Methoxy-3α,5α-cyclo-stigmast-24-ene (10). To a solution of (24ξ)-Ethyl-6β-Methoxy-3α,5α-cyclo-
5a-stigmast-24-en-26-acetate (21.5 mg, 0.040 mmol) in 1 mL of THF was added 0.5 cm of Li wire in 5 
mL of condensed NH3. After 30 min, 150 µL of tBuOH was added to reaction and the mixture was stirred 
for an additional 30 min before warming it to room temperature.  The reaction was extracted with 10% 
hydrochloric acid and 4:1 hexanes/EtOAc and the organic layer was washed with brine and dried over 
Na2SO4 before evaporation under reduced pressure. The crude product was purified with silica gel 
chromatography to afford 19.2 mg of desired product (96% yield). 1H NMR (600 MHz): 3.325 (3H, s), 
2.768 (1H, t, J = 2.7 Hz), 1.632 (3H, s), 1.023 (3H, s), 0.963 (3H, d, J = 6.6 Hz), 0.932 (3H, t, J = 7.4 
Hz), 0.720(3H, s), 0.646 (1H, dd, J = 4.0, 4.9 Hz), 0.429 (1H, dd, J = 5.0, 7.9 Hz). 
24(ξ),25-Dichloromethano-6β-methoxy-3α,5α-cyclo-stigmastane (11). To solution of 10 (17.1 mg, 
0.040 mmol) and benzyltriethylammonium chloride (BTEAC) (8.1 mg, 0.04 mmol) in 1.5 mL of CHCl3 
was added 1mL of 50% aqueous KOH. The mixture was stirred vigorously under a N2 atmosphere at rt 
for 16 h. The reaction was extracted with water and 4:1 hexanes/EtOAc. The organic layer was dried over 
Na2SO4, filtered through silica gel and evaporated under reduced pressure. Purification via silica get 
chromatography with 39:1 hexanes/EtOAc gave 20.1 mg the desired products (99% yield) 1H NMR (600 
MHz): 3.324 (6H, s), 2.770 (2H, t, J = 2.6 Hz),1.236 (3H, s), 1.232 (3H, s), 1,224 (6H, s), 1.021 (6H, s), 
0.950 (3H, d, J = 6.6 Hz), 0.6947 (3H, t, J = 7.4 Hz), 0.942 (3H, d, J = 6.6 Hz), 0.927 (3H, t, J = 7.4 Hz), 
0.722 (3H,s), 0.717 (3H, s), 0.676 (2H, m), 0.432 (2H, dd, J = 5.1, 8.0 Hz). 
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24(ξ),25-Dichloromethano-stigmast-5-en-3β-ol (12). Compound 11 (20.1 mg, 0.04 mmol) was treated 
with 1 mL of 1% solution of TFA in DCM for 8 min. 500 µL of 20% methanolic TEA was then added 
dropwise to reaction before heating the mixture for 1 h at 45 oC. The solvent was evaporated under a N2 
atmosphere and filtered through silica gel with 2:1 hexanes/EtOAc to obtain 19.0 mg of a crude mixture 
of 12a and 12b (98% yield). A sample of the mixture was separated via HPLC to obtain pure samples of 
12a and 12b. (24S)-Dichloromethano-stigmast-5-en-3β-ol (12a). 1H NMR (800 MHz): 5.352 (1H, m), 
3.523 (1H, m), 1.232 (3H, s), 1.224 (3H, s), 1.008 (3H, s), 0.948 (3H, d, J = 6.6 Hz), 0.925 (3H, t, J = 7.4 
Hz), 0.685 (3H, s). (24R)-Dichloromethano-stigmast-5-en-3β-ol (12b). 1H NMR (800 MHz): 5.351 (1H, 
m), 3.524 (1H, m), 1.235 (3H, s), 1.223 (3H, s), 1.008 (3H, s), 0.956 (3H, d, J = 6.6 Hz), 0.946 (3H, t, J = 
7.4 Hz), 0.680 (3H, s).  
24(ξ),25-Dichloromethano-6β-methoxy-3α,5α-cyclo-ergostane (19). The reaction was carried out as 
described for 11. Compound 18 (71.3 mg, 0.17 mmol) was used to obtain 81.6 mg of the desired products 
(95%).1H NMR (600 MHz):  3.323 (6H, br. s), 2.769 (2H, m), 1.235 (6H, s), 1.235 (6H, s), 1.195 (6H, s), 
1.171 (6H, s), 1.021 (6H, s), 0.931 (3H, d, J = 6.5 Hz),  0.924 (3H, d, J = 6.5 Hz),0.719 (3H, s), 0.713 
(3H, s), 0.646 (2H, m), 0.431 (2H, dd, J = 5.1, 7.9 Hz). 
24(ξ),25-Dichloromethano-ergost-5-en-3β-ol (20). The reaction was carried out as described for 
compound 12. Compound 19 (80.6 mg, 0.17 mmol) was treated with 3 mL of 1% TFA in DCM and 1 mL 
of 20% methanolic TEA was used to saponify the TFA esters. A silica gel filtration of the crude product 
with 4:1 hexanes/EtOAc provided 66.4 mg of a mixture of 20a and 20b (85% yield). (24S)-
Dichloromethano-ergost-5-en-3β-ol (20a). 1H NMR (800 MHz): 5.352 (1H, m), 3.522 (1H, m), 1.235 
(3H, s), 1.196 (3H, s), 1.171 (3H, s), 1.009 (3H, s), 0.931 (3H, d, J = 6.6 Hz), 0.685 (3H, s). (24R)-
Dichloromethano-ergost-5-en-3β-ol (20b). 1H NMR (800 MHz): 5.352 (1H, m), 3.524 (1H, m), 1.236 
(3H, s), 1.197 (3H, s), 1.172 (3H, s), 1.009 (3H, s), 0.940 (3H, d, J = 6.5 Hz), 0.680 (3H, s).  
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General method for the reduction of the dichlorocyclopropanes. To a mixture of 0.25 cm of Li wire in 
3 mL of NH3 was added the dichlorocyclopropane i-methyl ether (under 5 mg) in 1 mL of Et2O. The 
reaction was stirred for 1 h before removing the dry ice condenser to allow the NH3 to evaporate. After 
extraction with 10% hydrochloric acid and 4:1 hexanes/EtOAc, the organic layer was washed with brine 
and dried over Na2SO4 before evaporation under a N2 atmosphere. The crude product was purified via 
TLC with 4:1 hexanes/EtOAc. The obtained product was characterized by NMR. 
23-[(1R)-Ethyl-2,2-dimethylcyclopropyl]- 24-norchol-5-en-3β-ol (13) from 12a. 1H NMR (800 MHz): 
5.351(1H, m), 3.523 (1H, m), 1.093 (3H, s), 1.087 (3H, s), 1.007 (3H, s), 0.914 (3H, d, J = 6.6 Hz), 
0.871(3H, t, J = 7.5 Hz), 0.678 (3H, s), 0.028 (2H, s).  
23-[(1S)-Ethyl-2,2-dimethylcyclopropyl]- 24-norchol-5-en-3β-ol (15) from 12b. 1H NMR (800 MHz): 
5.351(1H, m), 3.523 (1H, m), 1.099 (3H, s), 1.085 (3H, s), 1.007 (3H, s), 0.913 (3H, d, J = 6.6 Hz), 
0.881(3H, t, J = 7.4 Hz), 0.673 (3H, s), 0.015 (2H, dd, J = 4.0, 15.4 Hz). 
23-[(1R)-1,2,2-trimethylcyclopropyl]- 24-norchol-5-en-3β-ol (21) from 20a. 1H NMR (600 MHz):  
5.352 (1H, m), 3.524 (1H, m), 1.084 (3H, s), 1.062 (3H, s), 1.171 (3H, s), 1.023 (3H, s), 1.010 (3H, 
s),0.905 (3H, d, J = 6.6 Hz), 0.680 (3H, s), 0.088 (1H, d, J = 3.9 Hz), 0.043 (1H, d, J = 3.9 Hz). 
23-[(1S)-1,2,2-trimethylcyclopropyl]- 24-norchol-5-en-3β-ol (22) from 20b. 1H NMR (600 MHz): 
5.353 (1H, m), 3.524 (1H, m), 1.087 (3H, s), 1.065 (3H, s), 1.171 (3H, s), 1.023 (3H, s), 1.010 (3H, 
s),0.906 (3H, d, J = 6.6 Hz), 0.675 (3H, s), 0.074 (1H, d, J = 3.9 Hz), 0.043 (1H, d, J = 3.9 Hz). 
General method for the TFA-catalyzed ring opening of sidechain cyclopropanes. Approximately 0.5 
to 1 mg of each substrate was treated with 500 µL 2% TFA in dry DCM overnight.  A solution of 20% 
methanolic TEA (500 µL) was then added dropwise to reaction before heating the mixture for 1 h at 45 
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oC. The solvent was evaporated under a N2 atmosphere and purified by preparative TLC with 4:1 
hexanes/EtOAc. HPLC purification was necessary to separate the desired product from any remaining 
starting material and minor side products.  
(24R)-24Ethyl-24-methyl-cholesta-5,25-dien-3-ol (14) from 13. 1H NMR (800 MHz): 5.349 (1 H, m), 
4.812 (1 H, br s), 4.620 (1H, d, J = 1.5 Hz), 3.520 (1H, m), 1.621 (3H, br s), 1.007 (3H, s), 0.930 (3H, s), 
0.912 (3H, d, J = 6.6 Hz), 0.711 (3H, t, J = 7.4 Hz), 0.668 (1H, s). 
(24S)-24Ethyl-24-methyl-cholesta-5,25-dien-3-ol (16) from 15. 1H NMR (800 MHz): 5.349 (1 H, m), 
4.801(1 H, br s), 4.623 (1H, d, J = 1.6 Hz), 3.520 (1H, m), 1.629 (3H, br s), 1.006 (3H, s), 0.941 (3H, s), 
0.912 (3H, d, J = 6.6 Hz), 0.716 (3H, t, J = 7.4 Hz), 0.671 (1H, s). 
 (24S)-24-Deutero-methyl-ergost-5,25-dien-3-ol (23) (minor) from 21. A solution of 2% deuterated 
TFA was used instead of non-deuterated TFA in the ring opening reaction. 1H NMR (800 MHz): 5.350 (1 
H, m), 4.718 (1 H, br s), 4.656 (1H, s), 3.522 (1H, m), 1.684 (3H, br s), 1.013 (3H, s), 1.009 (3H, s), 
0.912 (3H, d, J = 6.6 Hz), 0.672 (1H, s). 13C NMR (201 MHz): 152.4, 140.8, 121.7, 109.3, 71.8, 56.8, 
55.9, 50.2, 42.4, 43.3, 39.1 (2C), 38.6 (C24, ∆D = 70 ppb), 37.3, 37.0 (C23, ∆D = 20 ppb), 36.5, 36.2, 31.9, 
31.7, 30.5, 28.2, 27.5 (C28, 24α-Me), 26.9 (24β-Me, CHD2, ∆D = 320 ppb, t, J = 19.2Hz), 24.3, 21.1, 
19.40 (C27), 19.39 (C19), 18.9 (C21), 11.8 (C18). 
 (24R)-24-Deutero-methyl-ergost-5,25-dien-3-ol (24) (minor) from 22. A solution of 2% deuterated 
TFA was used instead of non-deuterated TFA in the ring opening reaction. 1H NMR (800 MHz): 5.350 (1 
H, m), 4.718 (1 H, br s), 4.656 (1H, s), 3.522 (1H, m), 1.684 (3H, br s), 1.013 (3H, s), 1.009 (3H, s), 
0.912 (3H, d, J = 6.6 Hz), 0.672 (1H, s). 13C NMR (201 MHz): 152.4, 140.8, 121.7, 109.3, 71.8, 56.8, 
55.9, 50.2, 42.4, 43.3, 39.1 (2C), 38.7 (C24, ∆D = 70 ppb), 37.3, 37.0 (C23, ∆D = 20 ppb), 36.5, 36.2, 31.9, 
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31.7, 30.5 (C22) , 28.2, 27.2 (24α-Me, CHD2, ∆D = 318 ppb, t, J = 19.5 Hz), 27.2 (C28, 24β-Me, ∆D = 21 
ppb), 24.3, 21.1, 19.4 (C19 and C27), 18.9 (C21), 11.8 (C18). 
General method for the hydrogenation of unsaturated i-methyl ethers. To a stirred suspension of 
about 5 mg of 10% w/w Pd/C in 500 µL EtOAc under H2 was added the dissolved starting material 
(approximately 1 mg) was in 1 mL of EtOAc. The reaction was stirred for 20 min before removing the 
catalyst via silica gel filtration. The solvent was evaporated, and the crude product was purified via 
preparative TLC before NMR analysis. 
(24R)-24Ethyl-24-methyl-cholestan-3-ol (14) from 3. 1H NMR (600 MHz): 3.587 (1 H, m), 0.907 (3H, 
d, J = 6.6 Hz), 0.802 (1H, s), 0.796 (3H, d, J = 6.6 Hz), 0.785 (3H, d, J = 6.6 Hz), 0.748 (3H, t, J = 7.5 
Hz), 0.672 (1H, s), 0.648 (1H, s). 
(24S)-24Ethyl-24-methyl-cholestan-3-ol (16) from 17.  1H NMR (600 MHz): 3.587 (1 H, m), 0.908 
(3H, d, J = 6.6 Hz), 0.803 (1H, s), 0.794 (3H, d, J = 7.0 Hz), 0.790 (3H, d, J = 6.9 Hz), 0.753 (3H, t, J = 
7.5 Hz), 0.671 (1H, s), 0.648 (1H, s). 
General method for the dichlorocyclopropanation of the allylic alcohol i-methyl ethers. To solution 
of the starting material (0.5-5 mg) and an excess of benzyltriethylammonium chloride (BTEAC) (4.2 mg, 
0.02 mmol) in 0.5 mL of CHCl3 was added 0.5 mL of 50% aqueous KOH. The mixture was stirred 
vigorously under a N2 atmosphere at room temperature for 75 min. The reaction was extracted with water 
and 4:1 hexanes/EtOAc. The organic layer was dried over Na2SO4, filtered through silica gel and 
evaporated under a flow of N2. The crude product was purified with preparative TLC with 9:1 
hexanes/EtOAc before HPLC separation with methanol to separate the mixture of diastereomers. 
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(24S,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-stigmastan-26-ol (25a) from 9a. 1H NMR (600 
MHz): 3.833 (1H, d, J = 11.8 Hz), 3.738 (1H, d, J = 11.8), 3.326 (3H, s), 2.771 (1H, t, J = 2.8 Hz), 1.347 
(3H, s), 1.024 (3H, s), 0.945 (3H, d, J = 6.6 Hz), 0.942 (3H, t, J = 7.4 Hz), 0.722 (3H, s), 0.650 (1H, dd, J 
= 4.1, 4.8 Hz), 0.434 (1H, dd, J = 5.1, 8.0). 
(24R,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-stigmastan-26-ol (25b) from 9a. 1H NMR (600 
MHz): 3.832 (1H, d, J = 11.8 Hz), 3.740 (1H, d, J = 11.8 Hz), 3.327 (3H, s), 2.771 (1H, d, J = 2.8Hz), 
1.349 (3H, s), 1.023 (3H, s), 0.959 (3H, t, J = 7.4 Hz), 0.953 (3H, d, J = 6.6 Hz ), 0.717 (3H, s), 0.650 
(1H, dd, J = 4.1, 4.8 Hz), 0.435 (1H, dd, J = 5.1, 8.0 Hz). 
(24S, 25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-stigmastan-26-ol (26a) from 9b. 1H NMR (600 
MHz): 3.824 (1H, d, J = 11.8 Hz), 3.738 (1H, d, J = 11.8 Hz), 3.325 (3H, s), 2.771 (1H, t, J = 2.8 Hz), 
1.356 (3H, s), 1.022 (1H, s), 0.949 (3H, t, J = 7.4 Hz) 0.946 (3H, d, J = 6.6 Hz), 0.723  (3H, s), 0.653 
(1H, dd, J = 4.1,4.8), 0.433 (1H, dd, J = 5.1, 8.0 Hz). 
(24R, 25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-stigmastan-26-ol (26b) from 9b. 1H NMR (600 
MHz): 3.827 (1H, d, J = 11.8 Hz), 3.741 (1H, d, J = 11.8 Hz) 3.325 (3H, s), 2.771 (1H, t, J = 2.8 Hz), 
1.355 (3H, s), 1.022 (3H, s), 0.974 (1H, t, J = 7.4 Hz), 0.955 (3H, d, J = 6.6 Hz), 0.719 (1H, s), 0.649 (1H, 
dd, J = 4.0,4.8 Hz), 0.433 (1H, dd, J = 5.1, 8.0 Hz). 
(24S, 25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-ergostan-26-ol (52a) from 51a. 1H NMR (600 
MHz): 3.840 (1H, d, J = 11.8 Hz), 3.739 (1H, d, J = 11.9 Hz), 3.325 (3H, s), 2.770 (1H, t, J = 2.7 Hz), 
1.328 (3H, s), 1.198 (3H, s), 1.023 (3H, s), 0.928 (3H, d, J = 6.4 Hz), 0.720 (3H, s), 0.649 (1H, dd, J = 
4.2, 4.8 Hz), 0.434 (1H, dd, J = 5.1, 8.0 Hz). 
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(24R, 25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-ergostan-26-ol (52b) from 51a. 1H NMR (600 
MHz): 3.830 (1H, d, J = 11.8 Hz), 3.737 (1H, d, J = 11.8 Hz), 3.326 (3H, s), 2.770 (1H, t, J = 2.7 Hz), 
1.328 (3H, s), 1.196 (3H, s), 1.023 (3H, s), 0.935 (3H, d, J = 6.4 Hz), 0.714 (3H, s), 0.649 (1H, dd, J = 
4.1, 4.7 Hz), 0.434 (1H, dd, J = 5.1, 8.0 Hz). 
(24S,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-ergostan-26-ol (53a) from 51b. 1H NMR (600 
MHz): 3.790 1H, d, J = 11.7 Hz), (3.694 (1H, d, J = 11.7 Hz), 3.325 (3H, s), 2.77 (1H, t, J = 2.7 Hz), 
1.351 (3H, s), 1.271 (3H, s), 1.023 (3H, s), 0.931 (3H, d, J = 6.4 Hz), 0.721 (3H, s), 0.649 (1H, dd, J = 
4.1, 4.7 Hz), 0.434 (1H, dd, J = 5.1, 8.0 Hz). 
(24R,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-ergostan-26-ol (53b) from 51b. 1H NMR (600 
MHz): 3.784 (1H, d, J = 11.7 Hz), 3.689 (1H, d, J = 11.7 Hz), 3.326 (3H, s), 2.771 (1H, t, J = 2.8 Hz), 
1.350 (3H, s), 1.270 (1H, s), 1.024 (1H, s), 0.939 (3H, d, J = 6.5 Hz), 0.718 (3H, s), 0.650 (1H, dd, J = 4.2, 
4.8 Hz), 0.435 (1H, dd, J = 5.1, 8.0 Hz). 
(24S,25S)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-27-homoergostan-26-ol (75a) from 74a. 1H 
NMR (600 MHz): 3.860 (1H, dd, J = 5.8, 12.1 Hz), 3.819 (1H, m), 3.325 (3H, s), 2.770 (1H, t, J = 2.7 
Hz), 1.222 (3H, s), 1.023 (3H, s), 0.995 (3H, t, J = 7.4 Hz), 0.927 (3H, d, J = 6.6 Hz), 0.719 (3H, s), 0.649 
(1H, dd, J = 4.2, 4.8 Hz), 0.434 (1H, dd, J = 5.1, 8.0 Hz). 
(24R,25R)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-27-homoergostan-26-ol (75b) from 74a. 1H 
NMR (600 MHz): 3.869 (1H, m), 3.796 (1H, m), 3.326 (3H, s), 2.771 (1H, t, J = 2.8 Hz), 1.218 (3H, s), 
0.992 (3H, t, J = 7.4 Hz), 0.933 (3H, d, J = 6.6 Hz), 0.714 (3H, s), 0.650 (1H, dd, J = 4.1, 4.8 Hz), 0.435 
(1H, dd, J = 5.1, 8.0 Hz). 
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(24S,25R)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-27-homoergostan-26-ol (76a) from 74b. 1H 
NMR (600 MHz): 3.886 (1H, m), 3.762 (1H, m), 3.326 (3H, s), 2.771 (1H, t, J = 2.7 Hz), 1.272 (3H, s), 
1.059 (3H, t, J = 7.4 Hz), 1.024 (3H, s), 0.930 (3H, d, J =  6.6 Hz), 0.722 (3H, s), 0.649 (1H, dd, J = 4.0, 
4.8 Hz), 0.434 (1H, dd, J = 5.1, 8.0 Hz). 
(24R,25S)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-27-homoergostan-26-ol (76b) from 74b. 1H 
NMR (600 MHz): 3.889 (3H, dd, J = 5.1, 12.1 Hz), 3.749 (3H, dd, J = 7.2, 12.1 Hz), 3.326 (3H, s), 2.771 
(1H, t, J =  2.7 Hz), 1.280 (3H, s), 1.073 (3H, t, J =  7.4 Hz), 1.023 (3H, s), 0.940 (3H, d, J =  6.6 Hz), 
0.719 (1H, s), 0.649 (3H, dd, J = 4.1, 4.8 Hz), 0.434 (1H, dd, J = 5.1, 8.0 Hz). 
23-[(1R,2R)-(1-Ethyl-2-methylcyclopropanemethanol)]-6β-Methoxy-3α,5α-cyclo-24-norcholane (27). 
Compound 26a (6.2 mg, 0.012 mmol) was dechlorinated as described above in the general methods for 
the reduction of the dichlorocyclopropanes to obtain 5.0 mg 27 (92% yield). 1H NMR (600 MHz): 3.616 
(1H, d, J = 11.3 Hz), 3.534 (1H, d, J = 11.3 Hz), 3.326 (3H, s), 2.770 (1H, t, J = 2.8 Hz), 1.225 (3H, s), 
1.025 (3H, s), 0.925 (3H, d, J =  6.6 Hz), 0.910 (3H, t, J = 7.4 Hz), 0.721 (3H, s), 0.648 (1H, dd, J = 4.0, 
4.8 Hz), 0.433 (1H, dd, J = 5.0, 8.0 Hz), 0.274 (1H, d, J = 4.4 Hz), 0.131 (1H, d, J = 4.4 Hz). 
General method for the DMP oxidation of the substituted cyclopropanemethanol i-methyl ethers. 
To a solution of approximately 0.5-2 mg of alcohol i-methyl ether in 1 mL of DCM was added 
approximately 2.6-4.3 mg of DMP. The reaction was stirred for 1 h and checked by analytical TLC before 
filtering the crude extract with 9:1 hexanes/EtOAc through 4 cm of silica gel in a Pasteur pipet. The 
solvent was evaporated under a flow of N2 and purified via preparative TLC with 19:1 hexanes/EtOAc. 
At least an 80% yield was observed for each reaction. 
23-[(1R,2R)-(1-Ethyl-2-methylcyclopropanecarboxaldehyde)]-6β-Methoxy-3α,5α-cyclo-24-
norcholane (28).  28 was obtained from 27 as described above in the general method for the DMP 
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oxidation. 1H NMR (600 MHz): 9.298 (1H, s), 3.327 (3H, s), 2.773 (1H, t, J = 2.8 Hz), 1.284 (3H, s), 
1.025 (3H, s), 0.927 (3H, d, J = 6.6 Hz), 0.867 (3H, t, J = 7.4 Hz), 0.724 (3H, s), 0.651 (1H, dd, J = 4.0, 
4.8 Hz), 0.435 (1H, d, J = 5.1, 8.0 Hz). 
General method for the methylenation of the substituted cyclopropanecarboxaldehyde i-methyl 
ethers. A mixture of methyltriphenylphosphonium iodide (72.8 mg, 0.200 mmol) and KtBuO (19.2 mg, 
0.170 mmol) in 3 mL of dry THF was heated to reflux for under a N2 atmosphere for 30 min. The 
resulting suspension was cooled to rt before adding 1 mL of the supernatant (ylide) to a solution of the 
cyclopropanecarboxaldehyde i-methyl ether (1-5 mg) in 500 µL of THF. The mixture was stirred under a 
N2 atmosphere for 20 min before extraction with water and 4:1 hexanes/EtOAc. The organic layer was 
washed with brine, dried over Na2SO4 and evaporated under a flow of N2. The crude product was purified 
by preparative TLC with 3:1 hexanes/DCM.  
23-[(1R, 2S)-(1-Ethyl-2-ethenyl-2-methylcyclopropyl)]-6β-Methoxy-3α,5α-cyclo-24-norcholane (29).  
29 was obtained from 28 as described above in the general method for the methylenation of the 
substituted cyclopropanecarboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.838 (1H, dd, J = 10.1, 
17.8 Hz), 4.976 (1H, dd, J = 1.7, 5.7 Hz), 4.953 (1H, m), 3.325 (3H, s), 3.770 (1H, t, J = 2.8 Hz), 1.215 
(3H, s), 1.024 (3H, s), 0.922 (3H, d, J = 6.6 Hz), 0.836 (3H, t, J = 7.4 Hz), 0.720 (3H, s), 0.649 (1H, dd, J 
= 4.0, 4.8 Hz), 0.569 (1H, d, J = 4.4 Hz), 0.431 (1H, dd, J = 5.1, 8.0 Hz), 0.319 (1H, d, J = 4.4 Hz). 
23-[(1R, 2S)-(1-Ethyl-2-methylcyclopropaneethanol]-6β-Methoxy-3α,5α-cyclo-24-norcholane (30). 
To a solution of 29 (1 mg, 0.002 mmol) in 900 µL of THF was added 100 µL 2 M BMS dropwise under a 
N2 atmosphere. The reaction was stirred for 2 h before adding 10 drops of 10% methanolic NaOH 
dropwise, followed by 10 drops of 30% H2O2. The reaction was stirred at room temperature for 3 h before 
extracting the product with water and 4:1 hexanes/EtOAc. The organic layer was washed with brine, dried 
over Na2SO4 and evaporated under a flow of N2. The crude product was purified by preparative TLC with 
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4:1 hexanes/EtOAc. 1H NMR (600 MHz): 3.739 (2H, m), 3.326 (3H, s), 2.769 (1H, t, J = 2.8 Hz), 1.111 
(3H, s), 1.023 (3H, s), 0.913 (3H, d, J = 6.6 Hz), 0.891 (3H, t, J = 7.4 Hz), 0.716 (3H, s), 0.648 (1H, dd, J 
= 4.0, 4.8 Hz), 0.432 (1H, dd, J = 5.1, 8.0 Hz), 0.160 (1H, d, J = 4.2 Hz), 0.066 (1H, t, J = 4.2 Hz). 
23-[(1R,2S)-(1-Ethyl-2-[(methylsulfonyl)oxy]ethyl]-2-methylcyclopropyl]-6β-Methoxy-3α,5α-cyclo-
24-norcholane (31). To a solution of 30 (approximately 1 mg, 0.002 mmol) and 750 µL of dry 1% TEA 
in DCM was added 250 µL of 1% MsCl in dry DCM at 0 oC. The reaction was stirred for 30 min at 0 oC 
before extraction with water and 4:1 hexanes/EtOAc. The organic layer was washed with 5% 
hydrochloric acid followed by a brine wash and dried over Na2SO4. The crude was evaporated under a 
flow of N2 and purified with preparative TLC with 4:1 hexanes/EtOAc. 1H NMR (600 MHz): 4.291 (2H, 
m), 3.326 (1H, s), 3.002 (3H, s), 2.770 (1H, t, J = 2.8 Hz), 1.128 (3H, s), 1.024 (3H, s), 0.912 (3H, d, J = 
6.6 Hz), 0.897 (3H, t, J = 7.4 Hz), 0.716 (3H, s), 0.648 (1H, dd, J = 4.0, 4.8Hz), 0.432 (1H, dd, J = 5.1, 
8.0 Hz), 0.193 (1H, d, J = 4.5 Hz), 0.112 (1H, d, J = 4.4 Hz). 
23-[(1R,2R)-(1,2-Diethyl-2-methylcyclopropyl]-6β-Methoxy-3α,5α-cyclo-24-norcholane (32). A 
solution of 31(approximately 1 mg, 0.002 mmol) in 1.5 mL of Et2O was treated with 3.6 mg of LAH. The 
mixture was stirred for 30 min at room temperature and the reaction was extracted with 10% hydrochloric 
acid and 4:1 hexanes/EtOAc. The organic layer was washed with brine and dried over Na2SO4. The crude 
product was purified with preparative TLC with 39:1 hexanes/EtOAc. 1H NMR (600 MHz): 3.326 (3H, 
s), 2.769 (1H, t, J = 2.8 Hz), 1.065 (3H, s), 1.024 (3H, s), 0.915 (3H, d, J = 6.6 Hz), 0.897 (3H, d, J = 7.4 
Hz), 0.876 (3H, t, J = 7.4 Hz), 718 (3H, s), 0.648 (1H, dd, J = 4.0, 4.9 Hz), 0.431 (1H, dd, J = 5.1, 8.0 
Hz), 0.045 (1H, d, J = 4.0 Hz), -0.010 (1H, d, J = 4.0 Hz).  
General method for the deprotection of i-methyl ethers. Approximately 1-5 mg of i-methyl ether was 
treated with 500 µL of 1% TFA in DCM for 8 min. A solution of 100 µL of 20% methanolic TEA was 
then added dropwise to the reaction before heating the mixture for 1 h at 45 oC. The solvent was 
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evaporated under a N2 atmosphere and the crude product was purified by preparative TLC with 4:1 
hexanes/EtOAc.  
23-[(1R,2R)-(1,2-Diethyl-2-methylcyclopropyl]-24-norchol-5-en-3β-ol (33). Compound 33 was 
obtained from 32 as described above in the general method for the deprotection of i-methyl ethers. The 
product was further purified by HPLC before the characterization by NMR. 1H NMR (800 MHz): 5.353 
(1H, m), 3.523 (1H, m), 1.065 (3H, s), 1.012 (3H, s), 0.932 (3H, d, J = 6.6 Hz), 0.897 (3H, t, J = 7.4 Hz), 
0.876 (3H, t, J = 7.4 Hz), 0.684 (3H, s), 0.047 (1H, d, J = 4.0 Hz), -0.009 (1H, t, J = 4.0 Hz). 
(24S,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-stigmastan-26-al (34). Compound 34 was 
obtained from 25a as described above in the general method for DMP oxidation of the cyclopropane 
alcohols. 1H NMR (600 MHz): 9.632 (1H, s), 3.326 (3H, s), 2.771 (1H, t, J = 2.8 Hz), 1.315 (3H, s), 
1.022 (3H, s), 0.982 (3H, t, J = 7.4 Hz), 0.936 (3H, d, J = 6.5 Hz), 0.719 (3H, s), 0.649 (1H, dd, J = 4.1, 
4.9 Hz), 0.434 (1H, dd, J = 5.1,8.0 Hz). 
(24R,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-stigmastan-26-al (35). Compound 35 was 
obtained from 25b as described above in the general method for DMP oxidation of the cyclopropane 
alcohols. 1H NMR (600 MHz): 9.616 (1H, s), 3.323 (3H, s), 2.768 (1H, t, J = 2.8 Hz), 1.315 (3H, s), 1.020 
(3H, s), 1.004 (3H, t, J = 7.4 Hz), 0.945 (3H, d, J = 6.5 Hz), 0.706 (3H, s), 0.648 (1H, dd, J = 4.1, 4.8 Hz), 
0.433 (1H, dd, J = 5.1, 8.0 Hz)  
(24R,25S)-Dichloromethano-6β-methoxy-3α,α5-cyclo-stigmastan-26-al (36). Compound 36 was 
obtained from 26b as described above in the general method for DMP oxidation of the cyclopropane 
alcohols. 1H NMR (600 MHz): 9.628 (1H, s), 3.327 (3H, s), 2.772 (1H, t, J = 2.8 Hz), 1.328 (3H, s), 
1.023 (3H, s), 0.994 (3H, t, J = 7.4 Hz), 0.956 (3H, d, J = 6.5 Hz), 0.720 (3H, s), 0.650 (1H, dd, J = 4.1, 
4.8 Hz), 0.436 (1H, t, J = 5.1, 8.0 Hz). 
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(24S,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-ergostan-26-ol (54). Compound 54 was obtained 
from 52a as described above in the general method for DMP oxidation of the cyclopropane alcohols. 1H 
NMR (600 MHz): 9.610 (1H, s), 3.324 (3H, s), 2.769 (1H, t, J = 2.7 Hz), 1.292 (3H, s), 1.280 (3H, s), 
1.020 (3H, s), 0.920 (3H, d, J = 6.5 Hz), 0.716 (3H, s), 0.648 (1H, dd, J = 4.1, 4.6 Hz), 0.433 (1H, dd, J = 
5.2, 8.1). 
(24R,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-ergostan-26-ol (55). Compound 55 was 
obtained from 52b as described above in the general method for DMP oxidation of the cyclopropane 
alcohols. 1H NMR (600 MHz): 9.588 (1H, s), 3.324 (3H, s), 2.767 (1H, t, J = 2.7 Hz), 1.292 (3H, s), 
1.276 (3H, s), 1.020 (3H, s), 0.931 (3H, d, J = 6.5 Hz), 0.704 (3H, s), 0.648 (1H, t, J = 4.1, 4.7 Hz), 0.434 
(1H, t, J = 5.1, 8.0 Hz). 
(24S,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-ergostan-26-al (56). Compound 56 was obtained 
from 53a as described above in the general method for DMP oxidation of the cyclopropane alcohols. 1H 
NMR (600 MHz): 9.597 (1H, s), 3.327 (3H, s), 2.772 (1H, t, J = 2.8 Hz), 1.530 (3H, s), 1.334 (3H, s), 
1.024 (3H, s), 0.931 (3H, d, J = 6.6 Hz), 0.723 (3H, s), 0.651 (1H, 1, J = 4.1, 4.7 Hz), 0.436 (1H, t, J = 
5.1, 8.0 Hz). 
(24R,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-ergostan-26-al (57). Compound 57 was obtained 
from 53b as described above in the general method for DMP oxidation of the cyclopropane alcohols. 1H 
NMR (600 MHz): 9.583 (1H, s), 3.326 (3H, s), 2.772 (1H, t, J = 2.7 Hz), 1.534 (3H, s), 1.333 (3H, s), 
1.022 (3H, s), 0.939 (3H, d, J = 6.6 Hz), 0.715 (3H, s), 0.650 (1H, dd, J = 4.1, 4.7 Hz), 0.436 (1H, dd, J = 
5.1, 8.0 Hz). 
(24S,25S)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-27-homoergostan-26-al (77). Compound 77 
was obtained from 75a as described above in the general method for DMP oxidation of the cyclopropane 
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alcohols. 1H NMR (600 MHz): 9.581 (1H, s), 3.324 (3H, s), 2.769 (1H, t, J = 2.7 Hz), 1.315 (3H, s), 
1.020 (3H, s), 0.972 (3H, t, J = 7.3 Hz), 0.916 (3H, d, J = 6.6 Hz), 0.714 (3H, s), 0.648 (1H, dd, J = 4.1, 
5.0 Hz), 0.433 (1H, dd, J = 5.1, 8.0 Hz). 
(24R,25R)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-27-homoergostan-26-al (78). Compound 78 
was obtained from 75b as described above in the general method for DMP oxidation of the cyclopropane 
alcohols. 1H NMR (600 MHz): 9.553 (1H, s), 3.324 (3H, s), 2.769 (1H, t, J = 2.8 Hz), 1.312 (3H, s), 
1.020 (3H, s), 0.970 (1H, t, J = 7.4 Hz), 0.927 (3H, d, J = 6.6 Hz), 0.704 (3H, s), 0.648 (1H, dd, J = 4.1, 
5.1 Hz), 0.434 (1H, dd, J = 5.1, 7.8 Hz). 
(24S,25R)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-27-homoergostan-26-al (79). Compound 79 
was obtained from 76a as described above in the general method for DMP oxidation of the cyclopropane 
alcohols. 1H NMR (600 MHz):  9.609 (1H, d, J = 1.0 Hz), 3.327 (3H, s), 2.773 (1H, t, J = 2.8 Hz), 1.437 
(3H, s), 1.023 (3H, s), 1.006 (3H, t, J = 7.3 Hz), 0.928 (3H, d, J = 6.5 Hz) ,0.721 (3H, s), 0.650 (1H, dd, J 
= 4.1, 4.9 Hz), 0.436 (1H, dd, J = 5.1, 8.0 Hz). 
(24R,25S)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-27-homoergostan-26-al (80). Compound 80 
was obtained from 76b as described above in the general method for DMP oxidation of the cyclopropane 
alcohols. 1H NMR (600 MHz): 9.601 (1H, d, J = 0.9 Hz), 3.327 (3H, s), 2.773 (1H, t, J = 2.8 Hz), 1.434 
(3H, s), 1.023 (3H, s), 1.016 (3H, t, J = 7.4 Hz), 0.936 (3H, d, J = 6.6 Hz), 0.717 (3H, s), 0.650 (1H, dd, J 
= 4.1, 4.8 Hz), 0.436 (1H, dd, J = 5.1, 8.1 Hz). 
(24S,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homostigmast-26-ene (37). Compound 37 
was obtained from 34 as described above in the general method for the methylenation of the substituted 
carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.999 (1H, dd, J = 10.9, 17.4 Hz), 5.277 (1H, dd, J 
= 0.9, 10.9 Hz), 5.247 (1H, t, J = 0.9, 17.4 Hz), 3.325 (3H, s), 2.770 (1H, t, J = 2.7 Hz), 1.359 (3H, s), 
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1.022 (3H, s), 0.944 (3H, t, J = 7.4 Hz), 0.926 (3H, d, J = 6.6 Hz), 0.715 (3H, s), 0.648 (1H, dd, J = 
3.9, 4.7 Hz), 0.433 (1H, dd, J = 5.1,7.9 Hz). 
(24R,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homostigmast-26-ene (38). Compound 38 
was obtained from 35 as described above in the general method for the methylenation of the substituted 
carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.995 (1H, dd, J = 10.9, 17.3 Hz), 5.287 (1H, 
dd, J = 1.1, 10.9 Hz), 5.257 (1H, t, J = 1.0, 17.4 Hz), 3.325 (3H, s), 2.769 (1H, t, J = 2.7 Hz), 1.358 (3H, 
s), 1.022 (3H, s), 0.964 (3H, t, J = 7.4 Hz), 0.931 (3H, d, J = 6.6 Hz), 0.708 (3H, s), 0.649 (1H, dd, J = 
4.0, 4.8 Hz), 0.432 (1H, dd, J = 5.0, 8.0 Hz).  
(24R,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homostigmast-26-ene (39). Compound 39 
was obtained from 36 as described above in the general method for the methylenation of the substituted 
carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.986 (1H, dd, J = 10.9, 17.4 Hz), 5.269 (1H, dd, J 
= 1.1, 10.9 Hz), 5.328 (1H, dd, J = 1.1, 17.4 Hz), 3.327 (3H, s), 2.772 (1H, t, J = 2.8 Hz), 1.367 (3H, s), 
1.025 (3H, s), 0.961(3H, d, J = 6.6 Hz), 0.933 (3H, t, J = 7.4 Hz), 0.722 (3H, s), 0.651 (1H, dd, J = 4.1, 
4.9 Hz), 0.435 (1H, t, J = 5.1, 8.0 Hz). 
(24S,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homoergost-26-ene (58). Compound 58 was 
obtained from 54 as described above in the general method for the methylenation of the substituted 
carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.991 (1H, dd, J = 11.0, 17.3 Hz), 5.276 (1H, 
dd, J = 10.9, 11.8 Hz), 5.259 (1H, dd, J = 17.3, 18.1 Hz), 3.324 (3H, s), 2.768 (1H, t, J = 2.7 Hz), 1.328 
(3H, s), 1.234 (3H, s), 1.022 (3H, s), 0.910 (3H, d, J = 6.6 Hz), 0.713 (3H, s), 0.647 (1H, dd, J = 4.1, 4.8 
Hz), 0.432 (1H, dd, J = 5.1, 8.0 Hz).  
(24R,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homoergost-26-ene (59). Compound 59 was 
obtained from 55 as described above in the general method for the methylenation of the substituted 
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carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.976 (1H, dd, J = 10.9, 17.3 Hz), 5.286 (1H, dd, J 
= 10.9, 11.7 Hz), 5.267 (1H, dd, J = 17.3, 18.1 Hz), 3.324 (3H, s), 2.768 (1H, t, J = 2.7 Hz), 1.326 (3H, s), 
1.234 (3H, s), 1.022 (3H, s), 0.915 (3H, d, J = 6.6 Hz), 0.705 (3H, s), 0.648 (1H, dd, J = 4.1, 4.7 Hz), 
0.432 (1H, dd, J = 5.1,7.9 Hz). 
(24S,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homoergost-26-ene (60). Compound 60 was 
obtained from 56 as described above in the general method for the methylenation of the substituted 
carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.934 (1H, dd, J = 10.9, 17.4 Hz), 5.268 (1H, 
dd, J = 10.9, 11.9 Hz), 5.225 (1H, dd, J = 17.4, 18.4 Hz), 3.326 (3H, s), 2.771 (1H, t, J = 2.7 Hz), 1.370 
(3H, s), 1.215 (3H, s), 1.025 (3H, s), 0.936 (1H, d, J = 6.6 Hz), 0.725 (3H, s), 0.649 (1H, dd, J = 4.2, 4.8 
Hz), 0.435 (1H, dd, J = 5.1, 7.9 Hz). 
 (24R,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homoergost-26-ene (61). Compound 61 was 
obtained from 57 as described above in the general method for the methylenation of the substituted 
carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.925 (1H, dd, J = 10.9, 17.4 Hz), 5.268 (1H, dd, J 
= 10.9, 11.8 Hz), 5.227 (1H, dd, J = 17.4, 18.2 Hz), 3.327 (3H, s), 2.772 (1H, dd, J = 2.7 Hz), 1.370 (3H, 
s), 1.216 (3H, s), 1.024 (3H, s), 0.942 (3H, d, J = 6.6 Hz), 0.719 (3H, s), 0.650 (1H, dd, J = 4.2, 4.8 Hz), 
0.435 (1H, dd, J = 5.1, 7.8 Hz). 
 (24S,25R)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-26,27-dihomoergost-26-ene (81). Compound 
81 was obtained from 77 as described above in the general method for the methylenation of the 
substituted carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.795 (1H, dd, J = 10.9, 17.7 Hz), 
5.384 (1H, dd, J = 1.1, 10.9 Hz), 5.214 (1H, dd, J = 1.1, 17.7 Hz), 3.323 (3H, s), 2.769 (1H, t, J = 2.7 Hz), 
1.247 (3H, s), 1.020 (3H, s), 0.976 (3H, t, J = 7.3 Hz), 0.912 (3H, d, J = 6.6 Hz), 0.709 (3H, s), 0.646 (1H, 
dd, J = 4.1, 5.0 Hz), 0.430 (1H, t, J = 5.1, 8.0 Hz). 
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(24R,25S)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-26,27-dihomoergost-26-ene (82). Compound 82 
was obtained from 78 as described above in the general method for the methylenation of the substituted 
carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.780 (1H, dd, J = 11.0, 17.6 Hz), 5.397 (1H, 
dd, J = 1.1, 11.0 Hz), 5.231(1H, dd, J = 1.1, 17.7 Hz), 3.324 (3H, s), 2.769 (1H, t, J = 2.7 Hz), 1.247 (3H, 
s), 1.021 (3H, s), 0.975 (3H, t, J = 7.4 Hz), 0.908 (3H, d, J = 6.6 Hz), 0.706 (3H, s), 0.648 (1H, dd, J = 
4.1, 4.8 Hz), 0.431 (1H, dd, J = 5.2, 8.0 Hz).  
(24S,25S)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-26,27-dihomoergost-26-ene (83). Compound 83 
was obtained from 79 as described above in the general method for the methylenation of the substituted 
carboxaldehyde i-methyl ethers. 1H NMR (600 MHz):  5.801 (1H, dd, J = 10.9, 17.7 Hz), 5.372 (1H, dd, J 
= 1.3, 10.9 Hz), 5.148 (1H, dd, J = 1.3, 17.7 Hz), 3.326 (3H, s), 2.771 (1H, t, J = 2.8 Hz), 1.139 (3H, s), 
1.026 (3H, s), 1.012 (3H, t, J = 7.3 Hz), 0.939 (3H, d, J = 6.6 Hz), 0.727 (3H, s), 0.650 (1H, dd, J = 4.1, 
4.8 Hz) 0.435 (1H, dd, J = 5.1, 8.0 Hz). 
 (24R,25R)-Dichloromethano-6β-Methoxy-3α,5α-cyclo-26,27-dihomoergost-26-ene (84). Compound 
84 was obtained from 80 as described above in the general method for the methylenation of the 
substituted carboxaldehyde i-methyl ethers. 1H NMR (600 MHz): 5.808 (1H, dd, J = 10.9, 17.7 Hz), 
5.371 (1H, dd, J = 1.3, 10.9 Hz), 5.145 (1H, dd, J = 1.3, 17.7 Hz), 3.328 (3H, s), 2.773 (1H, t, J = 2.8 Hz), 
1.132 (3H, s), 1.025 (3H, s), 1.022 (3H, t, J = 7.4 Hz), 0.945 (3H, d, J = 6.6 Hz), 0.723 (3H, s), 0.650 (1H, 
dd, J = 4.1, 4.8 Hz), 0.435 (1H, dd, J = 5.2, 8.2 Hz). 
 (24S,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homostigmastane (40). Compound 40 was 
obtained from 37 as described above in the general method for the hydrogenation of the unsaturated i-
methyl ethers. 1H NMR (600 MHz): 3.326 (3H, s), 2.771 (1H, t, J = 2.7 Hz), 1.201 (3H, s), 1.024 (3H, s), 
0.997 (3H, t, J = 7.4 Hz), 0.941 (3H, d, J = 6.6 Hz), 0.907 (3H, t, J = 7.4 Hz), 0.723 (3H, s), 0.650 
(1H, dd, J = 4.1, 4.8 Hz), 0.433 (1H, dd, J = 5.1, 8.0 Hz). 
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(24R,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homostigmastane (41). Compound 41 was 
obtained from 38 as described above in the general method for the hydrogenation of the unsaturated i-
methyl ethers. 1H NMR (600 MHz): 3.328 (3H, s), 2.772 (1H, t, J = 2.7 Hz), 1.202 (3H, s), 1.204 (3H, s), 
1.012 (3H, t, J = 7.4 Hz), 0.955 (3H, d, J = 6.6 Hz), 0.925 (3H, t, J = 7.4 Hz), 0.721 (3H, s), 0.650 (1H, 
dd, J = 4.1, 4.8 Hz), 0.434 (1H, dd, J = 5.1, 8.0 Hz). 
(24R,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homostigmastane (42). Compound 42 was 
obtained from 39 as described above in the general method for the hydrogenation of the unsaturated i-
methyl ethers. 1H NMR (600 MHz): 3.327 (3H, s), 2.772 (1H, t, J = 2.7 Hz), 1.206 (3H, s), 1.024 (3H, s), 
0.978 (3H, t, J = 7.4 Hz), 0.974 (3H, d, J = 6.6 Hz), 0.951 (1H, t, J = 7.4 Hz), 0.718 (3H, s), 0.650 (1H, 
dd, J = 4.1, 5.0 Hz), 0.434 (1H, t, J = 5.1, 8.1 Hz). 
(24S,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homoergostane (62). Compound 62 was 
obtained from 58 as described above in the general method for the hydrogenation of the unsaturated i-
methyl ethers. 1H NMR (600 MHz): 3.325 (3H, s), 2.770 (1H, t, J = 2.7 Hz), 1.177 (3H, s), 1.168 (3H, s), 
1.024 (3H, s), 1.016 (3H, t, J = 7.4 Hz), 0.926 (3H, d, J = 6.6 Hz), 0.721 (3H, s), 0.648 (1H, dd, J = 4.1, 
4.7 Hz), 0.433 (1H, dd, J = 5.1, 8.0 Hz). 
(24R,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homoergostane (63). Compound 63 was 
obtained from 59 as described above in the general method for the hydrogenation of the unsaturated i-
methyl ethers. 1H NMR (600 MHz): 3.327 (3H, s), 2.772 (1H, t, J = 2.7 Hz), 1.175 (3H, s), 1.173 (3H, s), 
1.031 (3H, t, J = 7.4 Hz), 1.024 (3H, s), 0.935 (3H, d, J = 6.6 Hz), 0.718 (3H, s), 0.650 (3H, dd, J = 4.1, 
4.7 Hz), 0.434 (1H, dd, J = 5.1,7.9 Hz).    
(24S,25S)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homoergostane (64). Compound 64 was 
obtained from 60 as described above in the general method for the hydrogenation of the unsaturated i-
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methyl ethers. 1H NMR (600 MHz): 3.326 (3H, s), 2.770 (1H, t, J = 2.7 Hz), 1.205 (3H, s), 1.195 (3H, s), 
1.024 (3H, s), 0.974 (3H, t, J = 7.4 Hz), 0.926 (3H, d, J = 6.6 Hz), 0.722 (3H, s), 0.649 (1H, dd, J = 4.0, 
4.8 Hz), 0.433 (1H, dd, J = 5.0, 7.9 Hz).  
 (24R,25R)-Dichloromethano-6β-methoxy-3α,5α-cyclo-26-homoergostane (65). Compound 65 was 
obtained from 61 as described above in the general method for the hydrogenation of the unsaturated i-
methyl ethers. 1H NMR (600 MHz): 3.327 (3H, s), 2.771 (1H, t, J = 2.7 Hz), 1.204 (3H, s), 1.194 (3H, s), 
1.023 (3H, s), 0.975 (3H, t, J = 7.4 Hz), 0.930 (3H, d, J = 6.6 Hz), 0.716 (3H, s), 0.650 (1H, dd, J = 4.1, 
4.7 Hz), 0.434 (1H, dd, J = 5.1, 7.9 Hz). 
(24S)-Dichloromethano-6β-Methoxy-3α,5-cyclo-26,27-dihomoergostane (85). Compound 85 was 
obtained from 81 and 83 as described above in the general method for the hydrogenation of the 
unsaturated i-methyl ethers. 1H NMR (600 Hz): 3.325 (3H, s), 2.770 (1H, t, J = 2.7 Hz), 1.194 (3H, s), 
1.023 (3H, s), 0.970 (3H, t, J = 7.4 Hz), 0.926 (3H, d, J = 6.6 Hz), 0.912 (1H, t, J = 7.4 Hz), 0.720 (3H, 
s), 0.650 (1H, dd, J = 4.1, 4.8 Hz), 0.433 (1H, dd, J = 5.1, 8.0 Hz). 
(24R)-Dichloromethano-6β-Methoxy-3α,5-cyclo-26,27-dihomoergostane (86). Compound 86 was 
obtained from 82 and 84 as described above in the general method for the hydrogenation of the 
unsaturated i-methyl ethers. 1H NMR (600 MHz): 3.327 (3H, s), 2.771 (1H, t, J = 2.7 Hz), 1.195 (3H, s), 
1.024 (3H, s), 0.983 (3H, t, J = 7.4 Hz), 0.934  (3H, d, J = 6.6 Hz), 0.908 (3H, t, J = 7.4 Hz), 0.717 
(3H, s), 0.650 (1H, dd, J = 4.1, 4.8 Hz), 0.434 (1H, dd, J = 5.1, 8.0 Hz). 
(24S,25R)-Dichloromethano-26-homostigmast-5-en-3β-ol (43). Compound 43 was obtained from 40 as 
described above in the general method for the deprotection of the i-methyl ethers. 1H NMR (600 MHz): 
5.355 (1H, m), 3.524 (1H, m), 1.201 (3H, s), 1.011 (3H, s), 0.997 (3H, t, J = 7.4 Hz), 0.947 (3H, d, J = 6.6 
Hz), 0.905 (3H, t, J = 7.4 Hz), 0.687 (3H, s).  
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(24R,25S)-Dichloromethano-26-homostigmast-5-en-3β-ol (44). Compound 44 was obtained from 41 as 
described above in the general method for the deprotection of the i-methyl ethers. 1H NMR (600 MHz): 
5.354 (3H, m), 3.526 (1H, m), 1.202 (3H, s), 1.012 (3H, t, J = 7.4 Hz), 1.011 (3H, s), 0.961 (3H, d, J = 6.6 
Hz), 0.925 (3H, t, J = 7.4 Hz), 0.685 (3H, s). 
(24R,25R)-Dichloromethano-26-homostigmast-5-en-3β-ol (45). Compound 45 was obtained from 42 as 
described above in the general method for the deprotection of the i-methyl ethers. 1H NMR (600 MHz): 
5.352 (1H, m), 3.525 (1H, m), 1.205 (3H, s), 1.010 (3H, s), 0.976 (3H, t, J = 7.4 Hz), 0.974 (3H, t, J = 7.4 
Hz), 0.958 (3H, d, J = 6.6 Hz), 0.683 (3H, s). 
(24S,25R)-Dichloromethano-6β-26-homoergost-5-en-3β-ol (66). Compound 66 was obtained from 62 
as described above in the general method for the deprotection of the i-methyl ethers. 1H NMR (600 MHz): 
5.353 (1H, m), 3.524 (1H, m), 1.177 (3H, s), 1.167 (3H, s), 1.011 (3H, s), 1.016 (3H, t, J = 7.4 Hz), 0.932 
(3H, d, J = 6.6 Hz), 0.686 (3H, s). 
(24R,25S)-Dichloromethano-26-homoergost-5-en-3β-ol (67). Compound 67 was obtained from 63 as 
described above in the general method for the deprotection of the i-methyl ethers. 1H NMR (600 MHz): 
5.353 (1H, m), 3.525 (1H, m), 1.174 (3H, s), 1.172 (3H, s), 1.010 (3H, s), 1.030 (3H, t, J = 7.4 Hz), 0.941 
(3H, d, J = 6.6 Hz), 0.682 (3H, s).  
(24S,25S)-Dichloromethano-26-homoergost-5-en-3β-ol (68). Compound 68 was obtained from 64 as 
described above in the general method for the deprotection of the i-methyl ethers. 1H NMR (600 MHz): 
5.353 (1H, m), 3.524 (1H, m), 1.205 (3H, s), 1.194 (3H, s), 1.010 (3H, s), 0.972 (3H, t, J = 7.4 Hz), 
0.933 (3H, d, J = 6.6 Hz), 0.686 (3H, s). 
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(24R,25R)-Dichloromethano-26-homoergost-5-en-3β-ol (69). Compound 69 was obtained from 65 as 
described above in the general method for the deprotection of the i-methyl ethers. 1H NMR (600 MHz): 
5.353 (1H, m), 3.524 (1H, m), 1.202 (3H, s), 1.193 (3H, s), 1.010 (3H, s), 0.973 (3H, t, J = 7.4 Hz), 0.941 
(3H, d, J = 6.6 Hz), 0.681 (3H, s). 
(24S)-Dichloromethano-26,27-dihomoergost-5-en-3β-ol (87). Compound 87 was obtained from 85 as 
described above in the general method for the deprotection of the i-methyl ethers. 1H NMR (600 MHz): 
5.354 (1H, m), 3.519 (1H, m), 1.193 (3H, s), 1.010 (3H, s), 0.970 (3H, t, J = 7.4 Hz), 0.932 (3H, d, J = 6.6 
Hz), 0.910 (3H, t, J = 7.4 Hz), 0.685 (3H, s). 
(24R)-Dichloromethano-26,27-dihomoergost-5-en-3β-ol (88). Compound 88 was obtained from 86 as 
described above in the general method for the deprotection of the i-methyl ethers. 1H NMR (600 MHz): 
5.353 (1H, m), 3.524 (1H, m), 1.194 (3H, s), 1.010 (3H, s), 0.983 (3H, t, J = 7.4 Hz), 0.941 (3H, d, J = 6.6 
Hz), 0.906 (3H, t, J = 7.4 Hz), 0.682 (3H, s). 
23-[(1R,2S)-(1,2-Diethyl-2-methylcyclopropyl]-24-norchol-5-en-3β-ol (46). Compound 46 was 
obtained from 43 as described above in the general method for the reduction of the 
dichlorocyclopropanes. 1H NMR (800 MHz): 5.353 (1H, m), 3.523 (1H, m), 1.060 (3H, s), 1.010 (3H, s), 
0.914 (3H, d, J = 6.6 Hz), 0.914 (3H, t, J = 7.4 Hz), 0.872 (3H, t, J = 7.4 Hz), 0.680 (3H, s), 0.047 (1H, d, 
J = 4.0 Hz), -0.004 (1H, t, J = 4.0 Hz). 
23-[(1S,2R)-(1,2-Diethyl-2-methylcyclopropyl]-24-norchol-5-en-3β-ol (47). Compound 47 was 
obtained from 44 as described above in the general method for the reduction of the 
dichlorocyclopropanes. 1H NMR (800 MHz): 5.353 (1H, m), 3.523 (1H, m), 1.057 (3H, s), 1.011 (3H, s), 
0.921 (3H, t, J = 7.4 Hz), 0.912 (3H, d, J = 6.6 Hz), 0.881 (3H, t, J = 7.4 Hz), 0.679 (3H, s), 0.020 (1H, d, 
J = 4.0 Hz), -0.012 (1H, d, J = 4.0 Hz). 
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23-[(1S,2S)-(1,2-Diethyl-2-methylcyclopropyl]-24-norchol-5-en-3β-ol (48). Compound 48 was 
obtained from 45 as described above in the general method for the reduction of the 
dichlorocyclopropanes. 1H NMR (800 MHz): 5.353 (1H, m), 3.523 (1H, m), 1.069 (3H, s), 1.011  
(3H, s), 0.922 (3H, t, J = 6.6 Hz), 0.893 (3H, t, J = 7.4 Hz), 0.886 (3H, t, J = 7.4 Hz), 0.679 (3H, s), 0.050 
(1H, d, J = 4.0 Hz), -0.021 (1H, d, J = 4.0 Hz). 
23-[(1R,2S)-(2-Ethyl-1,2-dimethylcyclopropyl)]-24-norchol-5-en-3β-ol (1). Compound 1 was obtained 
from 66 as described above in the general method for the reduction of the dichlorocyclopropanes. 1H 
NMR (800 MHz):  5.354 (1H, m), 3.523 (1H, m), 1.029 (3H, s), 1.029 (3H, s), 1.011 (3H, s), 0.919 (3H, t, 
J = 7.4 Hz), 0.905 (3H, d, J = 6.6 Hz), 0.680 (3H, s), 0.075 (1H, d, J = 4.0 Hz), - 0.014 (1H, d, J = 4.0 
Hz). 
23-[(1S,2R)-(2-Ethyl-1,2-dimethylcyclopropyl)]-24-norchol-5-en-3β-ol (70). Compound 70 was 
obtained from 67 as described above in the general method for the reduction of the 
dichlorocyclopropanes. 1H NMR (800 MHz): 5.354 (1H, m), 3.524 (1H, m), 1.033 (3H, s), 1.030 (3H, 
s), 1.011 (3H, s), 0.927 (3H, t, J = 7.4 Hz), 0.903 (3H, d, J = 6.6 Hz), 0.677 (3H, s), 0.055 (1H, d, J = 4.0 
Hz), - 0.017 (3H, t, J = 4.0 Hz) . 
23-[(1R,2R)-(2-Ethyl-1,2-dimethylcyclopropyl)]-24-norchol-5-en-3β-ol (71). Compound 71 was 
obtained from 68 as described above in the general method for the reduction of the 
dichlorocyclopropanes. 1H NMR (800 MHz): 5.353 (1H, m), 3.523 (1H, m), 1.053 (3H, s), 1.050  
(3H, s), 1.011 (3H, s), 0.910 (3H, d, J = 6.6 Hz), 0.906 (3H, t, J = 7.4 Hz), 0.683 (3H, s), 0.062 (2H, s). 
23-[(1S,2S)-(2-Ethyl-1,2-dimethylcyclopropyl)]-24-norchol-5-en-3β-ol (72). Compound 72 was 
obtained from 69 as described above in the general method for the reduction of the 
dichlorocyclopropanes. 1H NMR (800 MHz): 5.353 (1H, m), 3.524 (1H, m), 1.056 (3H, s), 1.049 (3H, s), 
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1.011 (3H, s), 0.911 (3H, d, J = 6.6 Hz), 0.909 (3H, t, J = 7.4 Hz), 0.679 (3H, s), 0.070 (1H, d, J = 3.9 
Hz), 0.051 (1H, d, J = 4.0 Hz). 
23-[(1R)-(2,2-Diethyl-1-methylcyclopropyl)]-24-norchol-5-en-3β-ol (89). Compound 89 was obtained 
from 87 as described above in the general method for the reduction of the dichlorocyclopropanes. 1H 
NMR (800 MHz): 5.353 (1H, m), 3.523 (1H, m), 1.061 (3H, s), 1.011 (3H, s), 0.906 (3H, d, J = 6.6 Hz), 
0.883 (3H, t, J = 7.4 Hz), 0.864 (3H, d, J = 7.4 Hz), 0.681 (3H, s), 0.049 (1H, d, J = 4.0 Hz), -0.007 (1H, 
d, J = 4.0 Hz).  
23-[(1S)-(2,2-Diethyl-1-methylcyclopropyl)]-24-norchol-5-en-3β-ol ol (2). Compound 2 was obtained 
from 88 as described above in the general method for the reduction of the dichlorocyclopropanes. 1H 
NMR (800 MHz): 5.353 (1H, m), 3.523 (1H, m), 1.061 (3H, s), 1.010 (3H, s), 0.905 (3H, d, J = 6.6 
Hz), 0.889 (3H, t, J = 7.4 Hz), 0.864 (3H, t, J = 7.4 Hz), 0.677 (1H, s), 0.036 (1H, d, J = 4.0 Hz), -0.006 
(1H, d, J = 4.0 Hz).      
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CHAPTER 7 
 
Modifications of the Kirk-Petrow Reaction: Use of a Sealed Reaction Vessel 
and an Odorless Thiol 
 
Abstract 
 
Improvements of the Kirk-Petrow reaction were made. The use of a sealed reaction vessel 
reduced the reaction time by at least a day with methanol as the solvent. The use of 1-dodecanethiol 
instead of thiophenol, the mercaptan normally used in the reaction, gave a relatively odorless reaction that 
proceeded in good yield and with equivalent reactivity to the typical Kirk-Petrow reaction product. 
Cholest-1-en-3-one was used as a substrate for the Kirk-Petrow reaction to probe its mechanism. These 
modifications of the Kirk-Petrow reaction make it a more appealing method for the selective alkylation of 
∆4-3-oxo-steroids. Cholest-1-en-3-one was used as a substrate for the Kirk-Petrow reaction to probe its 
mechanism. 
 
7.1 Introduction 
 
The primary sterols in most dinoflagellates are 4-methyl sterols, and they are present in other 
organisms as biosynthetic intermediates of normal 4-desmethyl sterols.1-3 The Kirk-Petrow reaction, a 
specific 4-thiomethylation of 3-oxo-∆4-steroids, followed by subsequent desulfurization offers a facile 
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and effective route to 4α-methyl sterols (Figure 7.1).4-5,7 Other reported methods to monomethylate at C-4 
of 3-oxo-∆4-steroids have been  described as awkward in practice and unselective.4,6 The Kirk-Petrow 
reaction is an easy and useful method; however, the traditionally used mercaptan in the reaction, 
thiophenol, makes the workup and purification process of the crude product extremely unpleasant due to 
the foul odor of unreacted excess thiophenol. The desulfurization of the phenylthiomethyl products also 
produces an unpleasant odor from the regenerated thiophenol as a side product of the dissolving metal 
reduction (Li/NH3). The reaction is also relatively slow as it requires days to reach completion when not 
done in triethanolamine as a polar basic catalyst and solvent.3 The addition of HCO2K with n-PrOH as a 
solvent was also found to reduce the reaction time to a day.8 A modified version of the Kirk-Petrow 
reaction using a relatively odorless mercaptan, 1-dodecanethiol, is reported. The use of a sealed pressure 
vessel was found to reduce the reaction time by at least one day with methanol as a solvent. The Kirk-
Petrov reaction was also carried out with cholest-1-en-3-one9 to probe the reaction mechanism. 
 
7.2 Results and Discussion 
 
To see if the Kirk-Petrow reaction could be improved, a series of solvents that included MeOH, 
EtOH and n-PrOH and THF were tested under reflux conditions with stigmast-22,4-dien-3-one as the 
starting 3-oxo-∆4-steroid (Table 7.1). The reactions were worked up after 19 h to make sure they could be 
compared before reaching completion. THF was found to be the least efficient solvent with only 27% of 
desired product observed compared to starting material. MeOH and EtOH worked similarly well and were 
found to be outperform n-PrOH. That result was a bit surprising since n-PrOH was expected to be the 
better solvent for this reaction because of its higher boiling point (97 oC), compared to 65 and 78 oC for 
MeOH and EtOH, respectively.  
 
 
 
132 
 
O
Kirk-Petrow
O
SPh
O
R R R
O
R
HO
R
Li/NH3
Li/NH
3
Ra
ney
 Ni/
Ace
ton
e
 
Figure 7.1. Possible 4-methyl sterols from the Kirk-Petrow reaction after desulfurization. 
 
 
Table 7.1. Product (P) and starting material (SM) ratios of the Kirk-Petrow reaction in different solvents 
at reflux after 19 h. 
 MeOH EtOH n-PrOH THF % SM 27 27 47 73 
% P 73 73 53 27 
      
 
Another experiment was conducted to study the effect of cutting the amounts of thiol, TEA and 
formalin (37% formaldehyde in water) on the yield of Kirk-Petrow reaction.  Since all reagents were in 
large excess in the general method, it made sense to determine if the excess reagents were necessary. A 
summary of the results is presented in Table 7.2. Using only 25 percent (3.4 eq.) of formalin did affect the 
reaction as only 18% of desired product observed after 19 h compared to 53% of product in the control 
reaction which contained 13.7 eq. of formalin. Reducing the amounts of TEA or thiophenol by 75% had 
relatively no effect on the reaction yield. Reducing the amounts of base and thiol by 75% simultaneously 
did not work as well. No significant difference in the amount of desired product was observed when the 
amount of the TEA was reduced to 25% (2.5 eq.).  This observation made sense as TEA is only used as 
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catalytic base in the Kirk-Petrow reaction.3 However, reducing the TEA to 6.25 % led to a significantly 
worse reaction with only 11% of desired product after 19 h.  
 
Table 7.2. Product (P) and starting material (SM) ratios of the Kirk-Petrow reaction with less thiol, 
formaldehyde and TEA. a) The control was set up in n-PrOH with 0.073 mmol of the starting enone, 1.00 
mmol of formalin, 0.72 mmol of TEA and 1.47 mmol of thiophenol for 19 h at reflux. 
  Controla 25% Thiol 
25% 
CH2O 
25% 
TEA 
12.5% 
TEA 
12.5% 
Thiol 
25%                   
(Thiol and TEA) 
% SM 47 46 82 45 89 86 65 
        
% P 53 54 18 55 11 14 35 
        
 
 
The Kirk-Petrow reaction was also set up with a series of substituted-phenylthiols, and 1-
dodecanethiol to investigate their reactivities (Scheme 7.1). The reactions were done at reflux overnight 
and the crude products were analyzed by NMR (Table 7.3). The reaction with thiophenol gave the best 
results after 19 h with 51% product and 49% starting material.  4-Methylthiophenyl and 4-
methoxyphiophenol also worked relatively well with 48% and 46% of product, respectively. 1-
Dodecanethiol only gave 30% of product under identical reaction conditions. The lowest product yields, 
18% and 7%, were observed in reactions with 4-nitrothiophenol and 4-(trifluoromethyl)thiophenol, 
respectively. It is worth noting that those two thiols are substituted with electron withdrawing groups, 
however, it is unclear how that property affected their reactivities as the thiol with the 4-nitro substituent, 
the stronger electron withdrawing group, outperformed the one with 4-trifluoromethyl substituent.  
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Scheme 7.1. Kirk-Petrow reaction with different thiols. 
 
Table 7.3. Product (P) and starting material (SM) ratios of the Kirk-Petrow reaction with different thiols 
at reflux after 19 h. 
Mercaptan % SM % Product 
PhSH 49 51 
p-Me-PhSH 52 48 
p-MeO-PhSH 54 46 
C12H25SH 70 30 
p-NO2-PhSH 82 18 
p-CF3-PhSH 93 7 
   
 
It was thought that evaporation of formaldehyde might adversely affect the Kirk-Petrow reaction. 
An attempt of the reaction in a sealed reaction pressure vessel showed an increased rate of product 
formation from about 53 to 90 % after 19 h with n-PrOH as the solvent. Product yields also increased to 
at least 90 % with MeOH and EtOH after 19 h at 120 oC. Reducing the large excess of formaldehyde 
negatively affected the rate of product formation (Table 7.2). Based on those observations, our standard 
method of the Kirk-Petrow reaction now used MeOH as solvent and the reaction was done in a sealed 
vessel with 10.0 eq. of thiol or mercaptan, 10.0 eq. 37% aqueous formaldehyde and 2.0 eq. TEA 120 oC 
for 36 h. 
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The Kirk-Petrow reaction has been used mainly to selectively phenylthiomethylate 3-oxo-∆4-
steroids at C4.3-6 Cholest-1-en-3-one was used as a substrate to help understand the mechanism of the 
reaction. The reaction was not as selective with that substrate, however, it produced predominantly 
compound 8 in a 71% yield by NMR. After 1H and 13C NMR characterization, the desulfurization and 
reduction of compound 8 using Li in liquid NH37c gave compound 1110,12 and 1210-12 to confirm its 
structure. COSY, HSQC and HMBC analyses were also used to characterize compound 8. The 1H signal 
at δ 6.680 (1H, s), assigned as the C1 hydrogen, had HMBC correlations with C2 (δ 132.3), C3 (δ 198.4), 
C5 (δ 44.2), C9 (δ 50.1) C19 (δ 12.8) and C28 (δ 33.3).  The structures of compounds 9 and 10 were 
deduced from the products obtained from their dissolving metal reduction (Li/NH3), compounds 13 and 
1412, respectively. Integration of phenyl hydrogens between δ 7.450 and δ 7.241 in the 1H NMR of 
compound 9 also suggested the presence of two phenylthiomethyl moieties in the molecule. The major 
product (8) from this reaction confirmed that the Kirk-Petrow reaction goes through a Baylis-Hillman 
type mechanism.13 Compound 10 is likely the normal enolization product.  
 
O
TEA, CH2O,PhSH        
MeOH
O
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7 8
O
PhS
9
O
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O
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13
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Li/NH3
(major)
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Scheme 7.2. The Kirk-Petrow reaction of compound 7 followed by a Li/NH3 reduction of its products. 
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A relatively odorless thiol, 1-dodecanethiol, was used in the Kirk-Petrow reaction as a substitute 
for thiophenol with cholest-4-en-3-one and stigmast-4,22-dien-3-one (Scheme 7.2). This thiol has been 
used previously in synthesis as a substitute for other foul-smelling thiols14. The reaction was done using 
the method described above for 92 h. A longer reaction time was required and expected, since 1-
dodecanethiol reacted slower than thiophenol in that reaction (Table 7.3). An extra step not listed in 
Scheme 6.4 was required to isolate the desired product from the unreacted thiol and its side products by 
chromatography. Treating the crude product with 5% TFA converted the thiol impurities to less polar 
substances that could easily be separated from the desired product by flash chromatography. Compounds 
4 and 15 were successfully made in a 74% yield using that method (Scheme 7.3). Both products were 
odorless and their treatment with Li/N3 produced their corresponding 4α-methyl products 1612 and 177 in 
yields comparable to the normal thiophenol Kirk-Petrow reaction products. 
 
O
TEA, CH2O,C12H25SH        
MeOH Li/NH3
O
SC12H25
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Scheme 7.3. Modified Kirk-Petrow reaction with 1-dodecanethiol followed by a Li/NH3 reduction of the 
product. 
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7.3 Summary 
 
The Kirk-Petrow reaction is a useful method to convert 3-oxo-∆4-steroids to 4-methyl steroids. 
However, dealing with thiophenol, a foul-smelling mercaptan, makes the process a bit unappealing. The 
use of an odorless mercaptan, 1-dodecanethiol, instead of thiophenol provided odorless alkylthiomethyl 
steroids with comparable reactivities as the phenylthiomethyl products. The reaction time was also 
reduced by performing the reaction in a sealed vessel at 120 oC. The Kirk-Petrow reaction with chlolest-
1-en-3-one gave the 2-phenylthiomethyl product in 71% yield. Unlike with the 3-oxo-∆4-steroids, two 
other minor side products were observed. However, the major product of the Kirk-Petrow reaction with 
the chlolest-1-en-3-one confirmed that the reaction goes through a Baylis-Hillman type mechanism.   
 
7.4 Experimental 
 
General Procedures. NMR spectra were obtained in CDCl3 on a Bruker 600 MHz spectrometer (1H at 
600 MHz and 13C at 151 MHz). Preparative thin layer chromatography (TLC) purifications were done 
with Sorbent Technologies (SORBTECH) silica gel HL thin TLC plates (20 x 20 cm2, 250 µm thick with 
glass backed support). All solvents were from commercial sources. 
Method for the normal Kirk-Petrow reaction in different solvents. To solutions of stigmast-4-dien-3-one 
(30.1 mg, 0.070 mmol) of 1 mL of solvent (EtOH, MeOH, n-PrOH and THF) in stretched glass 10-mL 
culture tubes was added 350 µL of a mixture of TEA (500 µL), 37% aqueous formaldehyde (500 µL) and 
thiophenol (750 µL). The tubes were flamed sealed and heated at 120 oC for 19 h. Each reaction was 
allowed to cool to room temperature before extraction with 9:1 hexanes/EtOAc. The combined organic 
layers for each reaction were washed with sodium bicarbonate and brine, dried over Na2SO4 and 
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concentrated under reduced pressure. A sample of each crude product was analyzed by 1H NMR (Table 
1). 
Method for the Kirk-Petrow reaction in n-PrOH with different mercaptans. To stretched tubes containing 
0.44 mmol of a mercaptan was added a 580 µL of a solution of cholest-4-en-3-one (210.1 mg, 0.540 
mmol), TEA (280 µL, 2.00 mmol), 37% aqueous formaldehyde (280 µL, 2.80 mmol) in 3.5 mL of n-
PrOH. The tubes were flamed sealed and heated at 120 oC for 19 h. Each reaction was allowed to cool to 
room temperature before extraction with 9:1 hexanes/EtOAc. The combined organic layers for each 
reaction were washed with sodium bicarbonate and brine, dried over Na2SO4 and concentrated under 
reduced pressure. A sample of each crude product was analyzed by 1H NMR (Table 2). 
4-Phenylthiomethyl-cholest-4-en-3-one (1). 1H NMR (600 MHz): 3.874 (2H, s), 2.696 (1H, dt, J = 3.3, 
14.7 Hz), 2.400 (1H, d, J = 4.5Hz), 2.384 (1H, d, J = 4.5Hz), 1.152 (3H, s), 0.906 (3H, d, J = 6.6 Hz), 
0.868 (3H, d, J = 6.6 Hz), 0.864 (3H, d, J = 6.6 Hz), 0.697. 
4-(p-Methyl-phenylthiomethyl)-cholest-4-en-3-one (2). 1H NMR (600 MHz): 3.832 (1H, d, J = 11.9 
Hz), 3.809 (1H, d, J = 11.9 Hz), 2.657 (1H, dt, J = 3.0, 14.7 Hz), 2.383 (2H, m), 2.311 (3H, s), 1.140 (3H, 
s), 0.908 (3H, d, J = 6.6 Hz), 0.870 (3H, d, J = 6.6 Hz), 0.865 (3H, d, J = 6.6 Hz), 0.695 (3H, s). 13C NMR 
(151 MHz): 197.0, 167.9, 136.8, 132.1, 129.5, 128.5, 56.2, 55.9, 54.2, 42.4, 39.7, 39.5, 39.4, 36.1, 35.8, 
35.1, 34.8, 33.7, 31.9, 29.6, 28.21, 28.16, 28.0, 24.1, 23.8, 22.8, 22.5, 21.1, 21.0, 18.6, 17.8, 12.0. 
4-(p-Methoxy-phenylthiomethyl)-cholest-4-en-3-one (3). 1H NMR (600 MHz): 3.785 (1H, d, J = 12 
Hz), 3.735(1H, d, J = 12 Hz), 2.597 (1H, dt, J = 3.2, 14.7 Hz), 2.368 (2H, m), 1.130 (3H, s), 0.906 (3H, d, 
J = 6.6 Hz), 0.869 (3H, d, J = 6.6 Hz), 0.865 (3H, d, J = 6.6 Hz), 0.690 (3H. s). 
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4-(1-Dodecanylthiomethyl)-cholest-4-en-3-one (4). See detailed procedure below. 1H NMR (600 MHz): 
3.489 (1H, d, J = 12.2 Hz), 3.430 (1H, d, J = 12.2 Hz), 2.802 (1H, dt, J = 3.2, 14.7 Hz), 2.503 (1H, d, J = 
7.4 Hz), 2.490 (1H, d, J = 7.4 Hz), 1.179 (3H, s), 0.903 (3H, d, J = 6.6 Hz), 0.876 (3H, t, J = 7.0 Hz), 
0.863 (3H, d, J = 6.6 Hz), 0.858 (3H, d, J = 6.7 Hz), 0.706 (3H, s). 13C NMR (151 MHz): 197.4, 167.2, 
129.9, 56.1, 55.9, 54.2, 42.4, 39.7, 39.5, 39.3, 36.1, 35.7, 35.3, 34.9, 33.7, 32.9, 32.2, 21.9, 29.8, 29.7, 
29.63, 29.62, 29.6, 29.34, 29.3, 28.9, 28.23, 28.2, 28.0, 25.9, 24.1, 23.8, 22.8, 22.7, 22.5, 21.1, 18.6, 17.9, 
14.1, 12.0. 
 4-(p-Nitro-phenylthiomethyl)-cholest-4-en-3-one (5). 1H NMR (600 MHz): 4.050 (1H, d, J = 11.0 Hz), 
3.969 (2H, d, J = 11.0 Hz), 2.765 (1H, dt, J = 3.2, 14.6 Hz), 2.442 (2H, m), 1.207 (3H, s), 0.912 (3H, d, J 
= 6.5 Hz), 0.869 (3H, d, J = 6.6 Hz), 0.865 (3H, d, J = 6.6 Hz), 0.715 (3H, s). 
4-(p-Trifluoromethyl-phenylthiomethyl)-cholest-4-en-3-one (6). 1H NMR (600 MHz): 3.971 (1H, d, J 
= 11.2 Hz), 3.915 (1H, d, J = 11.2 Hz), 2.732 (1H, dt, J = 3.2, 14.7 Hz), 2.417 (2H, m), 1.177 (3H, s), 
0.909 (3H, d, J = 6.6 Hz), 0.868 (3H, d, J = 6.6 Hz), 0.864 (3H, d, J = 6.6 Hz), 0.705 (3H, s). 
General method for the Kirk-Petrow reaction in sealed pressure vials. To a solution of 3-oxo-∆4-steroid 
in MeOH in a pressure flask was added thiophenol (10.0 eq.), 37% aqueous formaldehyde (10.0 eq.) and 
TEA (2.0 eq.). The flask was capped, and the mixture was stirred at 120 oC (oil bath) for 36 h. The 
reaction was allowed to cool to rt before extraction with 9:1 hexanes/EtOAc. The combined organic 
layers were washed with sodium bicarbonate and brine, dried over Na2SO4 and concentrated under 
reduced pressure. The crude product was purified via silica gel chromatography with 19:1 hexanes/EtOAc 
(72-88 % yield).  
2-phenylthiomethyl-cholest-1-en-3-one (8). This compound was obtained as the major product (71% by 
NMR) from the method described above from cholest-1-en-3-one 7. 1H NMR (600 MHz): 6.680 (1H, s), 
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3.698 (1H, d, J = 13.7 Hz), 3.559 (1H, d, J = 13.7 Hz), 2.339 (1H, dd, J = 14.3, 17.7 Hz), 2.236 (1H, dd, J 
= 4.2, 17.7 Hz), 1.967 (1H, dt, J = 3.3, 12.7 Hz), 0.912 (3H, d, J = 6.6 Hz), 0.872 (3H, d, J = 6.6 Hz), 
0.868 (3H, d, J = 6.6 Hz), 0.848 (3H, s), 0.648 (3H, s). 13C NMR (151 MHz): 198.4, 155.6, 135.5, 132.3, 
131.9, 128.8, 126.9, 56.4, 56.2, 50.1, 44.2, 42.7, 41.0, 39.7, 39.5, 39.0, 36.1, 35.8, 35.5, 33.3, 31.3, 28.2, 
28.0, 27.3, 24.1, 23.8, 22.8, 22.5, 21.1, 18.7, 12.8, 12.1. 
2,4α-Diphenylthiomethyl-cholest-1-en-3-one (9). This compound was obtained as a minor product 
(10% by NMR) from the method described above from cholest-1-en-3-one 7. 1H NMR (600 MHz): 7.156 
(1H, m), 3.505 (1H, m), 3.360 (1H, dd, J = 5.6, 13.1 Hz), 3.192 (1H, dd, J = 3.2, 13.1 Hz), 2.711 (1H, dd, 
J = 4.3, 15.5 Hz), 1.219 (3H, s), 0.920 (3H, d, J = 6.5 Hz), 0.869 (3H, d, J = 6.6 Hz), 0.865 (3H, d, J = 6.6 
Hz), 0.694 (3H, s). 
4α-Phenylthiomethyl-cholest-1-en-3-one (10). This compound was obtained as a minor product (5% by 
NMR) from the method described above from cholest-1-en-3-one 7. 1H NMR (600 MHz): 7.168 (1H, m), 
6.713 (1H, s), 3.667 (1H, d, J = 14.0), 3.618 (1H, d, J = 14.0), 3.574 (1H, dd, J = 3.6, 12.5 Hz), 3.301 
(1H, dd, J = 4.3, 12.5 Hz), 0.910 (3H, d, J = 6.6 Hz), 0.874 (3H, d, J = 6.6 Hz), 0.869 (3H, d, J = 6.6 Hz), 
0.854 (3H, s), 0.643 (3H, s). 
4-(1-Dodecanylthiomethyl)-cholest-4-en-3-one (4). To a solution of cholest-4-en-3-one (10.1 g, 0.026 0 
mol) in 150 mL of MeOH in a glass pressure flask was added thiophenol (25 mL, 0.24 mol), 37% 
aqueous formaldehyde (25 mL, 0.25 mol) and TEA (6 mL, 0.043 mol). The flask was capped, and the 
mixture was stirred and heated at 120 oC for 92 h. The reaction was allowed to cool to room temperature 
before extraction with 9:1 hexanes/EtOAc. The combined organic layers were washed with sodium 
bicarbonate and brine, dried over Na2SO4 and concentrated under reduced pressure. The solid crude 
product (34.5 g) was dissolved 85 mL of 5% TFA in DCM and stirred at 45 oC for 18 h. The mixture was 
diluted with 100 mL of hexanes and the solvents were removed under reduced pressure. The crude 
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product was purified via silica gel chromatography to afford 11.7 g, 74% yield. The less polar impurities 
from the excess thiol were removed with hexanes. The desired product was eluded with 39:1 and 19:1 
hexanes/EtOAc.  
4-(1-Dodecanylthiomethyl)-stigmast-4,22-dien-3-one (15). This compound was obtained from the 
method described above from stigmast-4,22-dien-3-one. 1H NMR (600 MHz): 5.148 (1H, dd, J = 8.7, 
15.2 Hz), 5.027 (1H, dd, J = 8.7, 15.2 Hz), 3.493 (1H, d, J = 12.2 Hz), 3.435 (1H, d, J = 12.2 Hz), 2.807 
(1H, dt, J = 3.2, 14.6 Hz), 2.509 1H, d, J = 7.5 Hz), 2.496 (1H, d, J = 7.5 Hz), 1.186 (3H, s), 1.015 (3H, d, 
J = 6.6 Hz), 0.881 (3H, t, J = 7.0 Hz), 0.849 (3H, d, J = 6.5 Hz), 0.806 (3H, t, J = 7.3 Hz), 0.799 (3H, d, J 
= 6.6 Hz), 0.731 (3H, s). 13C NMR (151 MHz): 197.4, 167.2, 138.1, 129.9, 129.5, 56.0, 55.9, 54.3, 51.2, 
42.3, 40.4, 39.6, 39.3, 35.3, 34.9, 33.7, 32.9, 32.2, 31.9, 31.85, 29.8, 29.7, 29.6, 29.56, 29.3, 29.27, 29.0, 
28.9, 28.2, 25.9, 25.4, 24.2, 22.7, 21.1, 21.05, 19.0, 17.9, 14.1, 14.2, 12.2, 12.16. 
General method for dissolving metal reduction of the Kirk-Petrow reaction products. To a solution of Li 
(approximatively 60 mg, 8.8 mmol) of in 15 mL of NH3 was added the 4-alkylthiomethyl-∆4-3-oxo 
steroid (about 15 mg, 0.02 mmol) of in 2 mL of Et2O. The mixture was stirred for 30 min before adding 
400 µL of MeOH dropwise. After 45 min, additional Li (35 mg, 5.1 mmol) was added to the reaction. 
After 1 h, NH3 (5 mL) was added and the reaction was left to stir overnight. The residue obtained after the 
NH3 slowly evaporated overnight was extracted with 4:1 hexanes/EtOAc and 10% hydrochloric acid. The 
combined organic layers were washed with sodium bicarbonate and brine, dried over Na2SO4 and 
concentrated under reduced pressure. The final product was purified via silica gel chromatography with 
19:1-9:1 hexanes/EtOAc.  
2α-Methylcholestan-3-one (11). This compound was isolated as the major product of the dissolving 
metal reduction of the crude Kirk-Petrow reaction of cholest-1-en-3-one 10 as described above. 1H NMR 
(600 MHz): 2.454 (1H, m), 2.310 (1H, t, J = 14.0 Hz), 1.056 (3H, s), 1.001 (3H, d, J = 6.6 Hz), 0.905 
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(3H, d, J = 6.6 Hz), 0.866 (3H, d, J = 6.6 Hz), 0.861 (3H, d, J = 6.6 Hz), 0.676 (3H, s). 13C NMR (151 
MHz): 213.2, 56.29, 56.27, 53.9, 48.6, 48.1, 44.8, 42.6, 41.2, 39.9, 39.5, 36.5, 36.2, 35.8, 35.2, 31.8, 28.8, 
28.2, 28.0, 24.2, 23.8, 22.8, 22.6, 21.5, 18.7, 14.6, 12.4, 12.1. 
2α-Methylcholestan-3β-ol (12). This compound was isolated as a minor product of the dissolving metal 
reduction of the crude Kirk-Petrow reaction of cholest-1-en-3-one 10 as described above. 1H NMR (600 
MHz): 3.132 (1H, m), 0.974 (3H, d, J = 6.4 Hz), 0.899 (3H, d, J = 6.6 Hz), 0.865 (3H, d, J = 6.6 Hz), 
0.860 (3H, d, J = 6.6 Hz), 0.817 (3H, s), 0.647 (3H, s). 
2α,4α-Dimethylcholestan-3β-ol (13). This compound was isolated as a minor product of the dissolving 
metal reduction of the crude Kirk-Petrow reaction of cholest-1-en-3-one 10 as described above. 1H NMR 
(600 MHz): 2.632 (1H, t, J = 9.9 Hz), 0.982 (3H, d, J = 6.5 Hz), 0.952 (3H, d, J = 6.5 Hz), 0.898 (3H, d, J 
= 6.6 Hz), 0.864 (3H, d, J = 6.6 Hz), 0.861 (3H, d, J = 6.6 Hz), 0.834 (3H, s), 0.646 (3H, s). 
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CHAPTER 8 
 
Light Activated Phenyl Disulfide Oxidation of Allylic Alcohols via Thiyl 
Radicals 
 
Abstract 
 
A new method for the oxidation of allylic alcohols developed. A solution of phenyl disulfide in 
hexanes/EtOAc was found to oxidize allylic alcohols to their corresponding ketones and aldehydes under 
visible light. This new oxidation method was found to be selective and works very well for 3-hydroxy-∆4-
sterols. A few non-steroidal allylic and benzylic alcohols were also oxidized with the reaction in CDCl3 as 
a solvent. This is the first report of the involvement of thiyl radicals in the oxidation of allylic alcohols. 
 
8.1 Introduction 
 
 
Numerous methods for the selective oxidation of allylic and benzylic alcohols to their respective 
α,β-unsaturated ketones and aldehydes have been reported.1-12 Those reactions often use metal based 
reagents that are either toxic, expensive or environmentally-unfriendly. Herein is described a new method 
that converts secondary allylic 3-hydroxy-∆4-sterols into their respective conjugated enones in good yield 
using phenyl disulfide (Ph2S2) and visible light from 90 W tungsten lamp. This reaction was discovered 
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when the 3-oxo-∆4-steroid (2)13 was mysteriously recovered as the only product from the hexanes/EtOAc 
extraction of the dissolving metal desulfurization of the phenylthiomethyl 3-hydroxy-∆4-sterol 1 (Scheme 
8.1).  The crude extract containing compound 3 had been left uncapped under light over a weekend and 
compound 2 was obtained after removing the solvent under reduced pressured. Thiophenol and phenyl 
disulfide, two potential byproducts of the desulfurization reaction, were suspected to be involved in the 
observed oxidation reaction. Since the S-S bonds in disulfides are much easier to cleave photochemically 
than the S-H bonds of thiols,14 phenyl disulfide was used in a test and found to be the reagent responsible 
for the visible light activated allylic alcohol oxidation. The intermediates produced from the visible light-
activated cleavage of the diphenyl sulfide are thiyl radicals, which have been well studied and extensively 
used in organic chemistry. 14 However, their application in the oxidation of allylic alcohols has not been 
reported. This reaction was tested with different substrates and solvents to evaluate its potential as a 
viable general method for the selective oxidation of other allylic and benzylic alcohols. 
 
1) Li/NH3
OHO
SPh
2) light1 2
 
Scheme 8.1. Desulfurization and oxidation of compound 1. 
 
8.2 Results and Discussion 
 
Stigmast-4,22-dien-3-β-ol (8), a steroidal allylic alcohol easily obtained from the commercially 
available ketone, was used as the substrate to test the reaction. Since the observed oxidation reaction 
occurred in a hexanes/EtOAc mixture, 9:1 hexanes/EtOAc reaction was used as the standard solvent. A 
mixture of hexanes/EtOAc has also been previously reported as one of the more efficient solvents for the 
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light activated reaction of 1-pentene, p-toluenethiol and oxygen to afford the corresponding β-
hydroperoxy sulfide in good yield.15 As a test, a sample of a solution of compound 8 and Ph2S2 in 9:1 
hexanes/EtOAc was left in a capped scintillation vial overnight under visible light while another sample 
of that same solution was left in another capped scintillation vial in dark. Compound 9 and some starting 
material were only observed in the scintillation vial that was left under the light and the vial that was left 
in the dark only contained starting material. The observation of product 9 only in the solution exposed to 
light confirmed that light is required for the oxidation to take place and that thiyl radicals were generated 
in situ during the reaction. Molecular oxygen maybe involved as an initiator in the formation of the thiyl 
radicals since this reaction is normally set up in the presence of air, which contains molecular oxygen. 
However, the oxidation product was still observed when the reaction was set up under a N2 atmosphere. A 
proposed reaction mechanism is displayed in Scheme 8.2. This mechanism involves the formation of a 
resonance stabilized radical that leads to the enone and two molecules of thiophenol as a side product. 
Two possible paths to the enone from the original allylic radical are illustrated. The relatively stronger 
smell of thiophenol in the crude products confirmed its generation in the reaction. Another potential 
mechanism involving the addition of the thiyl radical to C-4 is described in Scheme 8.3. Thiyl radicals are 
known to quickly add to unsaturated systems via a reversible process.14 A phenylthiyl radical is 
regenerated to leave a dienol intermediate that ultimately tautomerizes to the desired conjugated enone. 
Two molecules of thiophenol are also produced according to this mechanism.  
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Scheme 8.2. Proposed mechanism for the allylic alcohol oxidation via a resonance stabilized radical when 
exposed to visible light. 
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Scheme 8.3. Proposed mechanism for the allylic alcohol oxidation involving a reversible thiyl radical 
addition. 
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A few solvents were tested with compound 8 to determine potential solvent effects (Table 8.1). 
Each reaction was set up with 5 eq. of Ph2S2 side-by-side in the standard reaction solvent 9:1 
hexanes/EtOAc for 4 h. The use of less disulfide required a longer irradiation time and led to the 
formation of some side products. Out of the five tested solvents, hexanes and ethyl acetate gave the best 
results. No starting material was observed in any of the reactions, however, a dehydration product was 
present in all of them (Scheme 8.4). DCM and CDCl3 gave the lowest yields by NMR and many 
unidentifiable side products.  
 
Table 8.1. Product yields of oxidation reaction of compound 8 in a series of solvent. 
 
Entry   Solvent   Yield (%) 
1   Benzene   55 
2 
 
DCM 
 
11 
3 
 
CDCl3 
 
16 
4 
 
Hexanes 
 
92 
5 
 
EtOAc 
 
87 
6   9:1 (Hexanes/EtOAc)   95 
 
 
Thiophenol and di-tert-dodecyl disulfide were tested as potential thiyl radical sources in the 
oxidation reaction of compound 8 (Table 8.2). Since thiophenol, a foul-smelling thiol, is generated as a 
side product of this reaction with Ph2S2, di-tert-dodecyl disulfide was considered as an alternative source 
of thiyl radicals to keep the reaction odorless. Unfortunately, no reaction was observed with that disulfide. 
Since only starting material was observed, it is possible that the thiyl radicals were not generated under 
the reaction conditions or they self-quenched immediately to due instability. A 55% yield was observed 
with thiophenol compared to 95% yield with Ph2S2. The result with thiophenol was quite surprising as 
thiols normally require light less than 300 nm to generate thiyl radicals without an initiator.14 Since the 
oxidation reactions were done under air, molecular oxygen was likely the initiator involved in the 
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formation of the thiyl radicals in the reaction with thiophenol. Molecular oxygen has been reported as an 
initiator and co-initiator in many radical polymerization reactions.16 Molecular oxygen is also known to 
react with thiyl radicals form thiylperoxyl radicals (RSOO.) in a reversible process, a side reaction that 
may slow down the desired allylic oxidation. 
 
Table 8.2. Oxidation reaction tests with different thiyl radical sources. 
 
Entry   
Thiyl Radical 
Source   Yield (%) 
1   PhSH   55 
2 
 
Ph2S2 
 
95 
3   (tert-Dodecyl)2S2   0 
 
 
This light activated oxidation method with phenyl disulfide was also found to be chemoselective 
as the oxidation was only observed with allylic systems; no reaction was observed with cholesterol and 
cholestanol. A series of steroidal substrates containing allylic alcohol were used to investigate the 
application of the reaction as viable oxidation method (Table 8.3). The reaction clearly worked better for 
entries 1, 2 and 4 to give their corresponding enones. It appears that the stereochemistry at the C-3 in the 
3-hydroxy-∆4-sterols influenced the yield of the oxidation reaction. A dehydration reaction that accounted 
for about a third of the product mixture was observed for compound 7 of the third entry and sigmast-4,22-
dien-3-α-ol. A potential mechanism describing the dehydration reaction is described in Scheme 8.4. The 
3-axial OH, which is sterically more available, is abstracted by the thiyl radical to form phenylsulfenic 
acid17 and leave behind the stable allylic radical that ultimately leads to the diene18.  The same reactivity 
trend was observed for compounds 1019 and 1220 to give the ∆1-enone 1121. 
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Scheme 8.4. Proposed mechanism of the observed dehydration products. 
 
The reaction did not work as well with all steroidal substrates. The nuclear homoallylic alcohols 
of compounds 13 and 15 were not oxidized as expected; however, the side chain allylic alcohols only 
produced a 1:1 mixture of the E/Z aldehydes in approximately 20%. Some dehydration products of the 
side chain hydroxyl were also observed in the crude reaction product.  Compound 16, a cyclic secondary 
allylic alcohol with an i-methyl nucleus, was oxidized very poorly via this method. About 1% of the 
desired product 17 was observed by 1H NMR analysis of the crude reaction product. Overall, the reaction 
was extremely messy as the i-methyl nucleus was sensitive to the reaction conditions. To identify the 
desired product, compound 16 was oxidized with PCC and MnO2. Both oxidants gave a mixture of 
products that included compound 17, the unconjugated enone 18 (∆20-16-keto-i-methyl ether) a 
dehydration product 19 (∆16,20-i-methyl ether) (Scheme 8.5).  
 
OH
16 O
O
17 O
O
18 O 19 O
[O]
 
Scheme 8.5. Oxidation of compound 16 with PCC and MnO2. 
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Table 8.3. Oxidation reaction of steroidal allylic alcohols. 
Entry   Substrate    Product   Yield (%) 
1 
 
 
  
 
 
99 
       
       
    
 
  2 
     
97 
  
 
    
       
       3 
   
 
 
65 
       
       
    
 
  4 
 
 
   
95 
       
       
       5 
     
60 
       
       
       6 
     
12 
       
       
      
20 
7 
     
(1:1 E/Z) 
       
       
      
17 
8 
     
(1:1 E/Z) 
       
       
       9 
     
>1 
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Table 8.4. Oxidation of non-steroidal substrates in CDCl3 in sealed NMR tubes. 
Entry         Substrate  
Reaction 
time (h) Product Yield (%) 
 
 
 
 
  
 
 1 
  
22 3 
     
     2 
 
 
4 8 
     
 
 
  
 
 
 
  3 
  
24 
  
9 
            (2:1 E/Z) 
 
 
The oxidation reaction was also attempted with some non-steroidal allylic and benzylic alcohols 
(Table 8.4). The reactions were done in CDCl3 in flame sealed NMR tubes to assure a fairly accurate 
measurement of the yields by 1H NMR. The standard solvent mixture, 9:1 hexanes/EtOAc, could not be 
used with those reactions because of the volatility of the starting materials and potential products and 
because of the NMR analyses. Overall, this oxidation method did not work well with those substrates as 
the observed yields based on product and starting material ratios were under 10 percent. The formation of 
the desired product for those compounds was much slower as mainly starting material was observed for 
all the reactions after 4 h. The poor yields could be associated with the solvent used in the reactions, 
CDCl3, which was a relatively poor solvent in the oxidation of compound 8 (Table 8.1). Repeating those 
reactions on a larger scale and in the standard solvent should offer a better idea of the efficiency or 
limitation of that oxidation method. A signal observed at δ 3.444 in the crude products confirmed the 
production of thiophenol during the reactions as described in the proposed mechanisms. The formation of 
compound 19 during the oxidation of  compound 18 was verified by the presence of the methyl ketone 
signal at δ 2.609 (3H, s) in the 1H NMR of the crude reaction.22 Some side products and compound 2123 
were observed in the oxidation of compound 20 after 4 h. Compound 23, a 2:1 mixture of citral/neral , 
OH
18
O
19
OH
20
O
21
22
OH
23
O
H
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and a 2:1 mixture of compound 22/nerol were observed  from the oxidation of compound 22 after 24 h.24  
The presence of nerol and neral in the oxidation products is evidence of thiyl radical isomerization of the 
starting material, compound 22. 
 
 
8.3 Conclusions 
 
A new and selective method of oxidation of allylic and benzylic alcohols with phenyl disulfide 
under visible light was described. Based on the tested substrates, this reaction appeared to be limited as a 
good method for the oxidation of 3-hydroxy-∆4-sterols. 3β-Hydroxy-∆4-sterols were converted to their 
corresponding enones in near quantitative yield. Lower yields were obtained with 3α-hydroxy-∆4-sterols 
as a competing dehydration reaction was observed.  
 
This reaction provides an extraction free method for high molecular weight starting materials as 
the products can easily be isolated via flash chromatography after the evaporation of the solvent. This 
method also provides the first account of the use of thiyl radicals in the selective oxidation of allylic 
alcohols. The thiyl radicals involved in the reaction are generated from the irradiation of phenyl disulfide 
with visible light from a 90W tungsten lamp without a photocatalyst. A recent study reported the use of 
phenyl disulfide with visible light as a source of thiyl radicals in an anti-Markovnivov hydration of 
olefins, however a photocatalyst was used.25 It is unclear if molecular oxygen is involved in the 
generation of the thiyl radical in this reaction. The desired reaction product was observed when the 
reaction was set up under a nitrogen atmosphere. If molecular oxygen is important, it is more likely 
involved in the reaction in its triplet state, in which it can reversibly add to thiyl radicals to generate 
thiylperoxyl radicals. Singlet oxygen, which normally requires a sensitizer to be generated,26 is unlikely to 
be involved as an initiator in this oxidation reaction. 
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8.4 Experimental 
 
General Procedures. NMR spectra were obtained in CDCl3 on a Bruker 600 MHz spectrometer (1H at 
600 MHz and 13C at 151 MHz). A 90 W tungsten lamp was used as the source of light for the reactions. 
The lamp was placed 12 cm away at a 45-degree angle above the reaction vessels. Preparative thin layer 
chromatography (TLC) purifications were done with Sorbent Technologies (SORBTECH) silica gel HL 
thin TLC plates (20 x 20 cm2, 250 µm thick with glass backed support). All solvents were from 
commercial sources. 
4-Phenylthiomethyl-cholest-4-en-3β-ol (1). To a solution NaBH4 (250.1 mg, 6.60 mmol) in 10.0 mL of 
MeOH at -78 oC (dry-ice acetone bath) was added 4-phenylthiomethyl-cholest-4-en-3-one (1.01 g, 2.0 
mmol) in 10.0 mL of MeOH. The mixture was left to react overnight. The reaction was extracted with 
10% aqueous HCl and 2:1 hexanes/EtOAc. The combined organic layers were washed with sodium 
bicarbonate and brine, dried over Na2SO4 and concentrated under reduced pressure. The crude product 
was purified via silica gel chromatography with 19:1-4:1 hexanes/EtOAc to afford compound 1 (761.6 
mg, 75% yield). 1H NMR (600 MHz): 7.372 (2H, m), 7.270 (2H, t, J = 7.5 Hz), 7.183 (1H, m), 4.277 (1H, 
dd, J = 6.8, 13.4 Hz), 3.811 (1H, d, J = 11.7 Hz), 3.772 (1H, d, J = 11.7 Hz), 2.464 (1H, dt, J = 3.3, 14.1 
Hz), 1.040 (3H, s), 0.901 (3H, d, J = 6.6 Hz), 0.870 (3H, d, J = 6.6 Hz), 0.865 (3H, d, J = 6.6 Hz), 0.666 
(3H, s). 13C NMR (151 MHz): 147.3, 136.9, 130.3, 128.8, 126.2, 125.7, 69.1, 56.2, 56.1, 53.7, 53.7, 42.5, 
39.9, 39.5, 38.6, 36.1, 35.8, 35.5, 33.7, 33.2, 32.8, 29.0, 28.2, 28.0, 26.3, 24.1, 23.9, 22.8, 22.5, 21.3, 20.1, 
18.6, 12.0. 
General method for the light-activated Ph2S2 oxidation of the steroidal allylic alcohols. A solution the 
steroidal allylic alcohol (2-5 mg) and Ph2S2 (5.0 eq.) in 1.5 mL of 9:1 hexanes/EtOAc was irradiated with 
90W tungsten lamp for 4 h. The reaction was evaporated under a flow of air without heat and the crude 
 
 
 
155 
 
product was analyzed by 1H NMR. For the reactions in different solvents, 1.5 mL of each of the tested 
solvents were used instead of 1 .5 mL of the standard 9:1 hexanes/EtOAc.  
Cholest-1-en-3β-ol (10) and cholest-1-en-3α-ol (12). To a solution of compound 11 (5.2 mg, 0.014 
mmol) in 3.0 mL of Et2O was added 8.5 mg of LAH. The mixture was stirred at rt for 1 h before 
extraction with 10% hydrochloric acid and 2:1 hexanes/EtOAc. The combined organic layers were 
washed with brine, dried over Na2SO4 and filtered through a small pad of silica gel. The crude product of 
10:1 of 10/12 was isolated as a white solid after removing the solvent mixture under a flow of N2 and 
separated by preparative TLC with 4:1 hexanes/EtOAc to provide the compounds 12 (0. 5 mg) (less polar 
product) and 10 (4.4 mg). Cholest-1-en-3β-ol (10). 1H NMR (600 MHz): 5.196 (1H, dd, J = 1.6, 10.2 Hz), 
5.482 (1H, m), 4.302 (1H, m), 0.905 (3H, s), 0.902 (3H, d, J = 6.6 Hz), 0.865 (3H, d, J = 6.6 Hz), 0.860 
(3H, d, J = 6.6 Hz), 0.663 (3H, s). Cholest-1-en-3α-ol (12). 1H NMR (600 MHz): 6.078 (1H, d, J = 10.0 
Hz), 5.644 (1H, ddd, J = 1.2, 4.4, 10.0 Hz), 4.091 (1H, br s), 0.9(3H, d, J = 6.6 Hz), 0.867 (3H, d, J = 6.6 
Hz), 0.862 (3H, d, J = 6.6 Hz), 0.798 (3H, s), 0.669 (3H, s). 
(24E)-Ergost-5,24-dien-3β,26-diol (13). This compound was obtained from the deprotection of its 
corresponding i-methyl sterol (see Chapter 6, compound 51b). 1H NMR (600 MHz): 5.352 (3H, m), 4.117 
(2H, br s), 3.524 (1H, m), 1.747 (3H, m), 1.715 (3H, m), 1.010, 0.975 (3H, d, J = 6.5 Hz), 0.687 (3H, s). 
(24Z)-Ergost-5,24-dien-3β,26-diol (15). This compound was obtained from the deprotection of its 
corresponding i-methyl sterol (see Chapter 6 compound 51a). 1H NMR (600 MHz): 5.352 (3H, m), 4.107 
(2H, s), 3.524 (1H, m), 1.739 (3H, s), 1.669 (3H, s), 1.010 (3H, s), 0.965 (3H, d, J = 6.5 Hz), 0.680 (3H, 
s). 
(24ξ)-Ergost-5,24-dien-3β-OH-26-al (14). Compound 11 was observed as a 1:1 mixture from the light-
activated Ph2S2 oxidation of compounds 10 and 12 in 17% and 20% yields by NMR, respectively. The 
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products were not isolated from the crude reaction product. 1H NMR (600 MHz): 10.135 (1H, s) and 
10.103 (1H, s). 
Compounds 17, 18 and 19. Those compounds were obtained as a mixture from the PCC and MnO2 
oxidations of compound 16. For the PCC reaction, 5.2 mg of PCC was added to a solution 16 (2.1 mg, 6.1 
µmol) in 1.5 mL of DCM. The reaction was stirred for 1 h. Hexanes (3 mL) was added to the mixture 
before filtering it through silica gel. The product mixture was eluted with 4:1 hexanes/EtOAc. For MnO2 
oxidation, 8.3 mg of MnO2 were added to a solution of 13 (2.5 mg, 7.3 µmol) in 1.5 mL of DCM. The 
mixture was stirred for 16 h before filtering it through silica gel. The product mixture was eluted with 4:1 
hexanes/EtOAc. The crude products for both reactions were purified via preparative TLC with 19:1 
hexanes/EtOAc. Compound 19 was isolated pure while 17and 18 were not separable by that method.  
Compound 16: 1H NMR (600 MHz): 4.635 (1H, d, J = 5.1 Hz), 3.343 (3H, s), 2.807 (1H, t, J = 2.8 Hz), 
1.819 (3H, s), 1.759 (3H, s), 1.039 (3H, s), 0.903 (3H, s), 0.665 (1H, m), 0.452 (1H, dd, J = 5.1, 8.0 Hz). 
Compound 17: 1H NMR (600 MHz): 3.343 (3H, s), 2.806 (1H, t, J = 2.8 Hz), 2.184 (3H, s), 1.903 (3H, 
s), 1.074 (3H, s), 1.059 (3H, s), 0.680 (1H, m), 0.472 (1H, dd, J = 5.1, 8.0 Hz).  
Compound 18: 1H NMR (600 MHz): 5.076 (1H, m), 4.724 (1H, m), 3.347 (3H, s), 2.812 (1H, t, J = 2.8 
Hz), 2.546 (1H, s), 1.772 (3H, br s), 1.068 (3H, s), 0.827 (3H, s), 0.695 (1H, m), 0.487 (1H, dd, J = 5.1, 
8.1 Hz). 
Compound 19: 1H NMR (600 MHz): 5.727 (1H, m), 5.067 (1H, m), 4.859 (1H, m), 3.355 (3H, s), 2.805 
(1H, t, J = 2.8 Hz), 1.878 (3H, s), 1.063 (3H, s), 1.000 (3H, s), 0.671 (1H, m), 0.454 (1H, dd, J = 5.1, 8.1 
Hz). 
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General method for the light-activated Ph2S2 oxidation of the non-steroidal alcohols. A solution the 
steroidal allylic alcohol (2-5 mg) and Ph2S2 (5.0 eq.) in 500 µL of CDCl3 in a flame sealed NMR tube was 
irradiated with a 90W tungsten lamp for 4-24 h. The reaction was monitored over time by 1H NMR. 
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Conclusions 
 
The primary goal of this research was to synthesize unusual marine sterols and analogs for 
biological studies of their effects on ecologically important invertebrates like copepods. Unusual marine 
sterols are hypothesized to be present in some marine organisms as chemical defense against predation by 
invertebrates as they may interfere with the invertebrate phytosterol dealkylation pathway.1 Marine 
invertebrates are unable to biosynthesize sterols and depend on their diet as a source of cholesterol, an 
essential component for somatic and reproductive growth.2,3 Pfiesterol and the simple analogs of 
petrosterol were synthesized to study their effects on phytosterol metabolism and the life history of some 
marine invertebrates. Two synthetic 24-ethylpavlovols and 4-methylcholestane-3β,4β-diol were 
synthesized to generate samples to study their effects on bay scallop larvae. Natural pavlovols, unusual 
marine 3β,4β-dihydroxy-4-methylsterols, are reported to cause early metamorphosis and early settlement 
induction in northern bay scallop (Argopecten irradians irradians) larvae.4 The 24-epimer of two unusual 
bioactive marine sponge sterols were synthesized to verify the stereochemistry of the natural sterols and 
obtain samples for bioactivity studies. The natural marine sponge sterols, theonellasterol and conicasterol, 
and some of their natural analogs are natural ligands of the human nuclear receptors pregnane X receptor 
(PXR) and farnesoid X receptor (FXR).5 Two unusual 24,25-cyclopropyl sterols from a tropical jewel 
orchid were also synthesized and identified through a series of chemical correlations ultimately resting on 
(24R)-24-ethyl-24-methylcholestanol6, the structure of which rests on crystallography. Two methods for 
sterol synthesis were also developed, a modification of the Kirk-Petrow reaction and a novel method to 
selectively oxidize allylic alcohols via visible light activated thiyl radicals. 
 
The synthesis of 24-epiconicasterol was completed from ergosterol in a 10-step sequence and a 
13% overall yield. The 1H and 13C NMR data for 24-epiconiscasterol were used to confirm the reported 
stereochemistry at C24 (24R) for the natural product conicasterol7. Substantial differences were observed 
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between the side chain 1H and 13C NMR signals of conicasterol and 24-epiconicaterol. To confirm the 
stereochemistry reported for theonellasterol7, correlations of the ∆δ values between C29 and other side 
chain 1H NMR signals of 24-epitheonellasterol and theonellasterol, and 24S and 24R 24-ethylcholesterols 
were used. Samples for biological studies were also obtained at the end of the synthesis. Bioactivity of the 
synthetic epimers would be of great significance as they could be an alternative source of ligands with 
pharmaceutical interests for the nuclear receptors PXR and FXR. 
 
Pfiesterol, a potential biomarker of the toxic dinoflagellate Pfiesteria piscicida, was successfully 
synthesized from 16-dehydroprenolone acetate. Two different methods were used to generate the 4α-
methyl nucleus from the ∆4-enone intermediate 18b (Chapter 3). The structure of the synthesized 
pfiesterol was confirmed by 1H NMR comparison with the natural product and a sample previously 
prepared in our lab.8 The side chain of pfiesterol is unstable when stored in the freezer in CDCl3 and the 
decomposition product was identified as 4-methylandrosterone,8 an androgenic steroid hormone that may 
negatively affect reproduction in invertebrates.9 A sample of pfiesterol stored in the freezer in benzene for 
over 2.5 years was found unchanged by 1H NMR analysis. Pfiesterol was synthesized via a reductive 
methylation using 13CH3I to introduce a 13C label to facilitate a positive identification of the 
decomposition product in biological experiments in invertebrates. Introducing the label late in the 
synthesis provided an economic method to make the labeled product, but the reductive methylation was a 
challenge becasue the intermediate enolate was extremely sensitive to moisture.  
 
The synthesis of the 4-methylcholestane-3β,4β-diol, a pavlovol, was accomplished from 
cholestenone in seven steps with a 38% overall yield. Its structure was confirmed by comparison of its 1H 
and 13C NMR data to that of the natural pavlovols 24S-methylpavlovol and 24S-ethylpavlovol.10 Another 
seven-step sequence was used to make 4-methylcholestane-3β,4β-diol from 4-methylenechlestanol. The 
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second sequence was less effective as only an 8% yield overall yield was observed. Two new synthetic 
pavlovols, (24R)-4-methylstigmastane-3β,4β-diol and (24R)-4-methylstigmast-22-en-3β,4β-diol, were 
made from stigmasta-5,22-dien-3-one using the first method. All three pavlovols were made available for 
studies of their biological effects on bivalve growth and development. Natural pavlovols behave as 
analogs of ecdysone, a natural invertebrate hormone that is also involved in life-history transitions in 
bivalve molluscs.4 
 
Two simple analogs of petrosterol, (24R)-24-cyclopropyl-24-methylchol-5-en-3β-ol and (24S)-
24-cyclopropyl-24-methylchol-5-en-3β-ol, were successfully synthesized as a mixture from the i-methyl 
22-iodide in six steps with a 43% overall yield. Since the purpose of the sequence was to synthesize those 
compounds as potential inhibitors of invertebrate sterol metabolism, producing them as a mixture was not 
an issue. The possible enzymatic products of the simple analogs of petrosterol, 24-cyclopropyl-24-
methylenechol-5-en-3β-ol and (24R)-epoxy-24-cyclopropyl-24-homochol-5-en-3β-ol and (24S)-24,25-
epoxy-24-cyclopropyl-24-homochol-5-en-3β-ol, were also synthesized in good yield. Feeding 
experiments confirmed the inhibitory effects of these simple analogs of petrosterol and of the possible 
dehydrogenation product on invertebrate phytosterol metabolism. 
 
Two unusual cyclopropyl sterols from the tropical jewel orchid were synthesized and identified as 
23-[(1R,2S)-(2-ethyl-1,2-dimethylcyclopropyl)]-24-norchol-5-en-3β-ol and  23-[(1S)-(2,2-diethyl-1-
methylcyclopropyl)]-24-norchol-5-en-3β-ol. Both unusual phytosterols and all their possible isomers 
were synthesized and characterized by 800 MHz 1H NMR as only minute amounts of the natural sterols 
were isolated. Access to an 800 MHz NMR was instrumental to the process of discovering and ultimately 
characterizing those sterols. To the best of our knowledge, this is the first report of the isolation and 
characterization of sterols with a side chain cyclopropane in higher plants. The presence of those unusual 
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sterols in the aerial parts of those plants could be as chemical defense against herbivorous insects. Those 
complex sterols may impede the dealkylation process used by insects to convert phytosterols to 
cholesterol, an essential component for growth and reproduction.2,3 Feeding experiments with those 
sterols are necessary to verify this hypothesis. 
 
The Kirk-Petrow reaction, a selective method to convert 3-oxo-∆4-steroids to 4-methyl 
steroids11,12, was modified to significantly shorten the reaction time by using a sealed glass pressure 
vessel. This modification helped by eliminating the loss of formaldehyde during the reaction which 
negatively affects the rate of product formation. To eliminate the inconvenience of working with 
thiophenol, a foul smelling mercaptan typically used in the Kirk-Petrow reaction, 1-dodecanethiol was 
used to obtain odorless alkylthiomethyl steroids with comparable reactivities as the phenylthiomethyl 
products. To probe the mechanism of the Kirk-Petrow reaction, chlolest-1-en-3-one was used to obtain 
the 2-phenylthiomethyl product as the major product. Unlike with the 3-oxo-∆4-steroids, two other minor 
side products were observed. The major product of the Kirk-Petrow reaction with the chlolest-1-en-3-one 
confirmed that the reaction went through a Baylis-Hillman type mechanism.   
 
 A new and selective method of oxidation of allylic alcohols with phenyl disulfide under visible 
light was discovered and explored. Based on the tested substrates, this reaction appeared to be limited to  
the oxidation of 3-hydroxy-∆4-sterols, which were converted to their corresponding enones in near 
quantitative yield. Lower yields (around 60%) were obtained with 3α-hydroxy-∆4-sterols where a 
competing dehydration reaction was observed. This reaction provides useful free method for high 
molecular weight starting materials as the products can easily be isolated via flash chromatography after 
the evaporation of the solvent. This method also features the first account of the use of thiyl radicals in the 
selective oxidation of allylic alcohols. The thiyl radicals involved in the reaction are generated from the 
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irradiation of phenyl disulfide with visible light from a 90W tungsten lamp without a photocatalyst. A 
recent study reported the use of phenyl disulfide with visible light as a source of thiyl radicals in an anti-
Markovnivov hydration of olefins, however a photocatalyst was necessary to generate the thiyl radicals.13 
If molecular oxygen is important, it is more likely involved in the reaction in its triplet state, in which it 
can reversibly add to thiyl radicals to generate thiylperoxyl radicals. Singlet oxygen, which normally 
requires a sensitizer to be generated,14 is unlikely to be involved as an initiator in this oxidation reaction. 
 
Future research should include the biological studies of all the synthesized sterols. Feeding 
experiments already confirmed the inhibition of phytosterol metabolism in invertebrates by the 
synthesized simple analogs of petrosterol (not yet published). More tropical orchids can be investigated as 
potential source of unusual sterols with a highly substituted side chain cyclopropane. Biological studies of 
those sterols should also help determine their functions in the orchids. Like in marine species, unusual 
sterols may also be used by plants as chemical defense against herbivorous insects. The visible-light 
activated thiyl radical oxidation of allylic alcohol needs to be investigated further to determine any roles 
of molecular oxygen in the formation of the thiyl radicals from phenyl disulfide. The reactions with low 
molecular weight substrates should be repeated on a larger scale with the standard solvent (9:1 
hexanes/EtOAc) to determine if the reaction yields can be improved by changing the solvent. 
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17d
 
 
 
 
197 
 
HO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
H
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.650.700.750.800.850.900.95 ppm
4.85.0 ppm
4.0 ppm
4
 
 
 
198 
 
HO
151 MHz 13C NMR, 
 
CDCl3, 30 °C
H
2030405060708090100110120130140 ppm
4
 
 
 
199 
 
HO
H
600 MHz HSQC-DEPT, 
 
CDCl3, 30 °C
ppm
1.01.52.02.53.03.54.04.55.05.5 ppm
10
20
30
40
50
60
70
80
90
100
4
 
 
 
200 
 
HO
H
600 MHz HMBC, 
 
CDCl3, 30 °C
ppm
10
15
20
25
30
35
40
45
50
ppm
0.600.650.700.750.800.850.900.95 ppm
142
144
4
 
 
 
 
201 
 
 
HO
H
600 MHz COSY, 
 
CDCl3, 30 °C
ppm
1.01.52.02.53.03.54.04.55.05.5 ppm
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
4
 
 
 
202 
 
BnO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.650.700.750.800.850.900.951.00 ppm
4.44.54.64.7 ppm5.5 ppm
3.8 ppm
21a
 
 
 
203 
 
BnO
151 MHz 13C NMR, 
 
CDCl3, 30 °C
2030405060708090100110120130140 ppm
21a
 
 
 
204 
 
BnO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.900.951.001.05 ppm
4.44.54.64.7 ppm5.40 ppm
4.0 ppm
21b
 
 
 
205 
 
BnO
151 MHz 13C NMR, 
 
CDCl3, 30 °C
2030405060708090100110120130140 ppm
21b
 
 
 
206 
 
BnO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
OH
H
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.650.700.750.800.850.90 ppm
4.44.54.64.7 ppm
3.43.63.8 ppm 2.5 ppm
22
 
 
 
 
207 
 
 
BnO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
H
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.650.700.750.800.850.90 ppm
4.54.64.74.84.9 ppm
3.94.0 ppm
23
 
 
 
208 
 
BnO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
H
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.90 ppm
4.64.74.84.9 ppm
3.954.00 ppm
23b
 
 
 
209 
 
BnO
151 MHz 13C NMR, 
 
CDCl3, 30 °C
O
H
2030405060708090100110120130140150160170180190200210 ppm
23b
 
 
210 
 
BnO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
H
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.900.95 ppm
4.64.85.0 ppm
3.7 ppm
25 (Crude from 23�)
 
 
 
211 
 
BnO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
H
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.90 ppm
4.85.0 ppm
3.7 ppm
25 (Crude from 23b���)
 
 
 
212 
 
BnO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
H
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.90 ppm
4.85.0 ppm 3.653.70 ppm
25
 
 
 
213 
 
BnO
151 MHz 13C NMR, 
 
CDCl3, 30 °C
H
2030405060708090100110120130140150 ppm
25
 
 
 
214 
 
HO
600 MHz 1H NMR, 
 
CDCl3, 30 °C
H
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.90 ppm
4.64.74.84.95.05.1 ppm
3.954.004.05 ppm
26
 
 
 
215 
 
HO
O
600 MHz 1H NMR, 
 
CDCl3, 30 °C
5
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.6 ppm6.76.8 ppm 5.45.6 ppm
 
 
216 
 
HO
O
151 MHz 13C NMR, 
 
CDCl3, 30 °C
5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
217 
 
HO
O
600 MHz 1H NMR, 
 
CDCl3, 30 °C
6
OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.4 ppm5.45.6 ppm 3.6 ppm
 
 
218 
 
HO
O
151 MHz 13C NMR, 
 
CDCl3, 30 °C
6
OMe
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
219 
 
O
600 MHz 1H NMR, 
 
CDCl3, 30 °C
7 OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
6.686.706.72 ppm 2.782.802.82 ppm
 
 
220 
 
O
151 MHz 13C NMR, 
 
CDCl3, 30 °C
7 OMe
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
221 
 
O
600 MHz 1H NMR, 
 
CDCl3, 30 °C
8
OMe
OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.34.4 ppm 2.62.72.8 ppm
 
 
222 
 
O
151 MHz 13C NMR, 
 
CDCl3, 30 °C
8
OMe
OMe
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
223 
 
O
600 MHz 1H NMR, 
 
CDCl3, 30 °C
9 OMe
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.70 ppm 2.80 ppm
 
 
224 
 
O
151 MHz 13C NMR, 
 
CDCl3, 30 °C
9 OMe
O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
225 
 
O
600 MHz 1H NMR, 
 
CDCl3, 30 °C
11OMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.78 ppm 2.70 ppm
 
 
226 
 
O
151 MHz 13C NMR, 
 
CDCl3, 30 °C
11OMe
OH
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
227 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
12OMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.78 ppm4.955.00 ppm
 
 
228 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
12OMe
OH
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
229 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
13OMe
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.80 ppm4.004.05 ppm 1.82 ppm
 
 
230 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
14b
CO2Et
OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.80 ppm4.10 ppm 1.05 ppm
 
 
231 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
14b
CO2Et
OMe
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
232 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
15bOMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.9 ppm 3.6 ppm 2.8 ppm
1.021.041.06 ppm
 
 
233 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
15bOMe
OH
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
234 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
16bOMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.75 ppm 2.8 ppm
0.951.00 ppm
 
 
235 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
16bOMe
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
236 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
17b
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.75 ppm
0.900.951.001.05 ppm
 
 
237 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
17b
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
238 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
18b
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.75 ppm
0.951.001.05 ppm
5.75 ppm
 
 
239 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
18b
O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
240 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
19b
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.75 ppm
0.900.951.001.051.10 ppm
 
 
241 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
19b
O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
242 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
1
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.76 ppm
0.850.900.951.001.05 ppm
3.10 ppm
 
 
243 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
1
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
244 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
13
BnO
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.54.64.7 ppm
3.05 ppm
0.70.80.91.01.11.2 ppm
 
 
245 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
13
BnO
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
246 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
5
HO
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.3 ppm
0.70.80.91.01.11.2 ppm
 
 
247 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
5
HO
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
248 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
6
HO
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.3 ppm
0.700.750.800.850.900.951.001.05 ppm
 
 
249 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
6
HO
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
250 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
7
HO
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.3 ppm
0.700.750.800.850.900.951.001.05 ppm
5.05.15.2 ppm
 
 
251 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
7
HO
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
252 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
16
PhHNCO2 O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.90 ppm
5.0 ppm
 
 
253 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
16
PhHNCO2 O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
254 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
17b
HO
O
O
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.90 ppm
4.34.44.5 ppm
 
 
255 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
17b
HO
O
O
O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
256 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
18
EtOMO
O
O
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.650.700.750.800.850.900.95 ppm
4.44.64.8 ppm
3.63.7 ppm
3.33.4 ppm
 
 
257 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
18
EtOMO
O
O
O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
258 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
19
EtOMO
HO
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.650.700.750.800.850.900.95 ppm
4.74.8 ppm
3.53.63.7 ppm
 
 
259 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
19
EtOMO
HO
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
260 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
20
EtOMO
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.600.650.700.750.800.850.90 ppm
4.74.8 ppm
3.7 ppm
3.3 ppm
 
 
261 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
20
EtOMO
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
262 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
6 OMe
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.52.62.7 ppm
 
 
263 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
6 OMe
O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
264 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
7 OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.76 ppm4.60 ppm
 
 
265 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
7 OMe
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
266 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
11OMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.76 ppm3.603.65 ppm
 
 
267 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
11OMe
OH
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
268 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
12OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.76 ppm 0.6 0.4 0.2 ppm
 
 
269 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
12OMe
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
270 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
2a
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.6 0.4 0.2 ppm
0.80.91.0 ppm
 
 
271 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
2b
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.6 0.4 0.2 ppm
0.80.91.0 ppm
 
 
272 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
2
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
273 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
13
O
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.452.502.552.60 ppm
0.80.91.0 ppm
 
 
274 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
13
O
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
275 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
3
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.60 ppm
0.80.91.0 ppm
0.50.6 ppm
 
 
276 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
3
HO
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
 
 
277 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
4
HO
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
0.20.30.4 ppm
 
 
278 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
4
HO
O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
279 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
7 OMe
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.32.4 ppm2.80 ppm
 
 
280 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
7 OMe
O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
281 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
9aOMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.10 ppm 2.80 ppm
1.00 ppm
 
 
282 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
9aOMe
OH
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
283 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
9bOMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.10 ppm 2.80 ppm
1.00 ppm
 
 
284 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
9bOMe
OH
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
285 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
10OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
ppm
0.80.91.0 ppm
 
 
286 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
12a
HO
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
 
 
287 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
12b
HO
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
 
 
288 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
13
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
0.05 ppm
 
 
289 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
15
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
0.0 ppm
 
 
290 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
3
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.80 ppm
3.6 ppm
 
 
291 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
17
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.80 ppm
3.6 ppm
 
 
 
292 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
20a
Cl
Cl
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.70.80.91.01.11.2 ppm
3.53.6 ppm
 
 
293 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
20b
Cl
Cl
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.70.80.91.01.11.2 ppm
3.53.6 ppm
 
 
294 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
21
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.01.1 ppm
3.53.6 ppm 0.1 ppm
 
 
295 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
22
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.01.1 ppm
3.53.6 ppm 0.1 ppm
 
 
296 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
23
CH2D
HO
(Minor Product)
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
4.7 ppm 3.5 ppm
 
 
297 
 
201 MHz 13C NMR, 
 
CDCl3, 30 °C
23
CH2D
HO
(Minor Product)
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
26.827.027.227.4 ppm
 
 
298 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
24
CH2D
HO
(Minor Product)
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
4.7 ppm 3.5 ppm
 
 
299 
 
201 MHz 13C NMR, 
 
CDCl3, 30 °C
24
CH2D
HO
(Minor Product)
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
26.827.027.227.4 ppm
 
 
300 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
25aOMe
OH
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
 
 
301 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
25bOMe
OH
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
 
 
302 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
26aOMe
Cl
Cl
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
 
 
303 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
26bOMe
Cl
Cl
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
 
 
304 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
27 OMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm 0.2 ppm
 
 
305 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
28 OMe
O
H
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0 ppm
0.80.91.0 ppm
 
 
306 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
29 OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
ppm 5.00 ppm
 
 
307 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
30 OMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.8 ppm 0.1 ppm
 
 
308 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
31 OMe
OMs
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.3 ppm 0.2 ppm
 
 
309 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
32 OMe
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.8 ppm 0.0 ppm
 
 
310 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
33
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.55 ppm 0.05 ppm
0.90 ppm
DCM
 
 
311 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
34 OMe
O
Cl
Cl
H
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0 ppm
0.80.91.0 ppm
 
 
312 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
35 OMe
O
Cl
Cl
H
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0 ppm
0.80.91.0 ppm
 
 
313 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
36 OMe
Cl
Cl
O
H
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0 ppm
0.80.91.0 ppm
 
 
314 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
37 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
5.3 ppm6.0 ppm
 
 
315 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
38 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
5.3 ppm6.0 ppm
 
 
316 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
39 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
5.25 ppm6.0 ppm
 
 
317 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
40 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
2.80 ppm
 
 
318 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
41 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
2.80 ppm
 
 
319 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
42 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
2.80 ppm
 
 
320 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
43
Cl
Cl
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.5 ppm
 
 
321 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
44
Cl
Cl
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.5 ppm
 
 
322 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
45
Cl
Cl
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.5 ppm
 
 
323 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
46
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.5 ppm 0.0 ppm
 
 
324 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
47
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.5 ppm 0.00 ppm
DCM
 
 
325 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
48
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.5 ppm 0.00 ppm
Impurity
 
 
326 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
51aOMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
4.1 ppm 2.8 ppm
 
 
327 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
51bOMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
4.1 ppm 2.8 ppm
 
 
328 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
52a OMe
OH
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.8 ppm 2.8 ppm
 
 
329 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
52bOMe
OH
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.8 ppm 2.8 ppm
 
 
330 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
53aOMe
Cl
Cl
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.8 ppm 2.8 ppm
 
 
331 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
53bOMe
Cl
Cl
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.8 ppm 2.8 ppm
 
 
332 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
54 OMe
O
Cl
Cl
H
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
0.80.91.0 ppm
2.8 ppm
 
 
333 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
55 OMe
O
Cl
Cl
H
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
0.80.91.0 ppm
2.8 ppm
 
 
334 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
56 OMe
Cl
Cl H
O
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
0.80.91.0 ppm
2.8 ppm
 
 
335 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
57 OMe
Cl
Cl H
O
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
0.80.91.0 ppm
2.8 ppm
Impurity
 
 
336 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
58 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
2.8 ppm
6.0 ppm 5.3 ppm
 
 
337 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
59 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
2.8 ppm
6.0 ppm 5.3 ppm
 
 
338 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
60 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
2.8 ppm
6.0 ppm 5.25 ppm
 
 
339 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
61 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
2.8 ppm
6.0 ppm 5.25 ppm
 
 
340 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
62 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm 2.8 ppm
 
 
341 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
63 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.80 ppm0.750.800.850.900.951.001.05 ppm
 
 
342 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
64 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2.80 ppm0.750.800.850.900.951.001.05 ppm
 
 
343 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
1
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.55 ppm
0.700.750.800.850.900.951.00 ppm
0.0 ppm
 
 
344 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
70
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.55 ppm
0.700.750.800.850.900.951.00 ppm
0.0 ppm
 
 
345 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
71
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.55 ppm
0.700.750.800.850.900.951.00 ppm
0.060.08 ppm
 
 
346 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
72
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.55 ppm
0.700.750.800.850.900.951.00 ppm
0.06 ppm
 
 
347 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
74a OMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.104.15 ppm
0.750.800.850.900.951.001.05 ppm
2.762.78 ppm
 
 
348 
 
201 MHz 13C NMR, 
 
CDCl3, 30 °C
74a OMe
OH
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
349 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
74bOMe
OH
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.104.15 ppm
0.750.800.850.900.951.001.05 ppm
2.762.78 ppm
 
 
350 
 
201 MHz 13C NMR, 
 
CDCl3, 30 °C
74bOMe
OH
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
351 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
75a OMe
OH
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.9 ppm
0.750.800.850.900.951.001.05 ppm
2.762.78 ppm
 
 
352 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
75bOMe
OH
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.83.9 ppm
0.750.800.850.900.951.001.05 ppm
2.762.78 ppm
 
 
353 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
76a OMe
OH
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.83.9 ppm
0.750.800.850.900.951.00 ppm
2.762.78 ppm
Impurity
 
 
354 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
76bOMe
OH
Cl
Cl
Impurity
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.83.9 ppm
0.750.800.850.900.951.00 ppm
2.762.78 ppm
 
 
355 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
77 OMe
O
Cl
Cl
H
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
0.750.800.850.900.951.00 ppm
2.762.78 ppm
9.58 ppm
 
 
356 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
78 OMe
O
Cl
Cl
H
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
0.750.800.850.900.951.00 ppm
2.762.78 ppm
9.56 ppm
Impurity
 
 
357 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
79 OMe
Cl
Cl
H
O
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
0.750.800.850.900.951.00 ppm
2.78 ppm
9.60 ppm
Impurity
 
 
358 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
80 OMe
Cl
Cl
H
O
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
0.750.800.850.900.951.00 ppm
2.78 ppm
9.60 ppm
Impurity
 
 
359 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
81 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.750.800.850.900.951.00 ppm
2.78 ppm
5.8 ppm 5.35.4 ppm
Impurity
 
 
360 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
82 OMe
Cl
Cl
Impurity
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.750.800.850.900.951.00 ppm
2.78 ppm
5.8 ppm 5.35.4 ppm
 
 
361 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
83 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.750.800.850.900.951.00 ppm
2.78 ppm
5.80 ppm 5.25.3 ppm
Impurity
 
 
362 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
84 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.750.800.850.900.951.00 ppm
2.78 ppm
5.80 ppm 5.25.4 ppm
Impurity
 
 
363 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
85 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.750.800.850.900.951.00 ppm 2.78 ppm
 
 
364 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
86 OMe
Cl
Cl
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.750.800.850.900.951.00 ppm 2.78 ppm
 
 
365 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
87
Cl
Cl
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.900.951.00 ppm
3.453.503.55 ppm
 
 
366 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
88
Cl
Cl
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.900.951.00 ppm
3.453.503.55 ppm
 
 
367 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
89
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.900.951.00 ppm
3.453.503.55 ppm 0.05 0.00 ppm
 
 
368 
 
800 MHz 1H NMR, 
 
CDCl3, 30 °C
89
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.700.750.800.850.900.951.00 ppm
3.453.503.55 ppm 0.05 0.00 ppmMeOH
 
 
369 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
1
O
SPh
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.853.90 ppm
0.70.80.91.01.1 ppm
 
 
370 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
2
O
SPh-p-Me
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.85 ppm
0.70.80.91.01.1 ppm
 
 
371 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
2
O
SPh-p-Me
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
372 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
3
O
SPh-p-MeO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.75 ppm
0.70.80.91.01.1 ppm
Impurity
 
 
373 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
4
O
SC12H25
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.453.50 ppm
0.80.91.01.1 ppm
 
 
374 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
4
O
SC12H25
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
375 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
5
O
SPh-p-NO2
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.0 ppm
0.80.91.01.11.2 ppm
 
 
376 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
6
O
SPh-p-CF3
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
4.0 ppm
0.80.91.01.1 ppm
Impurity
 
 
377 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
8
O
SPh
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.63.7 ppm
0.700.750.800.850.90 ppm
 
 
378 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
8
O
SPh
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
379 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
9
O
SPh
SPh
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.01.11.2 ppm
7.2 ppm 3.33.4 ppm
 
 
380 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
10
O
SPh
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.70.80.9 ppm
7.15 ppm 3.65 ppm6.7 ppm
 
 
381 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
11
O
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
 
 
382 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
11
O
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
383 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
12
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.70.80.9 ppm
3.103.153.20 ppm
Impurity
 
 
384 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
13
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.70.80.9 ppm
2.65 ppm
 
 
385 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
1
HO
SPh
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.80.91.0 ppm
3.8 ppm
 
 
386 
 
151 MHz 13C NMR, 
 
CDCl3, 30 °C
1
HO
SPh
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
387 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
10
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.70.80.9 ppm
4.3 ppm5.65.8 ppm
 
 
388 
 
600 MHz 1H NMR, 
 
CDCl3, 30 °C
12
HO
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.70.80.9 ppm
4.1 ppm5.75.85.96.06.1 ppm
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